Index Sample Index Original Filename Sample Name Sample ID Sample Comment Sample Type Acquisition Date & Time Rack Number Plate Number Vial Number Dilution Factor Injection Volume Operator Name Acq. Method Name IS Component Name Component Index Component Comment IS Comment Mass Info IS Mass Info IS Name Component Group Name Conc. Units Failed Query IS Failed Query Peak Comment IS Peak Comment Actual Concentration IS Actual Concentration Concentration Ratio Expected RT IS Expected RT Integration Type IS Integration Type Area IS Area Corrected Area IS Corrected Area Area Ratio Height IS Height Corrected Height IS Corrected Height Height Ratio Area / Height IS Area / Height Corrected Area/Height IS Corrected Area/Height Region Height IS Region Height Quality IS Quality Retention Time IS Retention Time Start Time IS Start Time End Time IS End Time Total Width IS Total Width Width at 50% IS Width at 50% Signal / Noise IS Signal / Noise Baseline Delta / Height IS Baseline Delta / Height Modified Relative RT Used Calculated Concentration Accuracy SF Peak Width Confidence SF Model Source SF Candidate Model Quality SF Asymmetry SF Saturated SF Integration Quality SF Group Confidence SF Num Peaks Score_IMPAQT MSSimScore_IMPAQT HeightScore_IMPAQT RTminScore_IMPAQT RankScore_IMPAQT MSSim_IMPAQT MSSimSita_IMPAQT RTminDiff_IMPAQT RankSum_IMPAQT CosSimilarity_IMPAQT CosSimilaritySita_IMPAQT Height_IMPAQT InterfereTrans_IMPAQT InterfereTransAll_IMPAQT LScore_IMPAQT LRTminScore_IMPAQT LSNScore_IMPAQT LSNAllScore_IMPAQT HLSimScore_IMPAQT HLSim_IMPAQT HLSimSita_IMPAQT BaseLine_IMPAQT BaseLineUnitNum_IMPAQT BaseLineMaxCount_IMPAQT Symbol Description 1 1 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540613.[MT7]-LLSAEFLEQHYDR.3b6_1.heavy 588.973 / 805.458 54572.0 36.77519989013672 47 17 10 10 10 3.6579637786281665 21.82741830344382 0.0 3 0.9719547063502086 7.352112120409713 54572.0 93.74275180157534 0.0 - - - - - - - 680.0 109 12 CAB39 calcium binding protein 39 3 1 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540613.[MT7]-LLSAEFLEQHYDR.3y6_1.heavy 588.973 / 847.369 62120.0 36.77519989013672 47 17 10 10 10 3.6579637786281665 21.82741830344382 0.0 3 0.9719547063502086 7.352112120409713 62120.0 145.2173420479303 0.0 - - - - - - - 612.0 124 7 CAB39 calcium binding protein 39 5 1 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540613.[MT7]-LLSAEFLEQHYDR.3b4_1.heavy 588.973 / 529.347 30295.0 36.77519989013672 47 17 10 10 10 3.6579637786281665 21.82741830344382 0.0 3 0.9719547063502086 7.352112120409713 30295.0 86.8588671023965 0.0 - - - - - - - 233.14285714285714 60 7 CAB39 calcium binding protein 39 7 1 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540613.[MT7]-LLSAEFLEQHYDR.3y4_1.heavy 588.973 / 590.268 82419.0 36.77519989013672 47 17 10 10 10 3.6579637786281665 21.82741830344382 0.0 3 0.9719547063502086 7.352112120409713 82419.0 158.91245098039215 0.0 - - - - - - - 357.0 164 4 CAB39 calcium binding protein 39 9 2 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58214.[MT7]-QAHVER.2b3_1.heavy 442.247 / 481.264 758.0 12.658499717712402 45 15 10 10 10 2.5736137555155123 38.85586941151911 0.0 3 0.9553634382006211 5.8195334168710815 758.0 1.7172653676855356 0.0 - - - - - - - 0.0 1 0 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 11 2 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58214.[MT7]-QAHVER.2y4_1.heavy 442.247 / 540.289 1305.0 12.658499717712402 45 15 10 10 10 2.5736137555155123 38.85586941151911 0.0 3 0.9553634382006211 5.8195334168710815 1305.0 4.931972789115646 1.0 - - - - - - - 82.94736842105263 2 19 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 13 2 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58214.[MT7]-QAHVER.2y5_1.heavy 442.247 / 611.326 2988.0 12.658499717712402 45 15 10 10 10 2.5736137555155123 38.85586941151911 0.0 3 0.9553634382006211 5.8195334168710815 2988.0 23.03673469387755 0.0 - - - - - - - 91.04166666666667 5 24 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 15 2 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58214.[MT7]-QAHVER.2b4_1.heavy 442.247 / 580.332 589.0 12.658499717712402 45 15 10 10 10 2.5736137555155123 38.85586941151911 0.0 3 0.9553634382006211 5.8195334168710815 589.0 4.736931216931217 0.0 - - - - - - - 0.0 1 0 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 17 3 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539923.[MT7]-ESLDVYELDAK[MT7].3b6_1.heavy 523.947 / 851.427 23254.0 32.820098876953125 43 13 10 10 10 1.8139957549822305 55.12692062555547 0.0 3 0.9197430401687774 4.326858699428744 23254.0 45.428623588402615 0.0 - - - - - - - 291.22222222222223 46 9 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 19 3 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539923.[MT7]-ESLDVYELDAK[MT7].3b4_1.heavy 523.947 / 589.295 118451.0 32.820098876953125 43 13 10 10 10 1.8139957549822305 55.12692062555547 0.0 3 0.9197430401687774 4.326858699428744 118451.0 90.25196608424277 0.0 - - - - - - - 437.0 236 1 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 21 3 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539923.[MT7]-ESLDVYELDAK[MT7].3b5_1.heavy 523.947 / 688.363 96399.0 32.820098876953125 43 13 10 10 10 1.8139957549822305 55.12692062555547 0.0 3 0.9197430401687774 4.326858699428744 96399.0 67.22766585388138 0.0 - - - - - - - 364.0 192 3 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 23 3 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539923.[MT7]-ESLDVYELDAK[MT7].3y4_1.heavy 523.947 / 590.363 69542.0 32.820098876953125 43 13 10 10 10 1.8139957549822305 55.12692062555547 0.0 3 0.9197430401687774 4.326858699428744 69542.0 41.90375838341831 0.0 - - - - - - - 791.5 139 4 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 25 4 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58115.[MT7]-VMDIPYLNLEGPDLQPK[MT7].3y7_1.heavy 744.073 / 898.511 243.0 49.93159866333008 45 15 10 10 10 4.025627908356895 24.84084527345602 0.0 3 0.9550246685710506 5.797408219583861 243.0 10.14525 0.0 - - - - - - - 0.0 0 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 27 4 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58115.[MT7]-VMDIPYLNLEGPDLQPK[MT7].3b6_1.heavy 744.073 / 863.445 405.0 49.93159866333008 45 15 10 10 10 4.025627908356895 24.84084527345602 0.0 3 0.9550246685710506 5.797408219583861 405.0 7.6000000000000005 0.0 - - - - - - - 0.0 0 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 29 4 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58115.[MT7]-VMDIPYLNLEGPDLQPK[MT7].3b4_1.heavy 744.073 / 603.329 931.0 49.93159866333008 45 15 10 10 10 4.025627908356895 24.84084527345602 0.0 3 0.9550246685710506 5.797408219583861 931.0 8.435139271502909 0.0 - - - - - - - 0.0 1 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 31 4 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58115.[MT7]-VMDIPYLNLEGPDLQPK[MT7].3b5_1.heavy 744.073 / 700.382 243.0 49.93159866333008 45 15 10 10 10 4.025627908356895 24.84084527345602 0.0 3 0.9550246685710506 5.797408219583861 243.0 11.178 7.0 - - - - - - - 0.0 0 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 33 5 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541313.[MT7]-QHFPATPLLDYALEVEK[MT7].4y5_1.heavy 565.562 / 761.453 5531.0 42.17244815826416 37 10 10 7 10 0.7411606088901714 67.86871402379714 0.029399871826171875 3 0.8427272076496224 3.0702381298329353 5531.0 -0.41693373006782464 2.0 - - - - - - - 227.30769230769232 11 13 ACLY ATP citrate lyase 35 5 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541313.[MT7]-QHFPATPLLDYALEVEK[MT7].4y4_1.heavy 565.562 / 648.369 14205.0 42.17244815826416 37 10 10 7 10 0.7411606088901714 67.86871402379714 0.029399871826171875 3 0.8427272076496224 3.0702381298329353 14205.0 37.428157792585885 2.0 - - - - - - - 646.7142857142857 28 7 ACLY ATP citrate lyase 37 5 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541313.[MT7]-QHFPATPLLDYALEVEK[MT7].4y3_1.heavy 565.562 / 519.326 25769.0 42.17244815826416 37 10 10 7 10 0.7411606088901714 67.86871402379714 0.029399871826171875 3 0.8427272076496224 3.0702381298329353 25769.0 -0.4818650045941472 2.0 - - - - - - - 377.0 51 1 ACLY ATP citrate lyase 39 5 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541313.[MT7]-QHFPATPLLDYALEVEK[MT7].4b3_1.heavy 565.562 / 557.295 10622.0 42.17244815826416 37 10 10 7 10 0.7411606088901714 67.86871402379714 0.029399871826171875 3 0.8427272076496224 3.0702381298329353 10622.0 13.064876539054959 1.0 - - - - - - - 729.2 21 10 ACLY ATP citrate lyase 41 6 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538812.[MT7]-TYGEIFEK[MT7].3y3_1.heavy 425.567 / 567.326 43917.0 31.34160041809082 50 20 10 10 10 13.585542759268817 7.360765909170203 0.0 3 0.9981878379825965 28.98666503515129 43917.0 80.83748891555314 0.0 - - - - - - - 263.6666666666667 87 6 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 43 6 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538812.[MT7]-TYGEIFEK[MT7].3b4_1.heavy 425.567 / 595.284 61191.0 31.34160041809082 50 20 10 10 10 13.585542759268817 7.360765909170203 0.0 3 0.9981878379825965 28.98666503515129 61191.0 192.25879617799444 0.0 - - - - - - - 240.125 122 8 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 45 6 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538812.[MT7]-TYGEIFEK[MT7].3b5_1.heavy 425.567 / 708.369 15467.0 31.34160041809082 50 20 10 10 10 13.585542759268817 7.360765909170203 0.0 3 0.9981878379825965 28.98666503515129 15467.0 144.98983832075425 0.0 - - - - - - - 180.8 30 5 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 47 6 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538812.[MT7]-TYGEIFEK[MT7].3b3_1.heavy 425.567 / 466.242 14451.0 31.34160041809082 50 20 10 10 10 13.585542759268817 7.360765909170203 0.0 3 0.9981878379825965 28.98666503515129 14451.0 49.88532729253706 0.0 - - - - - - - 282.5 28 8 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 49 7 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47709.[MT7]-IAQWQSSIEDWEGEDLLVR.3y7_1.heavy 806.74 / 801.446 43481.0 44.93439865112305 46 16 10 10 10 5.343997324903297 18.712584217434944 0.0 3 0.9677954934270468 6.858538517017949 43481.0 36.24787979411689 0.0 - - - - - - - 1164.2857142857142 86 7 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 51 7 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47709.[MT7]-IAQWQSSIEDWEGEDLLVR.3y4_1.heavy 806.74 / 500.355 11021.0 44.93439865112305 46 16 10 10 10 5.343997324903297 18.712584217434944 0.0 3 0.9677954934270468 6.858538517017949 11021.0 5.78424803991447 1.0 - - - - - - - 648.7142857142857 22 7 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 53 7 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47709.[MT7]-IAQWQSSIEDWEGEDLLVR.3y8_1.heavy 806.74 / 930.489 21574.0 44.93439865112305 46 16 10 10 10 5.343997324903297 18.712584217434944 0.0 3 0.9677954934270468 6.858538517017949 21574.0 61.29692461231383 0.0 - - - - - - - 282.1111111111111 43 18 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 55 7 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47709.[MT7]-IAQWQSSIEDWEGEDLLVR.3y5_1.heavy 806.74 / 615.382 12223.0 44.93439865112305 46 16 10 10 10 5.343997324903297 18.712584217434944 0.0 3 0.9677954934270468 6.858538517017949 12223.0 25.30433916130183 0.0 - - - - - - - 712.3333333333334 24 9 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 57 8 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47707.[MT7]-IAQWQSSIEDWEGEDLLVR.2b3_1.heavy 1209.61 / 457.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 59 8 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47707.[MT7]-IAQWQSSIEDWEGEDLLVR.2y4_1.heavy 1209.61 / 500.355 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 61 8 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47707.[MT7]-IAQWQSSIEDWEGEDLLVR.2y5_1.heavy 1209.61 / 615.382 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 63 8 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47707.[MT7]-IAQWQSSIEDWEGEDLLVR.2y9_1.heavy 1209.61 / 1116.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 65 9 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58114.[MT7]-EC[CAM]LQALEFLHANQVIHR.4b4_1.heavy 556.296 / 675.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 67 9 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58114.[MT7]-EC[CAM]LQALEFLHANQVIHR.4b5_1.heavy 556.296 / 746.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 69 9 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58114.[MT7]-EC[CAM]LQALEFLHANQVIHR.4y7_1.heavy 556.296 / 837.469 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 71 9 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58114.[MT7]-EC[CAM]LQALEFLHANQVIHR.4b3_1.heavy 556.296 / 547.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 73 10 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57794.[MT7]-TQNPQC[CAM]PIFR.2y4_1.heavy 702.862 / 532.324 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 75 10 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57794.[MT7]-TQNPQC[CAM]PIFR.2y8_1.heavy 702.862 / 1031.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 77 10 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57794.[MT7]-TQNPQC[CAM]PIFR.2y9_1.heavy 702.862 / 1159.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 79 10 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57794.[MT7]-TQNPQC[CAM]PIFR.2y7_1.heavy 702.862 / 917.466 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 81 11 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59251.[MT7]-TC[CAM]EGC[CAM]K[MT7].2y5_1.heavy 521.749 / 797.34 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2;NR4A3 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2;nuclear receptor subfamily 4, group A, member 3 83 11 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59251.[MT7]-TC[CAM]EGC[CAM]K[MT7].2y3_1.heavy 521.749 / 508.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2;NR4A3 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2;nuclear receptor subfamily 4, group A, member 3 85 12 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539926.[MT7]-LEIIPASQFC[CAM]PR.3y6_1.heavy 525.621 / 794.361 58718.0 37.19219970703125 48 18 10 10 10 5.5380010042868255 18.057057036030248 0.0 3 0.989889769439427 12.263523238642827 58718.0 59.90462739375536 0.0 - - - - - - - 238.0 117 6 CXCL10 chemokine (C-X-C motif) ligand 10 87 12 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539926.[MT7]-LEIIPASQFC[CAM]PR.3b4_1.heavy 525.621 / 613.404 124879.0 37.19219970703125 48 18 10 10 10 5.5380010042868255 18.057057036030248 0.0 3 0.989889769439427 12.263523238642827 124879.0 89.72136199709044 0.0 - - - - - - - 408.0 249 1 CXCL10 chemokine (C-X-C motif) ligand 10 89 12 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539926.[MT7]-LEIIPASQFC[CAM]PR.3y4_1.heavy 525.621 / 579.271 85427.0 37.19219970703125 48 18 10 10 10 5.5380010042868255 18.057057036030248 0.0 3 0.989889769439427 12.263523238642827 85427.0 132.67217613590464 0.0 - - - - - - - 102.0 170 1 CXCL10 chemokine (C-X-C motif) ligand 10 91 12 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539926.[MT7]-LEIIPASQFC[CAM]PR.3b3_1.heavy 525.621 / 500.32 178908.0 37.19219970703125 48 18 10 10 10 5.5380010042868255 18.057057036030248 0.0 3 0.989889769439427 12.263523238642827 178908.0 88.7167238658268 0.0 - - - - - - - 815.6666666666666 357 3 CXCL10 chemokine (C-X-C motif) ligand 10 93 13 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538121.[MT7]-YIVISK[MT7].2b3_1.heavy 505.828 / 520.325 8903.0 29.793350219726562 46 20 10 6 10 9.983334421759276 10.01669339875503 0.0373992919921875 3 0.9960878020748402 19.724693874714973 8903.0 15.078067600005364 0.0 - - - - - - - 860.8571428571429 17 7 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 95 13 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538121.[MT7]-YIVISK[MT7].2y4_1.heavy 505.828 / 590.399 14189.0 29.793350219726562 46 20 10 6 10 9.983334421759276 10.01669339875503 0.0373992919921875 3 0.9960878020748402 19.724693874714973 14189.0 21.430643259856303 0.0 - - - - - - - 772.6666666666666 28 9 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 97 13 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538121.[MT7]-YIVISK[MT7].2y5_1.heavy 505.828 / 703.483 11685.0 29.793350219726562 46 20 10 6 10 9.983334421759276 10.01669339875503 0.0373992919921875 3 0.9960878020748402 19.724693874714973 11685.0 22.176304309716468 0.0 - - - - - - - 768.5714285714286 23 7 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 99 13 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538121.[MT7]-YIVISK[MT7].2b4_1.heavy 505.828 / 633.409 2226.0 29.793350219726562 46 20 10 6 10 9.983334421759276 10.01669339875503 0.0373992919921875 3 0.9960878020748402 19.724693874714973 2226.0 1.2000000000000002 3.0 - - - - - - - 765.125 19 8 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 101 14 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46985.[MT7]-LIMGIGHR.2b4_1.heavy 520.811 / 559.339 N/A 28.362300872802734 50 20 10 10 10 16.285282550233216 6.1405136626608865 0.0 2 0.9942625560625689 16.285281819979243 1055.0 0.6890691615978835 26.0 - - - - - - - 715.5714285714286 39 14 ACLY ATP citrate lyase 103 14 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46985.[MT7]-LIMGIGHR.2b6_1.heavy 520.811 / 729.445 N/A 28.362300872802734 50 20 10 10 10 16.285282550233216 6.1405136626608865 0.0 2 0.9942625560625689 16.285281819979243 1143.0 0.5195454545454544 14.0 - - - - - - - 268.63157894736844 66 19 ACLY ATP citrate lyase 105 14 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46985.[MT7]-LIMGIGHR.2y6_1.heavy 520.811 / 670.345 47563.0 28.362300872802734 50 20 10 10 10 16.285282550233216 6.1405136626608865 0.0 2 0.9942625560625689 16.285281819979243 47563.0 17.15998431372549 0.0 - - - - - - - 736.5238095238095 95 21 ACLY ATP citrate lyase 107 14 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46985.[MT7]-LIMGIGHR.2y7_1.heavy 520.811 / 783.429 65673.0 28.362300872802734 50 20 10 10 10 16.285282550233216 6.1405136626608865 0.0 2 0.9942625560625689 16.285281819979243 65673.0 187.60993270699308 0.0 - - - - - - - 259.1111111111111 131 18 ACLY ATP citrate lyase 109 15 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538609.[MT7]-LVVVGAGGVGK[MT7].3b4_1.heavy 415.271 / 555.399 50658.0 30.000499725341797 50 20 10 10 10 6.776455496333938 14.756977309760241 0.0 3 0.9940791747547549 16.030856756173534 50658.0 98.55199803202873 0.0 - - - - - - - 284.0 101 9 HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 111 15 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538609.[MT7]-LVVVGAGGVGK[MT7].3b5_1.heavy 415.271 / 612.42 111644.0 30.000499725341797 50 20 10 10 10 6.776455496333938 14.756977309760241 0.0 3 0.9940791747547549 16.030856756173534 111644.0 389.02189743639485 0.0 - - - - - - - 253.91666666666666 223 12 HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 113 15 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538609.[MT7]-LVVVGAGGVGK[MT7].3b3_1.heavy 415.271 / 456.33 136531.0 30.000499725341797 50 20 10 10 10 6.776455496333938 14.756977309760241 0.0 3 0.9940791747547549 16.030856756173534 136531.0 188.6902397208784 0.0 - - - - - - - 304.8 273 10 HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 115 15 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538609.[MT7]-LVVVGAGGVGK[MT7].3y5_1.heavy 415.271 / 561.348 60396.0 30.000499725341797 50 20 10 10 10 6.776455496333938 14.756977309760241 0.0 3 0.9940791747547549 16.030856756173534 60396.0 168.1758536585366 0.0 - - - - - - - 251.44444444444446 120 9 HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 117 16 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538606.[MT7]-SSYPIFIK[MT7].2y4_1.heavy 621.87 / 664.451 1453.0 34.541399002075195 37 13 10 6 8 2.494586702648336 40.08680070884555 0.036800384521484375 4 0.9229810969102296 4.41810550328134 1453.0 1.5755421686746989 7.0 - - - - - - - 688.6363636363636 6 11 SMAD7 SMAD family member 7 119 16 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538606.[MT7]-SSYPIFIK[MT7].2y5_1.heavy 621.87 / 761.504 13591.0 34.541399002075195 37 13 10 6 8 2.494586702648336 40.08680070884555 0.036800384521484375 4 0.9229810969102296 4.41810550328134 13591.0 15.407429120513605 0.0 - - - - - - - 752.25 27 8 SMAD7 SMAD family member 7 121 16 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538606.[MT7]-SSYPIFIK[MT7].2y3_1.heavy 621.87 / 551.367 4150.0 34.541399002075195 37 13 10 6 8 2.494586702648336 40.08680070884555 0.036800384521484375 4 0.9229810969102296 4.41810550328134 4150.0 3.109876387647165 0.0 - - - - - - - 681.8571428571429 8 7 SMAD7 SMAD family member 7 123 16 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538606.[MT7]-SSYPIFIK[MT7].2b5_1.heavy 621.87 / 692.374 2490.0 34.541399002075195 37 13 10 6 8 2.494586702648336 40.08680070884555 0.036800384521484375 4 0.9229810969102296 4.41810550328134 2490.0 5.458381502890173 3.0 - - - - - - - 287.38461538461536 5 13 SMAD7 SMAD family member 7 125 17 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59237.[MT7]-RNPEPLR.2y5_1.heavy 513.302 / 611.351 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 127 17 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59237.[MT7]-RNPEPLR.2b4_1.heavy 513.302 / 641.349 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 129 17 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59237.[MT7]-RNPEPLR.2b6_1.heavy 513.302 / 851.486 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 131 17 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59237.[MT7]-RNPEPLR.2y6_1.heavy 513.302 / 725.394 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 133 18 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540569.[MT7]-TIAIIAEGIPEALTR.3y6_1.heavy 571.341 / 686.383 242578.0 44.37310028076172 50 20 10 10 10 9.365446563078283 10.677547442770468 0.0 3 0.9971749419277108 23.21380781684465 242578.0 552.666569185245 0.0 - - - - - - - 172.5 485 6 ACLY ATP citrate lyase 135 18 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540569.[MT7]-TIAIIAEGIPEALTR.3b4_1.heavy 571.341 / 543.362 165902.0 44.37310028076172 50 20 10 10 10 9.365446563078283 10.677547442770468 0.0 3 0.9971749419277108 23.21380781684465 165902.0 189.18419105821917 0.0 - - - - - - - 1250.857142857143 331 7 ACLY ATP citrate lyase 137 18 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540569.[MT7]-TIAIIAEGIPEALTR.3b5_1.heavy 571.341 / 656.446 102051.0 44.37310028076172 50 20 10 10 10 9.365446563078283 10.677547442770468 0.0 3 0.9971749419277108 23.21380781684465 102051.0 220.53733855185908 0.0 - - - - - - - 276.0 204 9 ACLY ATP citrate lyase 139 18 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540569.[MT7]-TIAIIAEGIPEALTR.3y5_1.heavy 571.341 / 589.33 40751.0 44.37310028076172 50 20 10 10 10 9.365446563078283 10.677547442770468 0.0 3 0.9971749419277108 23.21380781684465 40751.0 122.07326635207897 0.0 - - - - - - - 234.6 81 10 ACLY ATP citrate lyase 141 19 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541078.[MT7]-LAQLLGEPAETQGTTEAR.3b4_1.heavy 677.028 / 570.373 132922.0 35.4184513092041 44 18 10 6 10 5.263373180430509 18.999222850434606 0.03620147705078125 3 0.9826135402464587 9.34599485570421 132922.0 100.78856576239448 0.0 - - - - - - - 303.0 265 3 GADD45B growth arrest and DNA-damage-inducible, beta 143 19 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541078.[MT7]-LAQLLGEPAETQGTTEAR.3b5_1.heavy 677.028 / 683.457 70454.0 35.4184513092041 44 18 10 6 10 5.263373180430509 18.999222850434606 0.03620147705078125 3 0.9826135402464587 9.34599485570421 70454.0 66.50716568161185 0.0 - - - - - - - 649.7142857142857 140 7 GADD45B growth arrest and DNA-damage-inducible, beta 145 19 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541078.[MT7]-LAQLLGEPAETQGTTEAR.3y8_1.heavy 677.028 / 863.422 55494.0 35.4184513092041 44 18 10 6 10 5.263373180430509 18.999222850434606 0.03620147705078125 3 0.9826135402464587 9.34599485570421 55494.0 115.36846140029067 0.0 - - - - - - - 214.625 110 8 GADD45B growth arrest and DNA-damage-inducible, beta 147 19 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541078.[MT7]-LAQLLGEPAETQGTTEAR.3b7_1.heavy 677.028 / 869.521 89558.0 35.4184513092041 44 18 10 6 10 5.263373180430509 18.999222850434606 0.03620147705078125 3 0.9826135402464587 9.34599485570421 89558.0 104.25325726305098 0.0 - - - - - - - 677.1 179 10 GADD45B growth arrest and DNA-damage-inducible, beta 149 20 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540079.[MT7]-ELIINEILVMK[MT7].3b6_1.heavy 534.996 / 856.49 70028.0 45.58720016479492 43 13 10 10 10 1.266181878248978 56.471382291036775 0.0 3 0.9147760889858457 4.197086574777793 70028.0 299.31714072415076 0.0 - - - - - - - 265.6 140 10 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 151 20 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540079.[MT7]-ELIINEILVMK[MT7].3y3_1.heavy 534.996 / 521.324 105805.0 45.58720016479492 43 13 10 10 10 1.266181878248978 56.471382291036775 0.0 3 0.9147760889858457 4.197086574777793 105805.0 293.01951794862657 0.0 - - - - - - - 294.8888888888889 211 9 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 153 20 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540079.[MT7]-ELIINEILVMK[MT7].3b5_1.heavy 534.996 / 727.447 36441.0 45.58720016479492 43 13 10 10 10 1.266181878248978 56.471382291036775 0.0 3 0.9147760889858457 4.197086574777793 36441.0 551.8592563020418 0.0 - - - - - - - 183.76923076923077 72 13 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 155 20 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540079.[MT7]-ELIINEILVMK[MT7].3b3_1.heavy 534.996 / 500.32 58478.0 45.58720016479492 43 13 10 10 10 1.266181878248978 56.471382291036775 0.0 3 0.9147760889858457 4.197086574777793 58478.0 138.07534386016553 0.0 - - - - - - - 279.0 116 10 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 157 21 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540606.[MT7]-TVLENSTSYEEAK[MT7].3b6_1.heavy 586.971 / 788.427 3045.0 25.92569923400879 47 17 10 10 10 2.691038577270913 30.50145441949722 0.0 3 0.9749355528687982 7.77896818173844 3045.0 9.038367931281316 0.0 - - - - - - - 191.55555555555554 6 18 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 159 21 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540606.[MT7]-TVLENSTSYEEAK[MT7].3y6_1.heavy 586.971 / 870.432 5429.0 25.92569923400879 47 17 10 10 10 2.691038577270913 30.50145441949722 0.0 3 0.9749355528687982 7.77896818173844 5429.0 8.404490799360438 0.0 - - - - - - - 183.0 10 18 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 161 21 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540606.[MT7]-TVLENSTSYEEAK[MT7].3y4_1.heavy 586.971 / 620.337 13142.0 25.92569923400879 47 17 10 10 10 2.691038577270913 30.50145441949722 0.0 3 0.9749355528687982 7.77896818173844 13142.0 16.291128015436634 0.0 - - - - - - - 241.84615384615384 26 13 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 163 21 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540606.[MT7]-TVLENSTSYEEAK[MT7].3y5_1.heavy 586.971 / 783.401 6596.0 25.92569923400879 47 17 10 10 10 2.691038577270913 30.50145441949722 0.0 3 0.9749355528687982 7.77896818173844 6596.0 26.6876317383404 0.0 - - - - - - - 704.0 13 8 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 165 22 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59763.[MT7]-AFDANTMTSAEK[MT7].2y4_1.heavy 787.392 / 578.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 167 22 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59763.[MT7]-AFDANTMTSAEK[MT7].2y5_1.heavy 787.392 / 679.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 169 22 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59763.[MT7]-AFDANTMTSAEK[MT7].2b4_1.heavy 787.392 / 549.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 171 22 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59763.[MT7]-AFDANTMTSAEK[MT7].2y6_1.heavy 787.392 / 810.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 173 23 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539915.[MT7]-HRDHQVAALSER.3y7_1.heavy 521.614 / 745.42 8480.0 16.0933256149292 46 20 10 6 10 3.5548312521045737 22.1197643457548 0.035900115966796875 3 0.9923321413879246 14.084694179626279 8480.0 81.36072896194389 0.0 - - - - - - - 158.76470588235293 16 17 MID1 midline 1 (Opitz/BBB syndrome) 175 23 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539915.[MT7]-HRDHQVAALSER.3y6_1.heavy 521.614 / 646.352 15611.0 16.0933256149292 46 20 10 6 10 3.5548312521045737 22.1197643457548 0.035900115966796875 3 0.9923321413879246 14.084694179626279 15611.0 87.7600291347316 0.0 - - - - - - - 195.58823529411765 31 17 MID1 midline 1 (Opitz/BBB syndrome) 177 23 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539915.[MT7]-HRDHQVAALSER.3b3_1.heavy 521.614 / 553.296 8239.0 16.0933256149292 46 20 10 6 10 3.5548312521045737 22.1197643457548 0.035900115966796875 3 0.9923321413879246 14.084694179626279 8239.0 35.07304498269896 0.0 - - - - - - - 226.5 16 20 MID1 midline 1 (Opitz/BBB syndrome) 179 23 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539915.[MT7]-HRDHQVAALSER.3y5_1.heavy 521.614 / 575.315 9348.0 16.0933256149292 46 20 10 6 10 3.5548312521045737 22.1197643457548 0.035900115966796875 3 0.9923321413879246 14.084694179626279 9348.0 15.941653122638634 0.0 - - - - - - - 223.21052631578948 18 19 MID1 midline 1 (Opitz/BBB syndrome) 181 24 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537759.[MT7]-ADEVAPAK[MT7]K[MT7].3y6_2.heavy 454.277 / 451.307 12995.0 14.88355016708374 23 -1 10 6 8 0.2539377690294373 160.36651813846788 0.03700065612792969 4 0.2514386985069592 1.325603532155308 12995.0 27.888812785388126 0.0 - - - - - - - 224.8095238095238 25 21 ACLY ATP citrate lyase 183 24 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537759.[MT7]-ADEVAPAK[MT7]K[MT7].3y7_2.heavy 454.277 / 515.829 730.0 14.88355016708374 23 -1 10 6 8 0.2539377690294373 160.36651813846788 0.03700065612792969 4 0.2514386985069592 1.325603532155308 730.0 0.0 3.0 - - - - - - - 210.0909090909091 8 22 ACLY ATP citrate lyase 185 24 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537759.[MT7]-ADEVAPAK[MT7]K[MT7].3b3_1.heavy 454.277 / 460.216 7398.0 14.88355016708374 23 -1 10 6 8 0.2539377690294373 160.36651813846788 0.03700065612792969 4 0.2514386985069592 1.325603532155308 7398.0 13.312596401028276 1.0 - - - - - - - 204.0 15 21 ACLY ATP citrate lyase 187 24 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537759.[MT7]-ADEVAPAK[MT7]K[MT7].3y8_2.heavy 454.277 / 573.342 65659.0 14.88355016708374 23 -1 10 6 8 0.2539377690294373 160.36651813846788 0.03700065612792969 4 0.2514386985069592 1.325603532155308 65659.0 60.390861056751454 0.0 - - - - - - - 208.05555555555554 131 18 ACLY ATP citrate lyase 189 25 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TPX_ECO57.AQTFTLVAK.2y7.peptide 489.78 / 779.47 1261750.0 29.299699783325195 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1261750.0 7392.395833333333 0.0 - - - - - - - 1179.375 2523 8 191 25 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TPX_ECO57.AQTFTLVAK.2y6.peptide 489.78 / 678.42 386150.0 29.299699783325195 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 386150.0 569.3550318670859 0.0 - - - - - - - 758.125 772 8 193 25 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TPX_ECO57.AQTFTLVAK.2y5.peptide 489.78 / 531.35 271838.0 29.299699783325195 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 271838.0 331.92670777432147 0.0 - - - - - - - 294.8333333333333 543 6 195 26 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538617.[MT7]-EILIPVFK[MT7].3y3_1.heavy 416.272 / 537.352 31877.0 41.17470169067383 46 16 10 10 10 3.828163184395721 26.122188418617554 0.0 3 0.9647892929536485 6.557561494263714 31877.0 537.5721795268374 0.0 - - - - - - - 112.3 63 10 ACLY ATP citrate lyase 197 26 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538617.[MT7]-EILIPVFK[MT7].3b4_1.heavy 416.272 / 613.404 49006.0 41.17470169067383 46 16 10 10 10 3.828163184395721 26.122188418617554 0.0 3 0.9647892929536485 6.557561494263714 49006.0 776.2091163738222 0.0 - - - - - - - 642.2857142857143 98 7 ACLY ATP citrate lyase 199 26 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538617.[MT7]-EILIPVFK[MT7].3y4_1.heavy 416.272 / 634.404 32737.0 41.17470169067383 46 16 10 10 10 3.828163184395721 26.122188418617554 0.0 3 0.9647892929536485 6.557561494263714 32737.0 521.8329485612427 0.0 - - - - - - - 165.1 65 10 ACLY ATP citrate lyase 201 26 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538617.[MT7]-EILIPVFK[MT7].3b3_1.heavy 416.272 / 500.32 79693.0 41.17470169067383 46 16 10 10 10 3.828163184395721 26.122188418617554 0.0 3 0.9647892929536485 6.557561494263714 79693.0 76.91818286153857 0.0 - - - - - - - 670.5714285714286 159 7 ACLY ATP citrate lyase 203 27 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538310.[MT7]-LIEFLSK[MT7].2b3_1.heavy 569.36 / 500.32 23549.0 39.54330062866211 50 20 10 10 10 5.974812075081255 16.736928081313764 0.0 3 0.9931420541070523 14.894188042256841 23549.0 43.91017382360941 0.0 - - - - - - - 746.0 47 7 CAB39 calcium binding protein 39 205 27 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538310.[MT7]-LIEFLSK[MT7].2y4_1.heavy 569.36 / 638.399 20481.0 39.54330062866211 50 20 10 10 10 5.974812075081255 16.736928081313764 0.0 3 0.9931420541070523 14.894188042256841 20481.0 45.22357676523203 0.0 - - - - - - - 307.1 40 10 CAB39 calcium binding protein 39 207 27 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538310.[MT7]-LIEFLSK[MT7].2y5_1.heavy 569.36 / 767.442 21144.0 39.54330062866211 50 20 10 10 10 5.974812075081255 16.736928081313764 0.0 3 0.9931420541070523 14.894188042256841 21144.0 66.41178849446041 0.0 - - - - - - - 315.4 42 15 CAB39 calcium binding protein 39 209 27 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538310.[MT7]-LIEFLSK[MT7].2y6_1.heavy 569.36 / 880.526 19983.0 39.54330062866211 50 20 10 10 10 5.974812075081255 16.736928081313764 0.0 3 0.9931420541070523 14.894188042256841 19983.0 239.10073204761144 0.0 - - - - - - - 215.8 39 10 CAB39 calcium binding protein 39 211 28 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539668.[MT7]-RWHELMLDK[MT7].3y3_1.heavy 505.95 / 519.326 21521.0 28.697500228881836 33 13 2 10 8 1.0056887718816072 58.37875170436279 0.0 4 0.9112631555517787 4.111926317833492 21521.0 29.963851383439014 0.0 - - - - - - - 1072.375 43 8 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 213 28 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539668.[MT7]-RWHELMLDK[MT7].3b4_1.heavy 505.95 / 753.391 8294.0 28.697500228881836 33 13 2 10 8 1.0056887718816072 58.37875170436279 0.0 4 0.9112631555517787 4.111926317833492 8294.0 18.995534212640333 1.0 - - - - - - - 630.4545454545455 30 11 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 215 28 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539668.[MT7]-RWHELMLDK[MT7].3b5_1.heavy 505.95 / 866.475 N/A 28.697500228881836 33 13 2 10 8 1.0056887718816072 58.37875170436279 0.0 4 0.9112631555517787 4.111926317833492 3575.0 2.3947471236642617 10.0 - - - - - - - 786.0 114 1 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 217 28 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539668.[MT7]-RWHELMLDK[MT7].3y4_1.heavy 505.95 / 650.366 16015.0 28.697500228881836 33 13 2 10 8 1.0056887718816072 58.37875170436279 0.0 4 0.9112631555517787 4.111926317833492 16015.0 43.67727272727272 0.0 - - - - - - - 612.5 32 14 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 219 29 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537645.[MT7]-LSPIFR.2y4_1.heavy 438.775 / 532.324 29882.0 33.83679962158203 45 15 10 10 10 2.8242238923964575 35.407957658465364 0.0 3 0.9544742329551219 5.761985678155004 29882.0 119.36392407616943 0.0 - - - - - - - 346.875 59 8 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 221 29 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537645.[MT7]-LSPIFR.2y5_1.heavy 438.775 / 619.356 184733.0 33.83679962158203 45 15 10 10 10 2.8242238923964575 35.407957658465364 0.0 3 0.9544742329551219 5.761985678155004 184733.0 419.49085576696075 0.0 - - - - - - - 107.0 369 2 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 223 29 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537645.[MT7]-LSPIFR.2b4_1.heavy 438.775 / 555.362 25079.0 33.83679962158203 45 15 10 10 10 2.8242238923964575 35.407957658465364 0.0 3 0.9544742329551219 5.761985678155004 25079.0 78.18727088127793 0.0 - - - - - - - 298.7 50 10 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 225 29 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537645.[MT7]-LSPIFR.2b5_1.heavy 438.775 / 702.431 7364.0 33.83679962158203 45 15 10 10 10 2.8242238923964575 35.407957658465364 0.0 3 0.9544742329551219 5.761985678155004 7364.0 29.66295081967213 0.0 - - - - - - - 263.06666666666666 14 15 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 227 30 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57672.[MT7]-FYDSNTVK[MT7].2b3_1.heavy 631.337 / 570.268 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 229 30 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57672.[MT7]-FYDSNTVK[MT7].2y5_1.heavy 631.337 / 692.406 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 231 30 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57672.[MT7]-FYDSNTVK[MT7].2b5_1.heavy 631.337 / 771.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 233 30 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57672.[MT7]-FYDSNTVK[MT7].2y7_1.heavy 631.337 / 970.496 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 235 31 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ODP2_ECOLI.AEAPAAAPAAK.2y7.peptide 484.26 / 599.35 438782.0 15.139900207519531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 438782.0 2374.0419979231174 0.0 - - - - - - - 706.7142857142857 877 7 237 31 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ODP2_ECOLI.AEAPAAAPAAK.2y8.peptide 484.26 / 696.4 856049.0 15.139900207519531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 856049.0 9405.340598472672 0.0 - - - - - - - 1231.5 1712 8 239 31 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ODP2_ECOLI.AEAPAAAPAAK.2y6.peptide 484.26 / 528.31 351832.0 15.139900207519531 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 351832.0 1358.1882336674732 0.0 - - - - - - - 394.125 703 8 241 32 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57884.[MT7]-TALEMVQAAGTDR.2b4_1.heavy 753.889 / 559.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 243 32 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57884.[MT7]-TALEMVQAAGTDR.2y9_1.heavy 753.889 / 948.457 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 245 32 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57884.[MT7]-TALEMVQAAGTDR.2y10_1.heavy 753.889 / 1077.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 247 32 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57884.[MT7]-TALEMVQAAGTDR.2b5_1.heavy 753.889 / 690.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 249 33 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538147.[MT7]-IAVNTSK[MT7].2y4_1.heavy 510.818 / 593.338 5488.0 21.091650009155273 46 20 10 6 10 19.386945521493065 5.158110125658341 0.03260040283203125 3 0.9988412165457787 36.25094065727701 5488.0 13.972887114584218 0.0 - - - - - - - 605.4 10 10 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 251 33 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538147.[MT7]-IAVNTSK[MT7].2y5_1.heavy 510.818 / 692.406 3293.0 21.091650009155273 46 20 10 6 10 19.386945521493065 5.158110125658341 0.03260040283203125 3 0.9988412165457787 36.25094065727701 3293.0 9.308279720279721 0.0 - - - - - - - 218.86206896551724 6 29 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 253 33 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538147.[MT7]-IAVNTSK[MT7].2b4_1.heavy 510.818 / 542.342 1585.0 21.091650009155273 46 20 10 6 10 19.386945521493065 5.158110125658341 0.03260040283203125 3 0.9988412165457787 36.25094065727701 1585.0 1.0637583892617448 4.0 - - - - - - - 251.17391304347825 3 23 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 255 33 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538147.[MT7]-IAVNTSK[MT7].2y6_1.heavy 510.818 / 763.443 6098.0 21.091650009155273 46 20 10 6 10 19.386945521493065 5.158110125658341 0.03260040283203125 3 0.9988412165457787 36.25094065727701 6098.0 33.16929281434545 0.0 - - - - - - - 204.92307692307693 12 26 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 257 34 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540592.[MT7]-DIINNTSLAELEK[MT7].3y3_1.heavy 583.328 / 533.341 25705.0 34.912601470947266 50 20 10 10 10 9.549510232813395 10.471741226726646 0.0 3 0.996478053061631 20.789470088822515 25705.0 33.4343853820598 0.0 - - - - - - - 674.6666666666666 51 9 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 259 34 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540592.[MT7]-DIINNTSLAELEK[MT7].3b4_1.heavy 583.328 / 600.347 N/A 34.912601470947266 50 20 10 10 10 9.549510232813395 10.471741226726646 0.0 3 0.996478053061631 20.789470088822515 14775.0 4.289221741815936 1.0 - - - - - - - 759.0 33 8 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 261 34 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540592.[MT7]-DIINNTSLAELEK[MT7].3y4_1.heavy 583.328 / 662.384 19532.0 34.912601470947266 50 20 10 10 10 9.549510232813395 10.471741226726646 0.0 3 0.996478053061631 20.789470088822515 19532.0 25.436393277112074 0.0 - - - - - - - 303.625 39 8 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 263 34 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540592.[MT7]-DIINNTSLAELEK[MT7].3y5_1.heavy 583.328 / 733.421 20645.0 34.912601470947266 50 20 10 10 10 9.549510232813395 10.471741226726646 0.0 3 0.996478053061631 20.789470088822515 20645.0 34.500197290492224 0.0 - - - - - - - 607.0 41 8 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 265 35 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59373.[MT7]-YDYTDSK[MT7].2b3_1.heavy 590.292 / 586.263 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 267 35 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59373.[MT7]-YDYTDSK[MT7].2y5_1.heavy 590.292 / 757.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 269 35 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59373.[MT7]-YDYTDSK[MT7].2y6_1.heavy 590.292 / 872.412 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 271 35 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59373.[MT7]-YDYTDSK[MT7].2b5_1.heavy 590.292 / 802.338 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 273 36 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538140.[MT7]-LENIDK[MT7].2y4_1.heavy 510.302 / 633.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF9;ARHGEF4 Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 275 36 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538140.[MT7]-LENIDK[MT7].2b3_1.heavy 510.302 / 501.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF9;ARHGEF4 Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 277 36 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538140.[MT7]-LENIDK[MT7].2y5_1.heavy 510.302 / 762.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF9;ARHGEF4 Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 279 36 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538140.[MT7]-LENIDK[MT7].2b5_1.heavy 510.302 / 729.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF9;ARHGEF4 Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 281 37 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58893.[MT7]-SHGLVEVASYC[CAM]EESR.3y7_1.heavy 622.964 / 930.362 2243.0 34.101034800211586 27 7 10 6 4 0.49121477767061283 104.08803001764436 0.037700653076171875 10 0.722382412424595 2.285794157302462 2243.0 12.545308254616854 0.0 - - - - - - - 0.0 4 0 GADD45B growth arrest and DNA-damage-inducible, beta 283 37 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58893.[MT7]-SHGLVEVASYC[CAM]EESR.3b6_1.heavy 622.964 / 767.417 561.0 34.101034800211586 27 7 10 6 4 0.49121477767061283 104.08803001764436 0.037700653076171875 10 0.722382412424595 2.285794157302462 561.0 1.2754850891057248 13.0 - - - - - - - 0.0 1 0 GADD45B growth arrest and DNA-damage-inducible, beta 285 37 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58893.[MT7]-SHGLVEVASYC[CAM]EESR.3b4_1.heavy 622.964 / 539.306 N/A 34.101034800211586 27 7 10 6 4 0.49121477767061283 104.08803001764436 0.037700653076171875 10 0.722382412424595 2.285794157302462 2355.0 0.2625418060200669 5.0 - - - - - - - 0.0 7 0 GADD45B growth arrest and DNA-damage-inducible, beta 287 37 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58893.[MT7]-SHGLVEVASYC[CAM]EESR.3y8_1.heavy 622.964 / 1001.4 7064.0 34.101034800211586 27 7 10 6 4 0.49121477767061283 104.08803001764436 0.037700653076171875 10 0.722382412424595 2.285794157302462 7064.0 66.225 0.0 - - - - - - - 0.0 14 0 GADD45B growth arrest and DNA-damage-inducible, beta 289 38 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58512.[MT7]-DSSYELQVR.2y4_1.heavy 620.818 / 515.33 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 291 38 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58512.[MT7]-DSSYELQVR.2y8_1.heavy 620.818 / 981.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 293 38 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58512.[MT7]-DSSYELQVR.2y5_1.heavy 620.818 / 644.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 295 38 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58512.[MT7]-DSSYELQVR.2b5_1.heavy 620.818 / 726.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 297 39 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47193.[MT7]-TSMAEGERK[MT7].2y4_1.heavy 648.845 / 633.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 299 39 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47193.[MT7]-TSMAEGERK[MT7].2y8_1.heavy 648.845 / 1051.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 301 39 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47193.[MT7]-TSMAEGERK[MT7].2b4_1.heavy 648.845 / 535.267 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 303 39 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47193.[MT7]-TSMAEGERK[MT7].2y6_1.heavy 648.845 / 833.46 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 305 40 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47577.[MT7]-IILWSEQFYDFFR.3y7_1.heavy 636.665 / 1022.47 211.0 49.93159866333008 41 11 10 10 10 0.877983103377461 69.62594108032371 0.0 3 0.8720479050149074 3.4126779184932743 211.0 3.9604365079365076 0.0 - - - - - - - 0.0 0 0 CAB39 calcium binding protein 39 307 40 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47577.[MT7]-IILWSEQFYDFFR.3y6_1.heavy 636.665 / 894.414 506.0 49.93159866333008 41 11 10 10 10 0.877983103377461 69.62594108032371 0.0 3 0.8720479050149074 3.4126779184932743 506.0 19.999047619047616 0.0 - - - - - - - 0.0 1 0 CAB39 calcium binding protein 39 309 40 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47577.[MT7]-IILWSEQFYDFFR.3y5_1.heavy 636.665 / 747.346 1053.0 49.93159866333008 41 11 10 10 10 0.877983103377461 69.62594108032371 0.0 3 0.8720479050149074 3.4126779184932743 1053.0 27.57857142857143 0.0 - - - - - - - 48.0 2 7 CAB39 calcium binding protein 39 311 40 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47577.[MT7]-IILWSEQFYDFFR.3y4_1.heavy 636.665 / 584.283 1053.0 49.93159866333008 41 11 10 10 10 0.877983103377461 69.62594108032371 0.0 3 0.8720479050149074 3.4126779184932743 1053.0 31.50642857142857 0.0 - - - - - - - 70.0 2 9 CAB39 calcium binding protein 39 313 41 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47579.[MT7]-IILWSEQFYDFFR.2b3_1.heavy 954.494 / 484.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 315 41 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47579.[MT7]-IILWSEQFYDFFR.2y9_1.heavy 954.494 / 1238.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 317 41 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47579.[MT7]-IILWSEQFYDFFR.2y3_1.heavy 954.494 / 469.256 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 319 41 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47579.[MT7]-IILWSEQFYDFFR.2y6_1.heavy 954.494 / 894.414 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 321 42 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y7.peptide 590.82 / 599.35 802308.0 17.70210075378418 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 802308.0 3793.0543392857144 0.0 - - - - - - - 298.6666666666667 1604 3 323 42 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y9.peptide 590.82 / 741.43 409382.0 17.70210075378418 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 409382.0 2156.2003732142857 0.0 - - - - - - - 277.6 818 5 325 42 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ODP2_ECOLI.EAAPAAAPAAAAAK.2y11.peptide 590.82 / 909.52 457218.0 17.70210075378418 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 457218.0 3417.281991674417 0.0 - - - - - - - 358.3333333333333 914 6 327 43 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47575.[MT7]-QWVVIPPPLSSPGPQAS.3y6_1.heavy 635.351 / 556.273 2088.0 41.36382484436035 39 16 10 3 10 2.3043850956855647 36.57820361500795 0.05429840087890625 3 0.9608596892150025 6.217609236181075 2088.0 -0.10266774256922417 2.0 - - - - - - - 1120.857142857143 5 7 IL21R interleukin 21 receptor 329 43 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47575.[MT7]-QWVVIPPPLSSPGPQAS.3b4_1.heavy 635.351 / 657.384 7466.0 41.36382484436035 39 16 10 3 10 2.3043850956855647 36.57820361500795 0.05429840087890625 3 0.9608596892150025 6.217609236181075 7466.0 17.282139886216523 0.0 - - - - - - - 225.0 14 9 IL21R interleukin 21 receptor 331 43 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47575.[MT7]-QWVVIPPPLSSPGPQAS.3b5_1.heavy 635.351 / 770.468 3733.0 41.36382484436035 39 16 10 3 10 2.3043850956855647 36.57820361500795 0.05429840087890625 3 0.9608596892150025 6.217609236181075 3733.0 1.1173150198601005 1.0 - - - - - - - 632.625 7 8 IL21R interleukin 21 receptor 333 43 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47575.[MT7]-QWVVIPPPLSSPGPQAS.3b3_1.heavy 635.351 / 558.316 5442.0 41.36382484436035 39 16 10 3 10 2.3043850956855647 36.57820361500795 0.05429840087890625 3 0.9608596892150025 6.217609236181075 5442.0 4.603708043306853 0.0 - - - - - - - 804.7142857142857 10 7 IL21R interleukin 21 receptor 335 44 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57876.[MT7]-SSELIYSGELTR.2y8_1.heavy 749.897 / 938.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 337 44 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57876.[MT7]-SSELIYSGELTR.2y9_1.heavy 749.897 / 1051.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 339 44 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57876.[MT7]-SSELIYSGELTR.2b4_1.heavy 749.897 / 561.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 341 44 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57876.[MT7]-SSELIYSGELTR.2y7_1.heavy 749.897 / 825.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 343 45 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538158.[MT7]-TSMAEGER.2y5_1.heavy 512.746 / 561.263 1651.0 15.792274951934814 46 20 10 6 10 3.144930336865546 23.960187800373717 0.03890037536621094 3 0.9919042787049199 13.706960639618556 1651.0 8.143946188340808 0.0 - - - - - - - 176.3 3 20 POLR1D polymerase (RNA) I polypeptide D, 16kDa 345 45 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538158.[MT7]-TSMAEGER.2b4_1.heavy 512.746 / 535.267 1919.0 15.792274951934814 46 20 10 6 10 3.144930336865546 23.960187800373717 0.03890037536621094 3 0.9919042787049199 13.706960639618556 1919.0 15.752985074626867 0.0 - - - - - - - 147.05882352941177 3 17 POLR1D polymerase (RNA) I polypeptide D, 16kDa 347 45 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538158.[MT7]-TSMAEGER.2b5_1.heavy 512.746 / 664.309 2454.0 15.792274951934814 46 20 10 6 10 3.144930336865546 23.960187800373717 0.03890037536621094 3 0.9919042787049199 13.706960639618556 2454.0 25.642921348314605 0.0 - - - - - - - 126.17391304347827 4 23 POLR1D polymerase (RNA) I polypeptide D, 16kDa 349 45 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538158.[MT7]-TSMAEGER.2y7_1.heavy 512.746 / 779.335 7363.0 15.792274951934814 46 20 10 6 10 3.144930336865546 23.960187800373717 0.03890037536621094 3 0.9919042787049199 13.706960639618556 7363.0 81.34160511244352 0.0 - - - - - - - 126.11764705882354 14 17 POLR1D polymerase (RNA) I polypeptide D, 16kDa 351 46 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539494.[MT7]-TQPILDILLK[MT7].3y3_1.heavy 481.313 / 517.383 97349.0 44.96042537689209 40 14 10 6 10 1.8330219067390403 43.485110144447816 0.034702301025390625 3 0.9379174765339148 4.927252606173084 97349.0 75.33461167447655 0.0 - - - - - - - 381.0 194 2 CAB39 calcium binding protein 39 353 46 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539494.[MT7]-TQPILDILLK[MT7].3b6_1.heavy 481.313 / 812.463 75369.0 44.96042537689209 40 14 10 6 10 1.8330219067390403 43.485110144447816 0.034702301025390625 3 0.9379174765339148 4.927252606173084 75369.0 175.72233266164358 0.0 - - - - - - - 369.6666666666667 150 6 CAB39 calcium binding protein 39 355 46 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539494.[MT7]-TQPILDILLK[MT7].3b4_1.heavy 481.313 / 584.352 60531.0 44.96042537689209 40 14 10 6 10 1.8330219067390403 43.485110144447816 0.034702301025390625 3 0.9379174765339148 4.927252606173084 60531.0 61.19991350378723 0.0 - - - - - - - 364.25 121 4 CAB39 calcium binding protein 39 357 46 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539494.[MT7]-TQPILDILLK[MT7].3b7_1.heavy 481.313 / 925.547 9915.0 44.96042537689209 40 14 10 6 10 1.8330219067390403 43.485110144447816 0.034702301025390625 3 0.9379174765339148 4.927252606173084 9915.0 45.72998499727223 0.0 - - - - - - - 220.45454545454547 19 11 CAB39 calcium binding protein 39 359 47 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57691.[MT7]-EMTTC[CAM]VFPR.2y8_1.heavy 642.813 / 1011.47 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 361 47 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57691.[MT7]-EMTTC[CAM]VFPR.2y5_1.heavy 642.813 / 678.339 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 363 47 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57691.[MT7]-EMTTC[CAM]VFPR.2y6_1.heavy 642.813 / 779.387 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 365 47 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57691.[MT7]-EMTTC[CAM]VFPR.2y7_1.heavy 642.813 / 880.435 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 367 48 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59749.[MT7]-HRDHQVAALSER.2b3_1.heavy 781.917 / 553.296 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 369 48 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59749.[MT7]-HRDHQVAALSER.2b4_1.heavy 781.917 / 690.355 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 371 48 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59749.[MT7]-HRDHQVAALSER.2y9_1.heavy 781.917 / 1010.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 373 48 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59749.[MT7]-HRDHQVAALSER.2y10_1.heavy 781.917 / 1125.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 375 49 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47440.[MT7]-ELIINEILVMK[MT7].2b3_1.heavy 801.991 / 500.32 3709.0 45.613725662231445 40 17 10 3 10 9.959360825514459 10.04080500264779 0.07070159912109375 3 0.9738106992374307 7.609357908908037 3709.0 12.838846153846154 1.0 - - - - - - - 249.16666666666666 7 18 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 377 49 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47440.[MT7]-ELIINEILVMK[MT7].2b4_1.heavy 801.991 / 613.404 2603.0 45.613725662231445 40 17 10 3 10 9.959360825514459 10.04080500264779 0.07070159912109375 3 0.9738106992374307 7.609357908908037 2603.0 19.916287179487178 0.0 - - - - - - - 198.61111111111111 5 18 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 379 49 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47440.[MT7]-ELIINEILVMK[MT7].2b6_1.heavy 801.991 / 856.49 455.0 45.613725662231445 40 17 10 3 10 9.959360825514459 10.04080500264779 0.07070159912109375 3 0.9738106992374307 7.609357908908037 455.0 0.2330345710627401 19.0 - - - - - - - 217.94117647058823 6 17 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 381 49 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47440.[MT7]-ELIINEILVMK[MT7].2y3_1.heavy 801.991 / 521.324 1822.0 45.613725662231445 40 17 10 3 10 9.959360825514459 10.04080500264779 0.07070159912109375 3 0.9738106992374307 7.609357908908037 1822.0 2.8454442485841804 0.0 - - - - - - - 240.88235294117646 3 17 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 383 50 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539894.[MT7]-QGVEDAFYTLVR.3b6_1.heavy 514.608 / 744.364 18940.0 40.30329895019531 40 14 8 10 8 2.7008788703416013 29.415621455658265 0.0 4 0.9490558015640578 5.444447384747719 18940.0 147.68690476190474 0.0 - - - - - - - 213.52631578947367 37 19 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 385 50 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539894.[MT7]-QGVEDAFYTLVR.3b4_1.heavy 514.608 / 558.3 6639.0 40.30329895019531 40 14 8 10 8 2.7008788703416013 29.415621455658265 0.0 4 0.9490558015640578 5.444447384747719 6639.0 4.974727520435968 2.0 - - - - - - - 808.7142857142857 73 7 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 387 50 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539894.[MT7]-QGVEDAFYTLVR.3b5_1.heavy 514.608 / 673.327 22294.0 40.30329895019531 40 14 8 10 8 2.7008788703416013 29.415621455658265 0.0 4 0.9490558015640578 5.444447384747719 22294.0 67.06057564411319 1.0 - - - - - - - 753.3333333333334 80 9 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 389 50 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539894.[MT7]-QGVEDAFYTLVR.3y5_1.heavy 514.608 / 651.382 28304.0 40.30329895019531 40 14 8 10 8 2.7008788703416013 29.415621455658265 0.0 4 0.9490558015640578 5.444447384747719 28304.0 110.45017555909807 0.0 - - - - - - - 687.25 56 12 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 391 51 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539284.[MT7]-YLSFTPPEK[MT7].3y3_1.heavy 457.258 / 517.31 94103.0 33.92945098876953 42 20 10 2 10 8.434951244204687 11.855433078964854 0.08119964599609375 3 0.9963105227347495 20.311702805092295 94103.0 99.20496987951807 0.0 - - - - - - - 778.0 188 2 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 393 51 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539284.[MT7]-YLSFTPPEK[MT7].3b4_1.heavy 457.258 / 655.357 9234.0 33.92945098876953 42 20 10 2 10 8.434951244204687 11.855433078964854 0.08119964599609375 3 0.9963105227347495 20.311702805092295 9234.0 28.42122227570284 1.0 - - - - - - - 233.5 18 8 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 395 51 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539284.[MT7]-YLSFTPPEK[MT7].3y4_1.heavy 457.258 / 614.363 35275.0 33.92945098876953 42 20 10 2 10 8.434951244204687 11.855433078964854 0.08119964599609375 3 0.9963105227347495 20.311702805092295 35275.0 72.35535256209722 0.0 - - - - - - - 104.0 70 1 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 397 51 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539284.[MT7]-YLSFTPPEK[MT7].3b3_1.heavy 457.258 / 508.289 23863.0 33.92945098876953 42 20 10 2 10 8.434951244204687 11.855433078964854 0.08119964599609375 3 0.9963105227347495 20.311702805092295 23863.0 0.002205355985527152 2.0 - - - - - - - 700.375 47 8 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 399 52 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 OPPA_ECOLI.LAIAASSLWK.2y7.peptide 530.31 / 762.41 2025350.0 36.68920135498047 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 2025350.0 806.548269642111 0.0 - - - - - - - 255.0 4050 6 401 52 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 OPPA_ECOLI.LAIAASSLWK.2y8.peptide 530.31 / 875.5 1054940.0 36.68920135498047 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1054940.0 1811.2720462543991 0.0 - - - - - - - 218.57142857142858 2109 7 403 52 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 OPPA_ECOLI.LAIAASSLWK.2y6.peptide 530.31 / 691.38 1485120.0 36.68920135498047 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 1485120.0 609.30493768901 0.0 - - - - - - - 289.0 2970 6 405 53 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59289.[MT7]-SINNPDMR.2y5_1.heavy 545.775 / 632.282 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 407 53 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59289.[MT7]-SINNPDMR.2b4_1.heavy 545.775 / 573.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 409 53 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59289.[MT7]-SINNPDMR.2y6_1.heavy 545.775 / 746.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 411 53 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59289.[MT7]-SINNPDMR.2y7_1.heavy 545.775 / 859.409 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 413 54 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59994.[MT7]-QHFPATPLLDYALEVEK[MT7].3y7_1.heavy 753.747 / 995.553 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 415 54 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59994.[MT7]-QHFPATPLLDYALEVEK[MT7].3y3_1.heavy 753.747 / 519.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 417 54 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59994.[MT7]-QHFPATPLLDYALEVEK[MT7].3b3_1.heavy 753.747 / 557.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 419 54 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59994.[MT7]-QHFPATPLLDYALEVEK[MT7].3y5_1.heavy 753.747 / 761.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 421 55 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57962.[MT7]-K[MT7]NPQAVLDVLK[MT7].4b4_2.heavy 415.015 / 378.734 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 423 55 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57962.[MT7]-K[MT7]NPQAVLDVLK[MT7].4b4_1.heavy 415.015 / 756.461 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 425 55 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57962.[MT7]-K[MT7]NPQAVLDVLK[MT7].4b5_2.heavy 415.015 / 414.253 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 427 55 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57962.[MT7]-K[MT7]NPQAVLDVLK[MT7].4b6_2.heavy 415.015 / 463.787 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 429 56 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47603.[MT7]-MQTVTAAVEELLVAAQR.3b6_1.heavy 658.699 / 776.409 530.0 48.412498474121094 33 5 10 10 8 3.3432517256414447 29.910999292407084 0.0 4 0.6961307149867467 2.179474930773821 530.0 6.651652298850574 1.0 - - - - - - - 0.0 1 0 GADD45B growth arrest and DNA-damage-inducible, beta 431 56 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47603.[MT7]-MQTVTAAVEELLVAAQR.3b4_1.heavy 658.699 / 604.325 530.0 48.412498474121094 33 5 10 10 8 3.3432517256414447 29.910999292407084 0.0 4 0.6961307149867467 2.179474930773821 530.0 4.416666666666667 0.0 - - - - - - - 0.0 1 0 GADD45B growth arrest and DNA-damage-inducible, beta 433 56 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47603.[MT7]-MQTVTAAVEELLVAAQR.3y5_1.heavy 658.699 / 544.32 2265.0 48.412498474121094 33 5 10 10 8 3.3432517256414447 29.910999292407084 0.0 4 0.6961307149867467 2.179474930773821 2265.0 7.437380102909803 0.0 - - - - - - - 232.88888888888889 4 18 GADD45B growth arrest and DNA-damage-inducible, beta 435 56 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47603.[MT7]-MQTVTAAVEELLVAAQR.3b7_1.heavy 658.699 / 847.446 289.0 48.412498474121094 33 5 10 10 8 3.3432517256414447 29.910999292407084 0.0 4 0.6961307149867467 2.179474930773821 289.0 8.429166666666667 2.0 - - - - - - - 0.0 1 0 GADD45B growth arrest and DNA-damage-inducible, beta 437 57 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539896.[MT7]-GIHVETLETEK[MT7].3y3_1.heavy 515.291 / 521.305 38030.0 26.09040069580078 44 14 10 10 10 1.9709036169526086 41.40342524333554 0.0 3 0.9371355511725562 4.896186906967075 38030.0 95.01706641872582 0.0 - - - - - - - 696.0 76 13 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 439 57 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539896.[MT7]-GIHVETLETEK[MT7].3b3_1.heavy 515.291 / 452.274 36708.0 26.09040069580078 44 14 10 10 10 1.9709036169526086 41.40342524333554 0.0 3 0.9371355511725562 4.896186906967075 36708.0 61.111350910785966 0.0 - - - - - - - 766.75 73 12 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 441 57 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539896.[MT7]-GIHVETLETEK[MT7].3y4_1.heavy 515.291 / 650.348 30912.0 26.09040069580078 44 14 10 10 10 1.9709036169526086 41.40342524333554 0.0 3 0.9371355511725562 4.896186906967075 30912.0 38.96366461172698 0.0 - - - - - - - 720.0833333333334 61 12 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 443 57 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539896.[MT7]-GIHVETLETEK[MT7].3y5_1.heavy 515.291 / 763.432 16269.0 26.09040069580078 44 14 10 10 10 1.9709036169526086 41.40342524333554 0.0 3 0.9371355511725562 4.896186906967075 16269.0 42.498359697434964 0.0 - - - - - - - 203.47619047619048 32 21 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 445 58 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57961.[MT7]-K[MT7]NPQAVLDVLK[MT7].2y9_1.heavy 829.022 / 1126.7 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 447 58 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57961.[MT7]-K[MT7]NPQAVLDVLK[MT7].2b4_1.heavy 829.022 / 756.461 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 449 58 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57961.[MT7]-K[MT7]NPQAVLDVLK[MT7].2b6_1.heavy 829.022 / 926.566 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 451 58 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57961.[MT7]-K[MT7]NPQAVLDVLK[MT7].2y3_1.heavy 829.022 / 503.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 453 59 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540430.[MT7]-VADGEGWFPASFVR.3b6_1.heavy 561.287 / 673.327 51073.0 41.85127544403076 43 20 10 7 6 9.33305263275913 10.714607956779195 0.029300689697265625 5 0.9970498166344911 22.715956915511494 51073.0 7.2176894169932435 1.0 - - - - - - - 768.0 102 8 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 455 59 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540430.[MT7]-VADGEGWFPASFVR.3y6_1.heavy 561.287 / 676.378 93441.0 41.85127544403076 43 20 10 7 6 9.33305263275913 10.714607956779195 0.029300689697265625 5 0.9970498166344911 22.715956915511494 93441.0 299.49038461538464 0.0 - - - - - - - 280.0 186 8 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 457 59 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540430.[MT7]-VADGEGWFPASFVR.3b5_1.heavy 561.287 / 616.306 17152.0 41.85127544403076 43 20 10 7 6 9.33305263275913 10.714607956779195 0.029300689697265625 5 0.9970498166344911 22.715956915511494 17152.0 1.254035087719298 2.0 - - - - - - - 1256.0 34 8 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 459 59 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540430.[MT7]-VADGEGWFPASFVR.3y5_1.heavy 561.287 / 579.325 20864.0 41.85127544403076 43 20 10 7 6 9.33305263275913 10.714607956779195 0.029300689697265625 5 0.9970498166344911 22.715956915511494 20864.0 -0.3945618339619877 2.0 - - - - - - - 690.2857142857143 42 14 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 461 60 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59072.[MT7]-LGDIFR.2y4_1.heavy 432.757 / 550.298 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 463 60 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59072.[MT7]-LGDIFR.2y5_1.heavy 432.757 / 607.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 465 60 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59072.[MT7]-LGDIFR.2b4_1.heavy 432.757 / 543.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 467 60 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59072.[MT7]-LGDIFR.2y3_1.heavy 432.757 / 435.271 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 469 61 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59489.[MT7]-HNFTIMTK[MT7].2y5_1.heavy 640.357 / 737.435 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 471 61 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59489.[MT7]-HNFTIMTK[MT7].2y3_1.heavy 640.357 / 523.303 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 473 61 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59489.[MT7]-HNFTIMTK[MT7].2y6_1.heavy 640.357 / 884.503 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 475 61 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59489.[MT7]-HNFTIMTK[MT7].2y7_1.heavy 640.357 / 998.546 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 477 62 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57955.[MT7]-RDHVLHVTFPK[MT7].3b4_1.heavy 546.322 / 652.365 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 479 62 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57955.[MT7]-RDHVLHVTFPK[MT7].3b5_1.heavy 546.322 / 765.449 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 481 62 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57955.[MT7]-RDHVLHVTFPK[MT7].3y4_1.heavy 546.322 / 636.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 483 62 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57955.[MT7]-RDHVLHVTFPK[MT7].3b3_1.heavy 546.322 / 553.296 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 485 63 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59485.[MT7]-TYGEIFEK[MT7].2y4_1.heavy 637.847 / 680.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 487 63 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59485.[MT7]-TYGEIFEK[MT7].2b4_1.heavy 637.847 / 595.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 489 63 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59485.[MT7]-TYGEIFEK[MT7].2y3_1.heavy 637.847 / 567.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 491 63 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59485.[MT7]-TYGEIFEK[MT7].2y6_1.heavy 637.847 / 866.474 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 493 64 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57957.[MT7]-GLMC[CAM]LEHEDEK[MT7].3b6_1.heavy 550.269 / 848.413 16906.0 32.56543477376302 32 7 10 5 10 0.5896694412903613 97.42167133995724 0.0457000732421875 3 0.7470642172202419 2.4001943540095647 16906.0 116.87191304347826 0.0 - - - - - - - 207.0 33 10 MID1 midline 1 (Opitz/BBB syndrome) 495 64 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57957.[MT7]-GLMC[CAM]LEHEDEK[MT7].3y3_1.heavy 550.269 / 535.284 8281.0 32.56543477376302 32 7 10 5 10 0.5896694412903613 97.42167133995724 0.0457000732421875 3 0.7470642172202419 2.4001943540095647 8281.0 10.385869565217392 0.0 - - - - - - - 1221.875 16 8 MID1 midline 1 (Opitz/BBB syndrome) 497 64 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57957.[MT7]-GLMC[CAM]LEHEDEK[MT7].3b4_1.heavy 550.269 / 606.286 N/A 32.56543477376302 32 7 10 5 10 0.5896694412903613 97.42167133995724 0.0457000732421875 3 0.7470642172202419 2.4001943540095647 920.0 1.6666666666666665 16.0 - - - - - - - 755.7142857142857 3 7 MID1 midline 1 (Opitz/BBB syndrome) 499 64 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57957.[MT7]-GLMC[CAM]LEHEDEK[MT7].3y4_1.heavy 550.269 / 664.327 5980.0 32.56543477376302 32 7 10 5 10 0.5896694412903613 97.42167133995724 0.0457000732421875 3 0.7470642172202419 2.4001943540095647 5980.0 10.864168421052632 0.0 - - - - - - - 377.85714285714283 11 7 MID1 midline 1 (Opitz/BBB syndrome) 501 65 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57959.[MT7]-LTVYTTLIDVTK[MT7].2y4_1.heavy 827.997 / 606.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 503 65 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57959.[MT7]-LTVYTTLIDVTK[MT7].2y8_1.heavy 827.997 / 1034.62 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 505 65 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57959.[MT7]-LTVYTTLIDVTK[MT7].2y9_1.heavy 827.997 / 1197.68 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 507 65 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57959.[MT7]-LTVYTTLIDVTK[MT7].2y6_1.heavy 827.997 / 832.526 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 509 66 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47416.[MT7]-RNTELETLLAK[MT7].2b8_1.heavy 788.469 / 1101.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 511 66 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47416.[MT7]-RNTELETLLAK[MT7].2y4_1.heavy 788.469 / 588.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 513 66 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47416.[MT7]-RNTELETLLAK[MT7].2b6_1.heavy 788.469 / 887.47 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 515 66 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47416.[MT7]-RNTELETLLAK[MT7].2b9_1.heavy 788.469 / 1214.69 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 517 67 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57958.[MT7]-WK[MT7]HPFFLDDR.3y7_1.heavy 550.299 / 909.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 519 67 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57958.[MT7]-WK[MT7]HPFFLDDR.3y6_1.heavy 550.299 / 812.394 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 521 67 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57958.[MT7]-WK[MT7]HPFFLDDR.3y4_1.heavy 550.299 / 518.257 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 523 67 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57958.[MT7]-WK[MT7]HPFFLDDR.3y5_1.heavy 550.299 / 665.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 525 68 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540702.[MT7]-LIQTC[CAM]QHVEVNASR.3y7_1.heavy 600.317 / 774.41 8785.0 24.72847557067871 43 17 10 6 10 4.384600977738548 22.807092482923533 0.0381011962890625 3 0.9733045288357204 7.536551474073274 8785.0 84.28932905885048 0.0 - - - - - - - 652.2857142857143 17 7 MID1 midline 1 (Opitz/BBB syndrome) 527 68 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540702.[MT7]-LIQTC[CAM]QHVEVNASR.3b6_1.heavy 600.317 / 888.473 2630.0 24.72847557067871 43 17 10 6 10 4.384600977738548 22.807092482923533 0.0381011962890625 3 0.9733045288357204 7.536551474073274 2630.0 59.63095477386935 0.0 - - - - - - - 175.23529411764707 5 17 MID1 midline 1 (Opitz/BBB syndrome) 529 68 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540702.[MT7]-LIQTC[CAM]QHVEVNASR.3y6_1.heavy 600.317 / 675.342 15882.0 24.72847557067871 43 17 10 6 10 4.384600977738548 22.807092482923533 0.0381011962890625 3 0.9733045288357204 7.536551474073274 15882.0 43.08741519054197 0.0 - - - - - - - 724.6 31 10 MID1 midline 1 (Opitz/BBB syndrome) 531 68 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540702.[MT7]-LIQTC[CAM]QHVEVNASR.3y5_1.heavy 600.317 / 546.299 3127.0 24.72847557067871 43 17 10 6 10 4.384600977738548 22.807092482923533 0.0381011962890625 3 0.9733045288357204 7.536551474073274 3127.0 10.141853448693166 0.0 - - - - - - - 729.5 6 10 MID1 midline 1 (Opitz/BBB syndrome) 533 69 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540032.[MT7]-GK[MT7]LQYELQYR.3y6_1.heavy 529.303 / 871.431 6081.0 27.75160026550293 41 13 10 10 8 2.1819036635017137 45.831537694707876 0.0 4 0.910443125980023 4.09276836618316 6081.0 48.09830508474577 0.0 - - - - - - - 203.8181818181818 12 22 IL21R interleukin 21 receptor 535 69 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540032.[MT7]-GK[MT7]LQYELQYR.3b4_1.heavy 529.303 / 715.471 2362.0 27.75160026550293 41 13 10 10 8 2.1819036635017137 45.831537694707876 0.0 4 0.910443125980023 4.09276836618316 2362.0 4.48488150858016 1.0 - - - - - - - 728.3333333333334 4 9 IL21R interleukin 21 receptor 537 69 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540032.[MT7]-GK[MT7]LQYELQYR.3b4_2.heavy 529.303 / 358.239 16178.0 27.75160026550293 41 13 10 10 8 2.1819036635017137 45.831537694707876 0.0 4 0.910443125980023 4.09276836618316 16178.0 18.302837998902362 1.0 - - - - - - - 1686.7142857142858 34 7 IL21R interleukin 21 receptor 539 69 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540032.[MT7]-GK[MT7]LQYELQYR.3y5_1.heavy 529.303 / 708.367 5137.0 27.75160026550293 41 13 10 10 8 2.1819036635017137 45.831537694707876 0.0 4 0.910443125980023 4.09276836618316 5137.0 15.087657957017523 0.0 - - - - - - - 642.0 10 8 IL21R interleukin 21 receptor 541 70 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47418.[MT7]-SVSLLPLEFRK[MT7].3y7_1.heavy 526.327 / 1046.65 N/A 37.06420135498047 41 13 10 10 8 2.118173432444304 47.21048733228762 0.0 4 0.9030045052700948 3.9301765266935256 0.0 0.0 10.0 - - - - - - - 0.0 0 0 IL21R interleukin 21 receptor 543 70 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47418.[MT7]-SVSLLPLEFRK[MT7].3y3_1.heavy 526.327 / 594.384 1636.0 37.06420135498047 41 13 10 10 8 2.118173432444304 47.21048733228762 0.0 4 0.9030045052700948 3.9301765266935256 1636.0 3.3021229050279333 0.0 - - - - - - - 668.4615384615385 3 13 IL21R interleukin 21 receptor 545 70 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47418.[MT7]-SVSLLPLEFRK[MT7].3y6_1.heavy 526.327 / 933.564 4294.0 37.06420135498047 41 13 10 10 8 2.118173432444304 47.21048733228762 0.0 4 0.9030045052700948 3.9301765266935256 4294.0 5.952677853406601 1.0 - - - - - - - 293.875 8 8 IL21R interleukin 21 receptor 547 70 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47418.[MT7]-SVSLLPLEFRK[MT7].3b4_1.heavy 526.327 / 531.326 3169.0 37.06420135498047 41 13 10 10 8 2.118173432444304 47.21048733228762 0.0 4 0.9030045052700948 3.9301765266935256 3169.0 0.050601711043999076 3.0 - - - - - - - 658.7777777777778 6 9 IL21R interleukin 21 receptor 549 71 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539272.[MT7]-GTLPAVEPFQR.3b6_1.heavy 453.59 / 683.421 54950.0 32.40909957885742 50 20 10 10 10 17.60295120661906 5.680865601808747 0.0 3 0.9988310770936881 36.09334405313542 54950.0 145.77126288659792 0.0 - - - - - - - 266.0 109 5 POLR1D polymerase (RNA) I polypeptide D, 16kDa 551 71 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539272.[MT7]-GTLPAVEPFQR.3b5_1.heavy 453.59 / 584.352 317072.0 32.40909957885742 50 20 10 10 10 17.60295120661906 5.680865601808747 0.0 3 0.9988310770936881 36.09334405313542 317072.0 395.60836780377235 0.0 - - - - - - - 387.5 634 2 POLR1D polymerase (RNA) I polypeptide D, 16kDa 553 71 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539272.[MT7]-GTLPAVEPFQR.3y4_1.heavy 453.59 / 547.299 438826.0 32.40909957885742 50 20 10 10 10 17.60295120661906 5.680865601808747 0.0 3 0.9988310770936881 36.09334405313542 438826.0 626.0780593154032 0.0 - - - - - - - 443.0 877 1 POLR1D polymerase (RNA) I polypeptide D, 16kDa 555 71 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539272.[MT7]-GTLPAVEPFQR.3y5_1.heavy 453.59 / 676.341 78105.0 32.40909957885742 50 20 10 10 10 17.60295120661906 5.680865601808747 0.0 3 0.9988310770936881 36.09334405313542 78105.0 195.6396235871275 0.0 - - - - - - - 237.57142857142858 156 7 POLR1D polymerase (RNA) I polypeptide D, 16kDa 557 72 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540705.[MT7]-TRQGVEDAFYTLVR.3y7_1.heavy 600.324 / 869.488 8490.0 36.90019989013672 43 13 10 10 10 10.592215345410283 9.440895670926011 0.0 3 0.9175647470381998 4.268510058301658 8490.0 115.50622668579626 0.0 - - - - - - - 215.0 16 10 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 559 72 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540705.[MT7]-TRQGVEDAFYTLVR.3y6_1.heavy 600.324 / 798.451 11763.0 36.90019989013672 43 13 10 10 10 10.592215345410283 9.440895670926011 0.0 3 0.9175647470381998 4.268510058301658 11763.0 124.70145842918173 0.0 - - - - - - - 276.2 23 10 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 561 72 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540705.[MT7]-TRQGVEDAFYTLVR.3b7_1.heavy 600.324 / 930.476 6240.0 36.90019989013672 43 13 10 10 10 10.592215345410283 9.440895670926011 0.0 3 0.9175647470381998 4.268510058301658 6240.0 48.734166997696036 0.0 - - - - - - - 181.77777777777777 12 9 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 563 72 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540705.[MT7]-TRQGVEDAFYTLVR.3y5_1.heavy 600.324 / 651.382 22197.0 36.90019989013672 43 13 10 10 10 10.592215345410283 9.440895670926011 0.0 3 0.9175647470381998 4.268510058301658 22197.0 39.37177374301676 0.0 - - - - - - - 726.3 44 10 HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 565 73 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537697.[MT7]-SNLHK[MT7].2y4_1.heavy 443.771 / 655.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 567 73 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537697.[MT7]-SNLHK[MT7].2b3_1.heavy 443.771 / 459.268 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 569 73 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537697.[MT7]-SNLHK[MT7].2b4_1.heavy 443.771 / 596.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 571 73 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537697.[MT7]-SNLHK[MT7].2y3_1.heavy 443.771 / 541.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 573 74 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59581.[MT7]-DVEAALHAMK[MT7].3y3_1.heavy 458.255 / 493.293 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 575 74 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59581.[MT7]-DVEAALHAMK[MT7].3b3_1.heavy 458.255 / 488.247 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 577 74 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59581.[MT7]-DVEAALHAMK[MT7].3b7_2.heavy 458.255 / 440.736 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 579 75 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538553.[MT7]-AIVWGMQTR.2y8_1.heavy 603.333 / 990.519 3208.0 33.67279815673828 46 16 10 10 10 2.2080583718512736 35.96878431857946 0.0 3 0.9609968870085206 6.228607451903766 3208.0 31.382513843822252 0.0 - - - - - - - 187.25 6 8 ACLY ATP citrate lyase 581 75 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538553.[MT7]-AIVWGMQTR.2y5_1.heavy 603.333 / 592.287 7058.0 33.67279815673828 46 16 10 10 10 2.2080583718512736 35.96878431857946 0.0 3 0.9609968870085206 6.228607451903766 7058.0 9.682057677318785 2.0 - - - - - - - 719.7272727272727 14 11 ACLY ATP citrate lyase 583 75 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538553.[MT7]-AIVWGMQTR.2y6_1.heavy 603.333 / 778.367 9946.0 33.67279815673828 46 16 10 10 10 2.2080583718512736 35.96878431857946 0.0 3 0.9609968870085206 6.228607451903766 9946.0 32.754962171784605 0.0 - - - - - - - 188.8235294117647 19 17 ACLY ATP citrate lyase 585 75 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538553.[MT7]-AIVWGMQTR.2y7_1.heavy 603.333 / 877.435 5454.0 33.67279815673828 46 16 10 10 10 2.2080583718512736 35.96878431857946 0.0 3 0.9609968870085206 6.228607451903766 5454.0 89.71065420560748 0.0 - - - - - - - 225.88888888888889 10 9 ACLY ATP citrate lyase 587 76 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540425.[MT7]-SPVSVDDLWLEK[MT7].3y3_1.heavy 559.31 / 533.341 199989.0 39.147701263427734 45 15 10 10 10 2.404191646000963 33.161410567911865 0.0 3 0.9583063692922178 6.022917311044818 199989.0 172.46380677273538 0.0 - - - - - - - 732.8571428571429 399 7 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 589 76 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540425.[MT7]-SPVSVDDLWLEK[MT7].3y4_1.heavy 559.31 / 719.421 67167.0 39.147701263427734 45 15 10 10 10 2.404191646000963 33.161410567911865 0.0 3 0.9583063692922178 6.022917311044818 67167.0 97.82492517835134 0.0 - - - - - - - 343.6363636363636 134 11 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 591 76 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540425.[MT7]-SPVSVDDLWLEK[MT7].3b8_1.heavy 559.31 / 957.501 45815.0 39.147701263427734 45 15 10 10 10 2.404191646000963 33.161410567911865 0.0 3 0.9583063692922178 6.022917311044818 45815.0 36.12580503584651 1.0 - - - - - - - 161.0 91 12 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 593 76 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540425.[MT7]-SPVSVDDLWLEK[MT7].3b7_1.heavy 559.31 / 844.417 110040.0 39.147701263427734 45 15 10 10 10 2.404191646000963 33.161410567911865 0.0 3 0.9583063692922178 6.022917311044818 110040.0 196.9067053861785 0.0 - - - - - - - 756.8571428571429 220 7 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 595 77 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539405.[MT7]-C[CAM]VVYEGNQK[MT7].3y3_1.heavy 462.243 / 533.316 3789.0 20.822399139404297 50 20 10 10 10 9.717853844529802 10.29033792850159 0.0 3 0.9949726145396991 17.3983940295649 3789.0 11.091796936131734 0.0 - - - - - - - 723.8571428571429 7 7 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 597 77 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539405.[MT7]-C[CAM]VVYEGNQK[MT7].3b4_1.heavy 462.243 / 666.34 5465.0 20.822399139404297 50 20 10 10 10 9.717853844529802 10.29033792850159 0.0 3 0.9949726145396991 17.3983940295649 5465.0 12.178272980501392 1.0 - - - - - - - 204.65217391304347 10 23 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 599 77 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539405.[MT7]-C[CAM]VVYEGNQK[MT7].3y4_1.heavy 462.243 / 590.338 5305.0 20.822399139404297 50 20 10 10 10 9.717853844529802 10.29033792850159 0.0 3 0.9949726145396991 17.3983940295649 5305.0 17.554822675417643 0.0 - - - - - - - 186.94736842105263 10 19 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 601 77 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539405.[MT7]-C[CAM]VVYEGNQK[MT7].3b3_1.heavy 462.243 / 503.277 16833.0 20.822399139404297 50 20 10 10 10 9.717853844529802 10.29033792850159 0.0 3 0.9949726145396991 17.3983940295649 16833.0 53.45930512016719 0.0 - - - - - - - 777.625 33 8 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 603 78 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47127.[MT7]-TLC[CAM]TQGLQR.2y8_1.heavy 610.831 / 975.504 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2 605 78 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47127.[MT7]-TLC[CAM]TQGLQR.2y5_1.heavy 610.831 / 601.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2 607 78 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47127.[MT7]-TLC[CAM]TQGLQR.2y6_1.heavy 610.831 / 702.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2 609 78 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47127.[MT7]-TLC[CAM]TQGLQR.2y7_1.heavy 610.831 / 862.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2 611 79 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539406.[MT7]-NPQAVLDVLK[MT7].3b4_1.heavy 462.285 / 555.301 61758.0 37.19219970703125 47 17 10 10 10 7.174590892757736 13.938076957244103 0.0 3 0.9775444714808336 8.220243263363948 61758.0 161.2957804819393 0.0 - - - - - - - 250.36363636363637 123 11 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 613 79 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539406.[MT7]-NPQAVLDVLK[MT7].3b5_1.heavy 462.285 / 654.369 32102.0 37.19219970703125 47 17 10 10 10 7.174590892757736 13.938076957244103 0.0 3 0.9775444714808336 8.220243263363948 32102.0 137.67655700244472 0.0 - - - - - - - 218.57142857142858 64 7 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 615 79 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539406.[MT7]-NPQAVLDVLK[MT7].3y4_1.heavy 462.285 / 618.394 33631.0 37.19219970703125 47 17 10 10 10 7.174590892757736 13.938076957244103 0.0 3 0.9775444714808336 8.220243263363948 33631.0 81.4456935251498 0.0 - - - - - - - 178.5 67 4 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 617 79 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539406.[MT7]-NPQAVLDVLK[MT7].3b3_1.heavy 462.285 / 484.264 22930.0 37.19219970703125 47 17 10 10 10 7.174590892757736 13.938076957244103 0.0 3 0.9775444714808336 8.220243263363948 22930.0 43.660281642654596 0.0 - - - - - - - 272.0 45 9 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 619 80 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538239.[MT7]-EQYDEK[MT7].2y4_1.heavy 550.279 / 698.348 2483.0 16.40120029449463 40 14 10 6 10 2.8300390861615177 35.33520101859566 0.03660011291503906 3 0.9455994943590796 5.267107060020044 2483.0 34.942938850444854 0.0 - - - - - - - 149.33333333333334 4 15 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 621 80 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538239.[MT7]-EQYDEK[MT7].2y5_1.heavy 550.279 / 826.406 3700.0 16.40120029449463 40 14 10 6 10 2.8300390861615177 35.33520101859566 0.03660011291503906 3 0.9455994943590796 5.267107060020044 3700.0 32.33465503568596 0.0 - - - - - - - 100.85714285714286 7 14 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 623 80 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538239.[MT7]-EQYDEK[MT7].2b4_1.heavy 550.279 / 680.301 8082.0 16.40120029449463 40 14 10 6 10 2.8300390861615177 35.33520101859566 0.03660011291503906 3 0.9455994943590796 5.267107060020044 8082.0 37.08067339877922 0.0 - - - - - - - 174.26315789473685 16 19 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 625 80 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538239.[MT7]-EQYDEK[MT7].2b5_1.heavy 550.279 / 809.343 2094.0 16.40120029449463 40 14 10 6 10 2.8300390861615177 35.33520101859566 0.03660011291503906 3 0.9455994943590796 5.267107060020044 2094.0 37.43120879120879 0.0 - - - - - - - 126.6 4 15 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 627 81 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59066.[MT7]-DQYMR.2b3_1.heavy 428.709 / 551.258 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS;RIT1 v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog;Ras-like without CAAX 1 629 81 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59066.[MT7]-DQYMR.2y4_1.heavy 428.709 / 597.281 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS;RIT1 v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog;Ras-like without CAAX 1 631 81 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59066.[MT7]-DQYMR.2b4_1.heavy 428.709 / 682.299 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS;RIT1 v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog;Ras-like without CAAX 1 633 81 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59066.[MT7]-DQYMR.2y3_1.heavy 428.709 / 469.223 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS;RIT1 v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog;Ras-like without CAAX 1 635 82 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59479.[MT7]-DHQVAALSER.2y8_1.heavy 635.337 / 873.479 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 637 82 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59479.[MT7]-DHQVAALSER.2b4_1.heavy 635.337 / 624.322 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 639 82 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59479.[MT7]-DHQVAALSER.2y6_1.heavy 635.337 / 646.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 641 82 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59479.[MT7]-DHQVAALSER.2y7_1.heavy 635.337 / 745.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 643 83 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 EFTU1_ECO24.FESEVYILSK.2y8.peptide 607.82 / 938.52 606868.0 33.7958984375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 606868.0 174.1946713479674 0.0 - - - - - - - 207.57142857142858 1213 7 645 83 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 EFTU1_ECO24.FESEVYILSK.2y6.peptide 607.82 / 722.44 171709.0 33.7958984375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 171709.0 110.89568902822171 0.0 - - - - - - - 637.4285714285714 343 7 647 83 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 EFTU1_ECO24.FESEVYILSK.2y5.peptide 607.82 / 623.38 228461.0 33.7958984375 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 228461.0 107.20383139319438 0.0 - - - - - - - 696.7142857142857 456 7 649 84 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539507.[MT7]-EFLPQSAFLK[MT7].3y3_1.heavy 489.953 / 551.367 114966.0 37.78340148925781 50 20 10 10 10 8.080648605608646 12.37524422613695 0.0 3 0.9903271488556676 12.538177764436487 114966.0 179.41183311353558 0.0 - - - - - - - 344.4 229 5 LIPA lipase A, lysosomal acid, cholesterol esterase 651 84 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539507.[MT7]-EFLPQSAFLK[MT7].3y4_1.heavy 489.953 / 622.404 27450.0 37.78340148925781 50 20 10 10 10 8.080648605608646 12.37524422613695 0.0 3 0.9903271488556676 12.538177764436487 27450.0 28.996717800615826 0.0 - - - - - - - 671.0 54 8 LIPA lipase A, lysosomal acid, cholesterol esterase 653 84 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539507.[MT7]-EFLPQSAFLK[MT7].3b3_1.heavy 489.953 / 534.304 205824.0 37.78340148925781 50 20 10 10 10 8.080648605608646 12.37524422613695 0.0 3 0.9903271488556676 12.538177764436487 205824.0 308.58575606859176 0.0 - - - - - - - 694.4285714285714 411 7 LIPA lipase A, lysosomal acid, cholesterol esterase 655 84 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539507.[MT7]-EFLPQSAFLK[MT7].3y5_1.heavy 489.953 / 709.437 43049.0 37.78340148925781 50 20 10 10 10 8.080648605608646 12.37524422613695 0.0 3 0.9903271488556676 12.538177764436487 43049.0 129.82374543716077 0.0 - - - - - - - 283.7 86 10 LIPA lipase A, lysosomal acid, cholesterol esterase 657 85 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540036.[MT7]-ASVSGPNSPSETRR.3y6_1.heavy 530.277 / 745.395 1743.0 15.840999603271484 39 9 10 10 10 0.8987456988651011 72.41023935290846 0.0 3 0.8007129068729693 2.7172609033697355 1743.0 13.456218295810771 0.0 - - - - - - - 223.66666666666666 3 21 MID1 midline 1 (Opitz/BBB syndrome) 659 85 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540036.[MT7]-ASVSGPNSPSETRR.3b5_1.heavy 530.277 / 546.3 3148.0 15.840999603271484 39 9 10 10 10 0.8987456988651011 72.41023935290846 0.0 3 0.8007129068729693 2.7172609033697355 3148.0 10.456171638281678 0.0 - - - - - - - 698.8571428571429 6 7 MID1 midline 1 (Opitz/BBB syndrome) 661 85 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540036.[MT7]-ASVSGPNSPSETRR.3b7_1.heavy 530.277 / 757.396 1017.0 15.840999603271484 39 9 10 10 10 0.8987456988651011 72.41023935290846 0.0 3 0.8007129068729693 2.7172609033697355 1017.0 2.9404958677685946 0.0 - - - - - - - 200.27272727272728 2 22 MID1 midline 1 (Opitz/BBB syndrome) 663 85 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540036.[MT7]-ASVSGPNSPSETRR.3y13_2.heavy 530.277 / 687.342 5327.0 15.840999603271484 39 9 10 10 10 0.8987456988651011 72.41023935290846 0.0 3 0.8007129068729693 2.7172609033697355 5327.0 18.02528499925295 0.0 - - - - - - - 224.85714285714286 10 14 MID1 midline 1 (Opitz/BBB syndrome) 665 86 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537513.[MT7]-ELGLIR.2b3_1.heavy 422.772 / 444.258 8738.0 30.555299758911133 43 13 10 10 10 1.6343242991142843 48.20252640556439 0.0 3 0.9293688811312477 4.616090779872752 8738.0 24.980162037037037 1.0 - - - - - - - 268.8 17 10 ACLY ATP citrate lyase 667 86 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537513.[MT7]-ELGLIR.2y5_1.heavy 422.772 / 571.393 26501.0 30.555299758911133 43 13 10 10 10 1.6343242991142843 48.20252640556439 0.0 3 0.9293688811312477 4.616090779872752 26501.0 68.46091666666666 0.0 - - - - - - - 324.9230769230769 53 13 ACLY ATP citrate lyase 669 86 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537513.[MT7]-ELGLIR.2b4_1.heavy 422.772 / 557.341 16227.0 30.555299758911133 43 13 10 10 10 1.6343242991142843 48.20252640556439 0.0 3 0.9293688811312477 4.616090779872752 16227.0 105.92625 0.0 - - - - - - - 192.0 32 13 ACLY ATP citrate lyase 671 86 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537513.[MT7]-ELGLIR.2b5_1.heavy 422.772 / 670.426 7393.0 30.555299758911133 43 13 10 10 10 1.6343242991142843 48.20252640556439 0.0 3 0.9293688811312477 4.616090779872752 7393.0 38.505208333333336 0.0 - - - - - - - 164.57142857142858 14 7 ACLY ATP citrate lyase 673 87 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538231.[MT7]-ADEVAPAK[MT7].2y4_1.heavy 544.813 / 530.342 7365.0 17.759300231933594 44 18 10 6 10 3.131251551509496 25.50422755664978 0.036998748779296875 3 0.9801607018644269 8.747391891714196 7365.0 14.273327995280034 0.0 - - - - - - - 700.375 14 16 ACLY ATP citrate lyase 675 87 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538231.[MT7]-ADEVAPAK[MT7].2y5_1.heavy 544.813 / 629.41 2745.0 17.759300231933594 44 18 10 6 10 3.131251551509496 25.50422755664978 0.036998748779296875 3 0.9801607018644269 8.747391891714196 2745.0 21.936026200873364 0.0 - - - - - - - 139.55 5 20 ACLY ATP citrate lyase 677 87 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538231.[MT7]-ADEVAPAK[MT7].2b4_1.heavy 544.813 / 559.284 4941.0 17.759300231933594 44 18 10 6 10 3.131251551509496 25.50422755664978 0.036998748779296875 3 0.9801607018644269 8.747391891714196 4941.0 38.837554585152844 0.0 - - - - - - - 142.9375 9 16 ACLY ATP citrate lyase 679 87 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538231.[MT7]-ADEVAPAK[MT7].2b5_1.heavy 544.813 / 630.321 5078.0 17.759300231933594 44 18 10 6 10 3.131251551509496 25.50422755664978 0.036998748779296875 3 0.9801607018644269 8.747391891714196 5078.0 56.72637312338635 0.0 - - - - - - - 162.61111111111111 10 18 ACLY ATP citrate lyase 681 88 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538233.[MT7]-DVLYYK[MT7].2y4_1.heavy 544.815 / 730.426 14209.0 29.131000518798828 50 20 10 10 10 9.057194208268006 11.040946865058208 0.0 3 0.9970437962829686 22.692803042771953 14209.0 20.68250822368421 0.0 - - - - - - - 662.2857142857143 28 14 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 683 88 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538233.[MT7]-DVLYYK[MT7].2y5_1.heavy 544.815 / 829.494 9194.0 29.131000518798828 50 20 10 10 10 9.057194208268006 11.040946865058208 0.0 3 0.9970437962829686 22.692803042771953 9194.0 35.48561403508772 0.0 - - - - - - - 231.61904761904762 18 21 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 685 88 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538233.[MT7]-DVLYYK[MT7].2b4_1.heavy 544.815 / 635.352 7902.0 29.131000518798828 50 20 10 10 10 9.057194208268006 11.040946865058208 0.0 3 0.9970437962829686 22.692803042771953 7902.0 16.569774436090228 0.0 - - - - - - - 713.2307692307693 15 13 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 687 88 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538233.[MT7]-DVLYYK[MT7].2y3_1.heavy 544.815 / 617.341 25303.0 29.131000518798828 50 20 10 10 10 9.057194208268006 11.040946865058208 0.0 3 0.9970437962829686 22.692803042771953 25303.0 36.30941331269349 0.0 - - - - - - - 1190.6666666666667 50 9 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 689 89 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540322.[MT7]-RDHVLHVTFPK[MT7].4b4_1.heavy 409.994 / 652.365 2437.0 26.024700164794922 32 2 10 10 10 0.3034698923598764 120.28816814236484 0.0 3 0.49284632186759625 1.6536533617423137 2437.0 45.39509803921568 0.0 - - - - - - - 158.875 4 16 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 691 89 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540322.[MT7]-RDHVLHVTFPK[MT7].4b5_1.heavy 409.994 / 765.449 3656.0 26.024700164794922 32 2 10 10 10 0.3034698923598764 120.28816814236484 0.0 3 0.49284632186759625 1.6536533617423137 3656.0 94.62588235294118 0.0 - - - - - - - 111.8 7 10 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 693 89 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540322.[MT7]-RDHVLHVTFPK[MT7].4b3_1.heavy 409.994 / 553.296 2691.0 26.024700164794922 32 2 10 10 10 0.3034698923598764 120.28816814236484 0.0 3 0.49284632186759625 1.6536533617423137 2691.0 10.774947452769132 1.0 - - - - - - - 237.8421052631579 5 19 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 695 89 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540322.[MT7]-RDHVLHVTFPK[MT7].4b6_2.heavy 409.994 / 451.758 16350.0 26.024700164794922 32 2 10 10 10 0.3034698923598764 120.28816814236484 0.0 3 0.49284632186759625 1.6536533617423137 16350.0 98.12156239090803 0.0 - - - - - - - 200.23529411764707 32 17 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 697 90 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47546.[MT7]-GIHVETLETEK[MT7]K[MT7].3b4_1.heavy 606.023 / 551.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 699 90 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47546.[MT7]-GIHVETLETEK[MT7]K[MT7].3b3_1.heavy 606.023 / 452.274 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 701 90 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47546.[MT7]-GIHVETLETEK[MT7]K[MT7].3y8_2.heavy 606.023 / 633.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 703 90 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47546.[MT7]-GIHVETLETEK[MT7]K[MT7].3y5_1.heavy 606.023 / 922.545 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 705 91 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537683.[MT7]-ENDHAR.2b3_1.heavy 443.218 / 503.222 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 707 91 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537683.[MT7]-ENDHAR.2y5_1.heavy 443.218 / 612.285 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 709 91 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537683.[MT7]-ENDHAR.2b4_1.heavy 443.218 / 640.281 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 711 91 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537683.[MT7]-ENDHAR.2b5_1.heavy 443.218 / 711.318 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 713 92 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59972.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3y7_1.heavy 728.022 / 872.496 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 715 92 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59972.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3b4_1.heavy 728.022 / 645.351 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 717 92 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59972.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3y4_1.heavy 728.022 / 576.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 719 92 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59972.[MT7]-VLC[CAM]QFC[CAM]DQDPAQDAVK[MT7].3b7_2.heavy 728.022 / 534.242 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 721 93 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57989.[MT7]-TIAIIAEGIPEALTR.2b4_1.heavy 856.507 / 543.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 723 93 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57989.[MT7]-TIAIIAEGIPEALTR.2y6_1.heavy 856.507 / 686.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 725 93 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57989.[MT7]-TIAIIAEGIPEALTR.2y10_1.heavy 856.507 / 1056.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 727 93 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57989.[MT7]-TIAIIAEGIPEALTR.2y11_1.heavy 856.507 / 1169.65 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 729 94 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47409.[MT7]-ESLDVYELDAK[MT7].2y8_1.heavy 785.416 / 1096.56 1529.0 32.79794883728027 42 17 10 5 10 4.432526266825114 22.56049800504104 0.044300079345703125 3 0.9772745610066276 8.171096128166326 1529.0 18.17966972477064 0.0 - - - - - - - 167.76923076923077 3 13 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 731 94 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47409.[MT7]-ESLDVYELDAK[MT7].2b4_1.heavy 785.416 / 589.295 5353.0 32.79794883728027 42 17 10 5 10 4.432526266825114 22.56049800504104 0.044300079345703125 3 0.9772745610066276 8.171096128166326 5353.0 25.873587413448565 0.0 - - - - - - - 235.07692307692307 10 13 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 733 94 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47409.[MT7]-ESLDVYELDAK[MT7].2b7_1.heavy 785.416 / 980.469 983.0 32.79794883728027 42 17 10 5 10 4.432526266825114 22.56049800504104 0.044300079345703125 3 0.9772745610066276 8.171096128166326 983.0 8.36743119266055 1.0 - - - - - - - 0.0 1 0 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 735 94 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47409.[MT7]-ESLDVYELDAK[MT7].2b5_1.heavy 785.416 / 688.363 2076.0 32.79794883728027 42 17 10 5 10 4.432526266825114 22.56049800504104 0.044300079345703125 3 0.9772745610066276 8.171096128166326 2076.0 22.130692587071987 0.0 - - - - - - - 251.1 4 10 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 737 95 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59472.[MT7]-FIDQVVEK[MT7].2b3_1.heavy 633.371 / 520.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 739 95 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59472.[MT7]-FIDQVVEK[MT7].2b4_1.heavy 633.371 / 648.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 741 95 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59472.[MT7]-FIDQVVEK[MT7].2y3_1.heavy 633.371 / 519.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 743 95 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59472.[MT7]-FIDQVVEK[MT7].2b5_1.heavy 633.371 / 747.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 745 96 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47627.[MT7]-MFFLFDHQLIYC[CAM]K[MT7].3b6_1.heavy 684.023 / 945.466 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 747 96 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47627.[MT7]-MFFLFDHQLIYC[CAM]K[MT7].3y3_1.heavy 684.023 / 614.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 749 96 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47627.[MT7]-MFFLFDHQLIYC[CAM]K[MT7].3b4_1.heavy 684.023 / 683.371 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 751 96 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47627.[MT7]-MFFLFDHQLIYC[CAM]K[MT7].3b3_1.heavy 684.023 / 570.287 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 753 97 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57844.[MT7]-EFLPQSAFLK[MT7].2b3_1.heavy 734.426 / 534.304 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 755 97 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57844.[MT7]-EFLPQSAFLK[MT7].2y5_1.heavy 734.426 / 709.437 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 757 97 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57844.[MT7]-EFLPQSAFLK[MT7].2y3_1.heavy 734.426 / 551.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 759 97 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57844.[MT7]-EFLPQSAFLK[MT7].2y7_1.heavy 734.426 / 934.548 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 761 98 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540417.[MT7]-TTNVSLYPGYNFR.3b6_1.heavy 559.29 / 760.432 23137.0 34.07590103149414 50 20 10 10 10 5.106907444694698 19.58132217647391 0.0 3 0.9933813767100245 15.161379235817265 23137.0 12.335622065029751 0.0 - - - - - - - 652.4285714285714 46 7 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 763 98 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540417.[MT7]-TTNVSLYPGYNFR.3y6_1.heavy 559.29 / 753.368 125539.0 34.07590103149414 50 20 10 10 10 5.106907444694698 19.58132217647391 0.0 3 0.9933813767100245 15.161379235817265 125539.0 105.08020291693089 0.0 - - - - - - - 352.6 251 5 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 765 98 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540417.[MT7]-TTNVSLYPGYNFR.3b5_1.heavy 559.29 / 647.348 42746.0 34.07590103149414 50 20 10 10 10 5.106907444694698 19.58132217647391 0.0 3 0.9933813767100245 15.161379235817265 42746.0 36.53829396747389 1.0 - - - - - - - 804.25 85 4 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 767 98 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540417.[MT7]-TTNVSLYPGYNFR.3y5_1.heavy 559.29 / 656.315 46792.0 34.07590103149414 50 20 10 10 10 5.106907444694698 19.58132217647391 0.0 3 0.9933813767100245 15.161379235817265 46792.0 36.36020483579061 0.0 - - - - - - - 252.0 93 7 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 769 99 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540412.[MT7]-QNLESNLTNLIK[MT7].3b6_1.heavy 558.992 / 830.412 35581.0 37.40549850463867 47 17 10 10 10 2.4444399889241106 33.53233943320801 0.0 3 0.9717856917706895 7.329953733023181 35581.0 106.10272050633893 0.0 - - - - - - - 203.4 71 10 MID1 midline 1 (Opitz/BBB syndrome) 771 99 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540412.[MT7]-QNLESNLTNLIK[MT7].3b4_1.heavy 558.992 / 629.338 27855.0 37.40549850463867 47 17 10 10 10 2.4444399889241106 33.53233943320801 0.0 3 0.9717856917706895 7.329953733023181 27855.0 59.468807795565276 0.0 - - - - - - - 691.4 55 10 MID1 midline 1 (Opitz/BBB syndrome) 773 99 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540412.[MT7]-QNLESNLTNLIK[MT7].3y4_1.heavy 558.992 / 631.426 31514.0 37.40549850463867 47 17 10 10 10 2.4444399889241106 33.53233943320801 0.0 3 0.9717856917706895 7.329953733023181 31514.0 51.28633913981105 0.0 - - - - - - - 1060.4285714285713 63 7 MID1 midline 1 (Opitz/BBB syndrome) 775 99 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540412.[MT7]-QNLESNLTNLIK[MT7].3b3_1.heavy 558.992 / 500.295 22263.0 37.40549850463867 47 17 10 10 10 2.4444399889241106 33.53233943320801 0.0 3 0.9717856917706895 7.329953733023181 22263.0 28.65253780169507 0.0 - - - - - - - 1108.3 44 10 MID1 midline 1 (Opitz/BBB syndrome) 777 100 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538205.[MT7]-ATEEVSK[MT7].2y4_1.heavy 526.297 / 606.358 5996.0 16.41035032272339 43 17 10 6 10 2.4504076208746874 32.5502839183421 0.03660011291503906 3 0.9782889752488293 8.360520458332752 5996.0 64.91887979557305 0.0 - - - - - - - 114.5 11 18 CAB39 calcium binding protein 39 779 100 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538205.[MT7]-ATEEVSK[MT7].2y5_1.heavy 526.297 / 735.401 3293.0 16.41035032272339 43 17 10 6 10 2.4504076208746874 32.5502839183421 0.03660011291503906 3 0.9782889752488293 8.360520458332752 3293.0 22.393766862677275 0.0 - - - - - - - 111.77777777777777 6 18 CAB39 calcium binding protein 39 781 100 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538205.[MT7]-ATEEVSK[MT7].2b4_1.heavy 526.297 / 575.279 5357.0 16.41035032272339 43 17 10 6 10 2.4504076208746874 32.5502839183421 0.03660011291503906 3 0.9782889752488293 8.360520458332752 5357.0 6.66372312529757 0.0 - - - - - - - 208.23809523809524 10 21 CAB39 calcium binding protein 39 783 100 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538205.[MT7]-ATEEVSK[MT7].2y6_1.heavy 526.297 / 836.448 8404.0 16.41035032272339 43 17 10 6 10 2.4504076208746874 32.5502839183421 0.03660011291503906 3 0.9782889752488293 8.360520458332752 8404.0 118.91374149659863 0.0 - - - - - - - 129.45454545454547 16 11 CAB39 calcium binding protein 39 785 101 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47206.[MT7]-VSHDNLTVER.3y3_1.heavy 438.569 / 403.23 15871.0 20.28042507171631 29 17 0 6 6 3.4674565261437023 28.839582917918804 0.030300140380859375 6 0.9794251319591502 8.58907482905239 15871.0 3.0202309282024418 3.0 - - - - - - - 930.0 433 2 MID1 midline 1 (Opitz/BBB syndrome) 787 101 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47206.[MT7]-VSHDNLTVER.3b4_1.heavy 438.569 / 583.296 4670.0 20.28042507171631 29 17 0 6 6 3.4674565261437023 28.839582917918804 0.030300140380859375 6 0.9794251319591502 8.58907482905239 4670.0 15.216061154293941 2.0 - - - - - - - 684.1428571428571 40 7 MID1 midline 1 (Opitz/BBB syndrome) 789 101 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47206.[MT7]-VSHDNLTVER.3y4_1.heavy 438.569 / 504.278 27310.0 20.28042507171631 29 17 0 6 6 3.4674565261437023 28.839582917918804 0.030300140380859375 6 0.9794251319591502 8.58907482905239 27310.0 28.00700057138376 0.0 - - - - - - - 698.0909090909091 54 11 MID1 midline 1 (Opitz/BBB syndrome) 791 101 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47206.[MT7]-VSHDNLTVER.3y5_1.heavy 438.569 / 617.362 6728.0 20.28042507171631 29 17 0 6 6 3.4674565261437023 28.839582917918804 0.030300140380859375 6 0.9794251319591502 8.58907482905239 6728.0 16.96158249158249 0.0 - - - - - - - 704.3 13 10 MID1 midline 1 (Opitz/BBB syndrome) 793 102 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59271.[MT7]-EWWWGR.2b3_1.heavy 532.265 / 646.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 795 102 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59271.[MT7]-EWWWGR.2y4_1.heavy 532.265 / 604.299 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 797 102 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59271.[MT7]-EWWWGR.2y5_1.heavy 532.265 / 790.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 799 102 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59271.[MT7]-EWWWGR.2y3_1.heavy 532.265 / 418.22 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 801 103 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539514.[MT7]-YPLQLAELLK[MT7].2y5_1.heavy 738.457 / 717.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 803 103 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539514.[MT7]-YPLQLAELLK[MT7].2y9_1.heavy 738.457 / 1168.74 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 805 103 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539514.[MT7]-YPLQLAELLK[MT7].2y3_1.heavy 738.457 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 807 103 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539514.[MT7]-YPLQLAELLK[MT7].2y7_1.heavy 738.457 / 958.605 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 809 104 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 SUCC_ECO24.LVQQFTK.2y4.peptide 432.25 / 523.29 206868.0 22.007300059000652 24 -3 10 7 10 null 0.0 0.02970123291015625 3 0.0 0.0 206868.0 335.3388543836102 0.0 - - - - - - - 672.5714285714286 413 7 811 104 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 SUCC_ECO24.LVQQFTK.2y6.peptide 432.25 / 750.41 331399.0 22.007300059000652 24 -3 10 7 10 null 0.0 0.02970123291015625 3 0.0 0.0 331399.0 2543.72170013471 0.0 - - - - - - - 331.60869565217394 662 23 813 104 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 SUCC_ECO24.LVQQFTK.2y5.peptide 432.25 / 651.35 1316830.0 22.007300059000652 24 -3 10 7 10 null 0.0 0.02970123291015625 3 0.0 0.0 1316830.0 991.2827444027018 0.0 - - - - - - - 1208.0 2633 7 815 105 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57438.[MT7]-SPADIVK[MT7].2y4_1.heavy 509.313 / 618.394 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 817 105 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57438.[MT7]-SPADIVK[MT7].2b4_1.heavy 509.313 / 515.258 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 819 105 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57438.[MT7]-SPADIVK[MT7].2y3_1.heavy 509.313 / 503.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 821 105 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57438.[MT7]-SPADIVK[MT7].2y6_1.heavy 509.313 / 786.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 823 106 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58095.[MT7]-GAVPWYTINLDLPPYK[MT7].3y3_1.heavy 712.398 / 551.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 825 106 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58095.[MT7]-GAVPWYTINLDLPPYK[MT7].3b5_1.heavy 712.398 / 655.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 827 106 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58095.[MT7]-GAVPWYTINLDLPPYK[MT7].3y4_1.heavy 712.398 / 648.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 829 106 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58095.[MT7]-GAVPWYTINLDLPPYK[MT7].3b7_1.heavy 712.398 / 919.479 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 831 107 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539518.[MT7]-YPLQLAELLK[MT7].3y3_1.heavy 492.641 / 517.383 904871.0 42.516499519348145 26 2 10 6 8 0.4775026105150582 117.71097390086513 0.033199310302734375 4 0.4483553026858317 1.5782382596865048 904871.0 165.30469267364413 0.0 - - - - - - - 691.4166666666666 1809 12 SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 833 107 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539518.[MT7]-YPLQLAELLK[MT7].3b5_1.heavy 492.641 / 759.452 1106.0 42.516499519348145 26 2 10 6 8 0.4775026105150582 117.71097390086513 0.033199310302734375 4 0.4483553026858317 1.5782382596865048 1106.0 3.205797101449275 2.0 - - - - - - - 253.5 61 12 SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 835 107 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539518.[MT7]-YPLQLAELLK[MT7].3b3_1.heavy 492.641 / 518.31 77863.0 42.516499519348145 26 2 10 6 8 0.4775026105150582 117.71097390086513 0.033199310302734375 4 0.4483553026858317 1.5782382596865048 77863.0 81.41403781979977 1.0 - - - - - - - 198.6875 155 16 SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 837 107 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539518.[MT7]-YPLQLAELLK[MT7].3y5_1.heavy 492.641 / 717.463 277.0 42.516499519348145 26 2 10 6 8 0.4775026105150582 117.71097390086513 0.033199310302734375 4 0.4483553026858317 1.5782382596865048 277.0 0.042923553719008266 18.0 - - - - - - - 191.05882352941177 56 17 SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 839 108 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58094.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].3y6_1.heavy 710.698 / 833.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 841 108 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58094.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].3y3_1.heavy 710.698 / 506.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 843 108 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58094.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].3b5_1.heavy 710.698 / 678.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 845 108 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58094.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].3y5_1.heavy 710.698 / 732.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 847 109 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540359.[MT7]-K[MT7]NPQAVLDVLK[MT7].3y3_1.heavy 553.017 / 503.367 30590.0 32.73059844970703 47 17 10 10 10 4.0039615971003135 24.975264516128334 0.0 3 0.9742696069676735 7.67721178937818 30590.0 40.89497315132302 0.0 - - - - - - - 405.0 61 4 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 849 109 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540359.[MT7]-K[MT7]NPQAVLDVLK[MT7].3b5_1.heavy 553.017 / 827.498 8107.0 32.73059844970703 47 17 10 10 10 4.0039615971003135 24.975264516128334 0.0 3 0.9742696069676735 7.67721178937818 8107.0 31.414624999999997 0.0 - - - - - - - 265.09090909090907 16 11 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 851 109 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540359.[MT7]-K[MT7]NPQAVLDVLK[MT7].3y4_1.heavy 553.017 / 618.394 57721.0 32.73059844970703 47 17 10 10 10 4.0039615971003135 24.975264516128334 0.0 3 0.9742696069676735 7.67721178937818 57721.0 79.33566182633268 0.0 - - - - - - - 678.0909090909091 115 11 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 853 109 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540359.[MT7]-K[MT7]NPQAVLDVLK[MT7].3y5_1.heavy 553.017 / 731.478 38049.0 32.73059844970703 47 17 10 10 10 4.0039615971003135 24.975264516128334 0.0 3 0.9742696069676735 7.67721178937818 38049.0 138.28515454066167 0.0 - - - - - - - 288.0 76 9 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 855 110 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539253.[MT7]-EILYGTNEK[MT7].3y3_1.heavy 452.253 / 534.3 22547.0 26.188899993896484 50 20 10 10 10 16.28224500709544 6.1416592095514 0.0 3 0.9982559480890657 29.547417351561 22547.0 53.35900481838399 0.0 - - - - - - - 798.125 45 8 CAB39 calcium binding protein 39 857 110 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539253.[MT7]-EILYGTNEK[MT7].3b5_1.heavy 452.253 / 720.405 8765.0 26.188899993896484 50 20 10 10 10 16.28224500709544 6.1416592095514 0.0 3 0.9982559480890657 29.547417351561 8765.0 58.989043772798325 0.0 - - - - - - - 240.0 17 19 CAB39 calcium binding protein 39 859 110 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539253.[MT7]-EILYGTNEK[MT7].3y4_1.heavy 452.253 / 635.348 7448.0 26.188899993896484 50 20 10 10 10 16.28224500709544 6.1416592095514 0.0 3 0.9982559480890657 29.547417351561 7448.0 42.372411067193674 0.0 - - - - - - - 253.30769230769232 14 26 CAB39 calcium binding protein 39 861 110 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539253.[MT7]-EILYGTNEK[MT7].3b3_1.heavy 452.253 / 500.32 73569.0 26.188899993896484 50 20 10 10 10 16.28224500709544 6.1416592095514 0.0 3 0.9982559480890657 29.547417351561 73569.0 139.9633482474189 0.0 - - - - - - - 321.0 147 3 CAB39 calcium binding protein 39 863 111 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47534.[MT7]-DLVSSLTSGLLTIGDR.2y10_1.heavy 896.003 / 1032.57 1180.0 48.6885986328125 42 12 10 10 10 0.9500556772540136 60.91199691887449 0.0 3 0.8859213826647918 3.6186154566436937 1180.0 24.067670474212527 0.0 - - - - - - - 144.46153846153845 2 13 ACLY ATP citrate lyase 865 111 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47534.[MT7]-DLVSSLTSGLLTIGDR.2y12_1.heavy 896.003 / 1232.68 N/A 48.6885986328125 42 12 10 10 10 0.9500556772540136 60.91199691887449 0.0 3 0.8859213826647918 3.6186154566436937 214.0 1.5851851851851853 7.0 - - - - - - - 0.0 1 0 ACLY ATP citrate lyase 867 111 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47534.[MT7]-DLVSSLTSGLLTIGDR.2y5_1.heavy 896.003 / 561.299 858.0 48.6885986328125 42 12 10 10 10 0.9500556772540136 60.91199691887449 0.0 3 0.8859213826647918 3.6186154566436937 858.0 6.414953271028037 0.0 - - - - - - - 0.0 1 0 ACLY ATP citrate lyase 869 111 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47534.[MT7]-DLVSSLTSGLLTIGDR.2y9_1.heavy 896.003 / 931.521 590.0 48.6885986328125 42 12 10 10 10 0.9500556772540136 60.91199691887449 0.0 3 0.8859213826647918 3.6186154566436937 590.0 6.300276912426445 2.0 - - - - - - - 0.0 1 0 ACLY ATP citrate lyase 871 112 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46873.[MT7]-SSPDVK[MT7].2y4_1.heavy 460.768 / 602.363 5114.0 15.346574783325195 34 11 10 3 10 1.31600094011109 60.3460687569204 0.073699951171875 3 0.8741266121604895 3.4413668311355257 5114.0 15.304671532846715 0.0 - - - - - - - 190.76470588235293 10 17 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 873 112 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46873.[MT7]-SSPDVK[MT7].2y5_1.heavy 460.768 / 689.395 4064.0 15.346574783325195 34 11 10 3 10 1.31600094011109 60.3460687569204 0.073699951171875 3 0.8741266121604895 3.4413668311355257 4064.0 49.129157991304695 0.0 - - - - - - - 142.8125 8 16 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 875 112 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46873.[MT7]-SSPDVK[MT7].2b4_1.heavy 460.768 / 531.253 9406.0 15.346574783325195 34 11 10 3 10 1.31600094011109 60.3460687569204 0.073699951171875 3 0.8741266121604895 3.4413668311355257 9406.0 26.12232881473757 0.0 - - - - - - - 221.45 18 20 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 877 112 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46873.[MT7]-SSPDVK[MT7].2y3_1.heavy 460.768 / 505.31 776.0 15.346574783325195 34 11 10 3 10 1.31600094011109 60.3460687569204 0.073699951171875 3 0.8741266121604895 3.4413668311355257 776.0 1.4882191780821918 8.0 - - - - - - - 246.1304347826087 2 23 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 879 113 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59981.[MT7]-DLHC[CAM]LLVTNPHTDAWK[MT7].4y4_1.heavy 552.792 / 663.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 881 113 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59981.[MT7]-DLHC[CAM]LLVTNPHTDAWK[MT7].4y5_1.heavy 552.792 / 764.406 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 883 113 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59981.[MT7]-DLHC[CAM]LLVTNPHTDAWK[MT7].4y3_1.heavy 552.792 / 548.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 885 113 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59981.[MT7]-DLHC[CAM]LLVTNPHTDAWK[MT7].4b3_1.heavy 552.792 / 510.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 887 114 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539257.[MT7]-LTVGVYESAK[MT7].3b4_1.heavy 452.266 / 515.331 279670.0 29.548900604248047 48 18 10 10 10 6.02601053298517 16.594727050777642 0.0 3 0.9842742911975958 9.828482634666006 279670.0 409.9693592495614 0.0 - - - - - - - 358.0 559 2 GADD45B growth arrest and DNA-damage-inducible, beta 889 114 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539257.[MT7]-LTVGVYESAK[MT7].3b5_1.heavy 452.266 / 614.399 193493.0 29.548900604248047 48 18 10 10 10 6.02601053298517 16.594727050777642 0.0 3 0.9842742911975958 9.828482634666006 193493.0 270.0939965505 0.0 - - - - - - - 448.0 386 2 GADD45B growth arrest and DNA-damage-inducible, beta 891 114 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539257.[MT7]-LTVGVYESAK[MT7].3y4_1.heavy 452.266 / 578.327 97822.0 29.548900604248047 48 18 10 10 10 6.02601053298517 16.594727050777642 0.0 3 0.9842742911975958 9.828482634666006 97822.0 378.09693986442466 0.0 - - - - - - - 278.6666666666667 195 9 GADD45B growth arrest and DNA-damage-inducible, beta 893 114 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539257.[MT7]-LTVGVYESAK[MT7].3y5_1.heavy 452.266 / 741.39 19439.0 29.548900604248047 48 18 10 10 10 6.02601053298517 16.594727050777642 0.0 3 0.9842742911975958 9.828482634666006 19439.0 54.44428554732241 0.0 - - - - - - - 755.0 38 7 GADD45B growth arrest and DNA-damage-inducible, beta 895 115 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59987.[MT7]-VMDIPYLNLEGPDLQPK[MT7].2y6_1.heavy 1115.61 / 841.49 671.0 49.93159866333008 40 10 10 10 10 1.7007484356310223 58.797643381572406 0.0 3 0.8321742701417018 2.969362732373339 671.0 21.28209023044466 0.0 - - - - - - - 0.0 1 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 897 115 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59987.[MT7]-VMDIPYLNLEGPDLQPK[MT7].2b3_1.heavy 1115.61 / 490.245 1145.0 49.93159866333008 40 10 10 10 10 1.7007484356310223 58.797643381572406 0.0 3 0.8321742701417018 2.969362732373339 1145.0 26.074113924050636 0.0 - - - - - - - 59.0 2 6 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 899 115 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59987.[MT7]-VMDIPYLNLEGPDLQPK[MT7].2b4_1.heavy 1115.61 / 603.329 474.0 49.93159866333008 40 10 10 10 10 1.7007484356310223 58.797643381572406 0.0 3 0.8321742701417018 2.969362732373339 474.0 15.723076923076924 2.0 - - - - - - - 0.0 0 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 901 115 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59987.[MT7]-VMDIPYLNLEGPDLQPK[MT7].2y7_1.heavy 1115.61 / 898.511 632.0 49.93159866333008 40 10 10 10 10 1.7007484356310223 58.797643381572406 0.0 3 0.8321742701417018 2.969362732373339 632.0 12.559999999999999 0.0 - - - - - - - 0.0 1 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 903 116 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57832.[MT7]-DVAQIFNNILR.2y8_1.heavy 723.913 / 1017.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 905 116 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57832.[MT7]-DVAQIFNNILR.2y9_1.heavy 723.913 / 1088.62 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 907 116 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57832.[MT7]-DVAQIFNNILR.2b4_1.heavy 723.913 / 558.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 909 116 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57832.[MT7]-DVAQIFNNILR.2y6_1.heavy 723.913 / 776.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 911 117 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47715.[MT7]-ILAPAYFILGGNQSGEGC[CAM]VITR.3y6_1.heavy 827.441 / 705.371 6088.0 45.76679992675781 46 16 10 10 10 2.5392829017097873 39.38119692479579 0.0 3 0.9671146916222956 6.786783732678831 6088.0 10.736597510373443 0.0 - - - - - - - 661.4285714285714 12 7 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 913 117 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47715.[MT7]-ILAPAYFILGGNQSGEGC[CAM]VITR.3b6_1.heavy 827.441 / 773.468 15284.0 45.76679992675781 46 16 10 10 10 2.5392829017097873 39.38119692479579 0.0 3 0.9671146916222956 6.786783732678831 15284.0 29.14138103514052 0.0 - - - - - - - 643.2857142857143 30 7 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 915 117 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47715.[MT7]-ILAPAYFILGGNQSGEGC[CAM]VITR.3b5_1.heavy 827.441 / 610.404 10528.0 45.76679992675781 46 16 10 10 10 2.5392829017097873 39.38119692479579 0.0 3 0.9671146916222956 6.786783732678831 10528.0 24.848379152791757 0.0 - - - - - - - 662.5555555555555 21 9 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 917 117 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47715.[MT7]-ILAPAYFILGGNQSGEGC[CAM]VITR.3b7_1.heavy 827.441 / 920.536 9069.0 45.76679992675781 46 16 10 10 10 2.5392829017097873 39.38119692479579 0.0 3 0.9671146916222956 6.786783732678831 9069.0 36.44021920564346 0.0 - - - - - - - 221.91666666666666 18 12 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 919 118 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57831.[MT7]-TQPILDILLK[MT7].2y8_1.heavy 721.465 / 1068.71 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 921 118 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57831.[MT7]-TQPILDILLK[MT7].2y5_1.heavy 721.465 / 745.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 923 118 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57831.[MT7]-TQPILDILLK[MT7].2b6_1.heavy 721.465 / 812.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 925 118 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57831.[MT7]-TQPILDILLK[MT7].2y3_1.heavy 721.465 / 517.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 927 119 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57835.[MT7]-DVAQIFNNILR.3y6_1.heavy 482.944 / 776.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 929 119 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57835.[MT7]-DVAQIFNNILR.3b4_1.heavy 482.944 / 558.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 931 119 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57835.[MT7]-DVAQIFNNILR.3y4_1.heavy 482.944 / 515.33 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 933 119 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57835.[MT7]-DVAQIFNNILR.3y5_1.heavy 482.944 / 629.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 935 120 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57974.[MT7]-VADGEGWFPASFVR.2y9_1.heavy 841.426 / 1066.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 937 120 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57974.[MT7]-VADGEGWFPASFVR.2b6_1.heavy 841.426 / 673.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 939 120 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57974.[MT7]-VADGEGWFPASFVR.2y6_1.heavy 841.426 / 676.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 941 120 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57974.[MT7]-VADGEGWFPASFVR.2y7_1.heavy 841.426 / 823.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 943 121 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541094.[MT7]-RNVTLQNIIDRFQK[MT7].4y8_2.heavy 509.052 / 589.344 91837.0 36.560298919677734 43 13 10 10 10 2.1552575886918977 46.398166290969215 0.0 3 0.9144256867723702 4.188358556018801 91837.0 163.00692046298568 0.0 - - - - - - - 686.5714285714286 183 7 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 945 121 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541094.[MT7]-RNVTLQNIIDRFQK[MT7].4b4_1.heavy 509.052 / 615.37 19942.0 36.560298919677734 43 13 10 10 10 2.1552575886918977 46.398166290969215 0.0 3 0.9144256867723702 4.188358556018801 19942.0 15.749352327746742 1.0 - - - - - - - 358.0 39 6 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 947 121 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541094.[MT7]-RNVTLQNIIDRFQK[MT7].4b5_1.heavy 509.052 / 728.453 20249.0 36.560298919677734 43 13 10 10 10 2.1552575886918977 46.398166290969215 0.0 3 0.9144256867723702 4.188358556018801 20249.0 48.6451395410819 0.0 - - - - - - - 639.0 40 8 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 949 121 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541094.[MT7]-RNVTLQNIIDRFQK[MT7].4y7_2.heavy 509.052 / 532.323 37942.0 36.560298919677734 43 13 10 10 10 2.1552575886918977 46.398166290969215 0.0 3 0.9144256867723702 4.188358556018801 37942.0 53.66685196976044 0.0 - - - - - - - 774.2857142857143 75 7 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 951 122 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47618.[MT7]-LTEEC[CAM]DLLIEIIQQR.3y6_1.heavy 673.03 / 786.447 39944.0 47.70750045776367 44 14 10 10 10 2.4530973617538088 40.764790488587195 0.0 3 0.9408977452643711 5.051237647206114 39944.0 722.087963525836 0.0 - - - - - - - 162.1875 79 16 MID1 midline 1 (Opitz/BBB syndrome) 953 122 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47618.[MT7]-LTEEC[CAM]DLLIEIIQQR.3b6_1.heavy 673.03 / 892.384 46601.0 47.70750045776367 44 14 10 10 10 2.4530973617538088 40.764790488587195 0.0 3 0.9408977452643711 5.051237647206114 46601.0 1063.5900253592563 0.0 - - - - - - - 193.42857142857142 93 14 MID1 midline 1 (Opitz/BBB syndrome) 955 122 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47618.[MT7]-LTEEC[CAM]DLLIEIIQQR.3b7_1.heavy 673.03 / 1005.47 26065.0 47.70750045776367 44 14 10 10 10 2.4530973617538088 40.764790488587195 0.0 3 0.9408977452643711 5.051237647206114 26065.0 278.3342182890856 0.0 - - - - - - - 173.69230769230768 52 13 MID1 midline 1 (Opitz/BBB syndrome) 957 122 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47618.[MT7]-LTEEC[CAM]DLLIEIIQQR.3y5_1.heavy 673.03 / 657.404 26629.0 47.70750045776367 44 14 10 10 10 2.4530973617538088 40.764790488587195 0.0 3 0.9408977452643711 5.051237647206114 26629.0 174.67702021833213 0.0 - - - - - - - 188.16666666666666 53 12 MID1 midline 1 (Opitz/BBB syndrome) 959 123 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57971.[MT7]-TTNVSLYPGYNFR.2b4_1.heavy 838.432 / 560.316 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 961 123 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57971.[MT7]-TTNVSLYPGYNFR.2y9_1.heavy 838.432 / 1116.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 963 123 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57971.[MT7]-TTNVSLYPGYNFR.2y6_1.heavy 838.432 / 753.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 965 123 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57971.[MT7]-TTNVSLYPGYNFR.2y7_1.heavy 838.432 / 916.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 967 124 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538218.[MT7]-VIVNSLK[MT7].2y4_1.heavy 530.852 / 605.374 15705.0 27.91604995727539 46 20 10 6 10 11.853383843988357 8.436409494215162 0.03070068359375 3 0.9980436969561686 27.89802621674106 15705.0 20.318016347310262 0.0 - - - - - - - 1213.7777777777778 31 9 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 969 124 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538218.[MT7]-VIVNSLK[MT7].2y5_1.heavy 530.852 / 704.442 16650.0 27.91604995727539 46 20 10 6 10 11.853383843988357 8.436409494215162 0.03070068359375 3 0.9980436969561686 27.89802621674106 16650.0 57.053760484460376 0.0 - - - - - - - 282.57894736842104 33 19 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 971 124 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538218.[MT7]-VIVNSLK[MT7].2b4_1.heavy 530.852 / 570.373 4664.0 27.91604995727539 46 20 10 6 10 11.853383843988357 8.436409494215162 0.03070068359375 3 0.9980436969561686 27.89802621674106 4664.0 5.922838618875504 0.0 - - - - - - - 758.6153846153846 9 13 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 973 124 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538218.[MT7]-VIVNSLK[MT7].2y6_1.heavy 530.852 / 817.526 17654.0 27.91604995727539 46 20 10 6 10 11.853383843988357 8.436409494215162 0.03070068359375 3 0.9980436969561686 27.89802621674106 17654.0 29.917862417209545 0.0 - - - - - - - 734.7777777777778 35 9 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 975 125 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57446.[MT7]-K[MT7]ADQK[MT7].2y4_1.heavy 511.322 / 605.338 N/A N/A - - - - - - - - - 0.0 - - - - - - - NEK8;ACLY NIMA (never in mitosis gene a)- related kinase 8;ATP citrate lyase 977 125 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57446.[MT7]-K[MT7]ADQK[MT7].2b3_1.heavy 511.322 / 603.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - NEK8;ACLY NIMA (never in mitosis gene a)- related kinase 8;ATP citrate lyase 979 125 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57446.[MT7]-K[MT7]ADQK[MT7].2b4_1.heavy 511.322 / 731.429 N/A N/A - - - - - - - - - 0.0 - - - - - - - NEK8;ACLY NIMA (never in mitosis gene a)- related kinase 8;ATP citrate lyase 981 125 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57446.[MT7]-K[MT7]ADQK[MT7].2y3_1.heavy 511.322 / 534.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - NEK8;ACLY NIMA (never in mitosis gene a)- related kinase 8;ATP citrate lyase 983 126 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538214.[MT7]-VTQPQAK[MT7].2b3_1.heavy 530.324 / 473.284 8634.0 16.31885004043579 41 15 10 6 10 2.829252757063037 35.34502166706626 0.03660011291503906 3 0.9571976992775242 5.943844577404474 8634.0 14.60075211733113 0.0 - - - - - - - 1134.25 17 8 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 985 126 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538214.[MT7]-VTQPQAK[MT7].2y4_1.heavy 530.324 / 587.363 14128.0 16.31885004043579 41 15 10 6 10 2.829252757063037 35.34502166706626 0.03660011291503906 3 0.9571976992775242 5.943844577404474 14128.0 74.00380952380952 0.0 - - - - - - - 256.5882352941176 28 17 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 987 126 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538214.[MT7]-VTQPQAK[MT7].2y6_1.heavy 530.324 / 816.47 8486.0 16.31885004043579 41 15 10 6 10 2.829252757063037 35.34502166706626 0.03660011291503906 3 0.9571976992775242 5.943844577404474 8486.0 74.00715646258503 0.0 - - - - - - - 168.4375 16 16 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 989 126 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538214.[MT7]-VTQPQAK[MT7].2b5_1.heavy 530.324 / 698.395 1815.0 16.31885004043579 41 15 10 6 10 2.829252757063037 35.34502166706626 0.03660011291503906 3 0.9571976992775242 5.943844577404474 1815.0 16.668367346938776 1.0 - - - - - - - 173.13333333333333 3 15 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 991 127 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538216.[MT7]-AFDYEK[MT7].2y4_1.heavy 530.781 / 698.348 8402.0 24.878600597381592 46 20 10 6 10 8.796898365035121 11.36764298624482 0.03840065002441406 3 0.9933179959917889 15.089223012044794 8402.0 53.15659271284271 0.0 - - - - - - - 182.4375 16 16 SMAD7 SMAD family member 7 993 127 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538216.[MT7]-AFDYEK[MT7].2y5_1.heavy 530.781 / 845.416 11371.0 24.878600597381592 46 20 10 6 10 8.796898365035121 11.36764298624482 0.03840065002441406 3 0.9933179959917889 15.089223012044794 11371.0 61.63463078670832 1.0 - - - - - - - 207.23529411764707 22 17 SMAD7 SMAD family member 7 995 127 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538216.[MT7]-AFDYEK[MT7].2y3_1.heavy 530.781 / 583.321 27571.0 24.878600597381592 46 20 10 6 10 8.796898365035121 11.36764298624482 0.03840065002441406 3 0.9933179959917889 15.089223012044794 27571.0 95.43744865245611 0.0 - - - - - - - 641.3333333333334 55 12 SMAD7 SMAD family member 7 997 127 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538216.[MT7]-AFDYEK[MT7].2b5_1.heavy 530.781 / 770.348 5937.0 24.878600597381592 46 20 10 6 10 8.796898365035121 11.36764298624482 0.03840065002441406 3 0.9933179959917889 15.089223012044794 5937.0 38.369165760600964 1.0 - - - - - - - 239.7058823529412 12 17 SMAD7 SMAD family member 7 999 128 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57440.[MT7]-EAGVFVPR.2b4_1.heavy 509.794 / 501.279 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1001 128 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57440.[MT7]-EAGVFVPR.2y6_1.heavy 509.794 / 674.398 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1003 128 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57440.[MT7]-EAGVFVPR.2b5_1.heavy 509.794 / 648.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1005 128 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57440.[MT7]-EAGVFVPR.2y7_1.heavy 509.794 / 745.435 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1007 129 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537926.[MT7]-IFYLK[MT7].2y4_1.heavy 486.312 / 714.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2;NR4A3 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2;nuclear receptor subfamily 4, group A, member 3 1009 129 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537926.[MT7]-IFYLK[MT7].2y3_1.heavy 486.312 / 567.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - NR4A1;NR4A2;NR4A3 nuclear receptor subfamily 4, group A, member 1;nuclear receptor subfamily 4, group A, member 2;nuclear receptor subfamily 4, group A, member 3 1011 130 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540969.[MT7]-NILPGLNITC[CAM]TFHK[MT7].3y6_1.heavy 639.36 / 937.468 3802.0 37.700199127197266 45 15 10 10 10 1.7279176673317365 39.80675249937346 0.0 3 0.9574968737117421 5.964877978366172 3802.0 50.55392666666667 0.0 - - - - - - - 233.33333333333334 7 6 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1013 130 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540969.[MT7]-NILPGLNITC[CAM]TFHK[MT7].3y4_1.heavy 639.36 / 676.39 4003.0 37.700199127197266 45 15 10 10 10 1.7279176673317365 39.80675249937346 0.0 3 0.9574968737117421 5.964877978366172 4003.0 13.903753333333334 0.0 - - - - - - - 241.66666666666666 8 12 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1015 130 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540969.[MT7]-NILPGLNITC[CAM]TFHK[MT7].3b7_1.heavy 639.36 / 866.522 4303.0 37.700199127197266 45 15 10 10 10 1.7279176673317365 39.80675249937346 0.0 3 0.9574968737117421 5.964877978366172 4303.0 34.424 0.0 - - - - - - - 220.0 8 10 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1017 130 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540969.[MT7]-NILPGLNITC[CAM]TFHK[MT7].3y5_1.heavy 639.36 / 836.42 3202.0 37.700199127197266 45 15 10 10 10 1.7279176673317365 39.80675249937346 0.0 3 0.9574968737117421 5.964877978366172 3202.0 10.908146666666667 0.0 - - - - - - - 200.0 6 13 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1019 131 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TNAA_ECO24.GLTFTYEPK.2y7.peptide 528.27 / 885.44 521863.0 31.204700469970703 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 521863.0 729.8851019942568 0.0 - - - - - - - 342.0 1043 4 1021 131 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TNAA_ECO24.GLTFTYEPK.2y6.peptide 528.27 / 784.39 487303.0 31.204700469970703 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 487303.0 1384.3705803300143 0.0 - - - - - - - 228.0 974 4 1023 131 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TNAA_ECO24.GLTFTYEPK.2y5.peptide 528.27 / 637.32 832363.0 31.204700469970703 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 832363.0 25.871954990560372 1.0 - - - - - - - 456.0 1821 1 1025 132 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57584.[MT7]-VFVANPNK[MT7].2y4_1.heavy 588.853 / 616.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1027 132 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57584.[MT7]-VFVANPNK[MT7].2y5_1.heavy 588.853 / 687.391 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1029 132 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57584.[MT7]-VFVANPNK[MT7].2y3_1.heavy 588.853 / 502.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1031 132 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57584.[MT7]-VFVANPNK[MT7].2y7_1.heavy 588.853 / 933.527 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1033 133 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59783.[MT7]-NLDLEPC[CAM]TGFQR.2y8_1.heavy 797.394 / 994.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1035 133 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59783.[MT7]-NLDLEPC[CAM]TGFQR.2y9_1.heavy 797.394 / 1107.53 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1037 133 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59783.[MT7]-NLDLEPC[CAM]TGFQR.2b5_1.heavy 797.394 / 729.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1039 133 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59783.[MT7]-NLDLEPC[CAM]TGFQR.2y7_1.heavy 797.394 / 865.398 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1041 134 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540344.[MT7]-LTVYTTLIDVTK[MT7].3b6_1.heavy 552.334 / 823.468 34627.0 41.44940185546875 48 18 10 10 10 2.745032969537823 27.823094534030083 0.0 3 0.9851045542175139 10.099387942465945 34627.0 293.9268604651163 0.0 - - - - - - - 202.95 69 20 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1043 134 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540344.[MT7]-LTVYTTLIDVTK[MT7].3b4_1.heavy 552.334 / 621.373 63193.0 41.44940185546875 48 18 10 10 10 2.745032969537823 27.823094534030083 0.0 3 0.9851045542175139 10.099387942465945 63193.0 190.82911667601783 0.0 - - - - - - - 715.7 126 10 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1045 134 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540344.[MT7]-LTVYTTLIDVTK[MT7].3y4_1.heavy 552.334 / 606.358 272698.0 41.44940185546875 48 18 10 10 10 2.745032969537823 27.823094534030083 0.0 3 0.9851045542175139 10.099387942465945 272698.0 825.9088285987475 0.0 - - - - - - - 285.35714285714283 545 14 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1047 134 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540344.[MT7]-LTVYTTLIDVTK[MT7].3y5_1.heavy 552.334 / 719.442 84731.0 41.44940185546875 48 18 10 10 10 2.745032969537823 27.823094534030083 0.0 3 0.9851045542175139 10.099387942465945 84731.0 226.60616279069768 0.0 - - - - - - - 714.75 169 12 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1049 135 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47008.[MT7]-YTHPQHR.2b3_1.heavy 541.784 / 546.279 700.0 13.129999876022339 47 20 10 7 10 4.854082115249754 15.657390237046323 0.02679920196533203 3 0.993310003750344 15.080197037763815 700.0 6.885245901639344 0.0 - - - - - - - 0.0 1 0 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1051 135 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47008.[MT7]-YTHPQHR.2y4_1.heavy 541.784 / 537.289 3746.0 13.129999876022339 47 20 10 7 10 4.854082115249754 15.657390237046323 0.02679920196533203 3 0.993310003750344 15.080197037763815 3746.0 16.531031627752938 0.0 - - - - - - - 188.3181818181818 7 22 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1053 135 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47008.[MT7]-YTHPQHR.2y5_1.heavy 541.784 / 674.348 1005.0 13.129999876022339 47 20 10 7 10 4.854082115249754 15.657390237046323 0.02679920196533203 3 0.993310003750344 15.080197037763815 1005.0 10.763330931363718 0.0 - - - - - - - 104.0 2 19 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1055 135 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47008.[MT7]-YTHPQHR.2y6_1.heavy 541.784 / 775.396 1127.0 13.129999876022339 47 20 10 7 10 4.854082115249754 15.657390237046323 0.02679920196533203 3 0.993310003750344 15.080197037763815 1127.0 7.430769230769231 0.0 - - - - - - - 71.5 2 14 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1057 136 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57307.[MT7]-WEFPR.2b3_1.heavy 439.736 / 607.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSF1R;FGFR2;FLT3;KDR;KIT;PDGFRA;RET colony stimulating factor 1 receptor;fibroblast growth factor receptor 2;fms-related tyrosine kinase 3;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;ret proto-oncogene 1059 136 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57307.[MT7]-WEFPR.2y4_1.heavy 439.736 / 548.283 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSF1R;FGFR2;FLT3;KDR;KIT;PDGFRA;RET colony stimulating factor 1 receptor;fibroblast growth factor receptor 2;fms-related tyrosine kinase 3;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;ret proto-oncogene 1061 136 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57307.[MT7]-WEFPR.2y3_1.heavy 439.736 / 419.24 N/A N/A - - - - - - - - - 0.0 - - - - - - - CSF1R;FGFR2;FLT3;KDR;KIT;PDGFRA;RET colony stimulating factor 1 receptor;fibroblast growth factor receptor 2;fms-related tyrosine kinase 3;kinase insert domain receptor (a type III receptor tyrosine kinase);v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;platelet-derived growth factor receptor, alpha polypeptide;ret proto-oncogene 1063 137 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540961.[MT7]-LHPEDFPEEDK[MT7]K[MT7].4b5_2.heavy 479.759 / 368.691 11056.0 24.248000144958496 42 18 10 6 8 10.393820084576944 9.62110169180115 0.03339958190917969 4 0.9835168045190222 9.599382731009044 11056.0 30.22931314037327 0.0 - - - - - - - 240.6153846153846 22 13 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1065 137 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540961.[MT7]-LHPEDFPEEDK[MT7]K[MT7].4b5_1.heavy 479.759 / 736.375 3382.0 24.248000144958496 42 18 10 6 8 10.393820084576944 9.62110169180115 0.03339958190917969 4 0.9835168045190222 9.599382731009044 3382.0 36.008731230738974 0.0 - - - - - - - 156.57894736842104 6 19 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1067 137 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540961.[MT7]-LHPEDFPEEDK[MT7]K[MT7].4y6_2.heavy 479.759 / 517.292 26553.0 24.248000144958496 42 18 10 6 8 10.393820084576944 9.62110169180115 0.03339958190917969 4 0.9835168045190222 9.599382731009044 26553.0 46.041995575457904 0.0 - - - - - - - 701.2222222222222 53 9 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1069 137 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540961.[MT7]-LHPEDFPEEDK[MT7]K[MT7].4y7_2.heavy 479.759 / 590.826 5704.0 24.248000144958496 42 18 10 6 8 10.393820084576944 9.62110169180115 0.03339958190917969 4 0.9835168045190222 9.599382731009044 5704.0 9.047946769037853 2.0 - - - - - - - 712.4444444444445 27 9 NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1071 138 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57587.[MT7]-LC[CAM]PEYPTR.2y4_1.heavy 590.301 / 536.283 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1073 138 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57587.[MT7]-LC[CAM]PEYPTR.2y5_1.heavy 590.301 / 665.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1075 138 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57587.[MT7]-LC[CAM]PEYPTR.2y6_1.heavy 590.301 / 762.378 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1077 138 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57587.[MT7]-LC[CAM]PEYPTR.2y7_1.heavy 590.301 / 922.409 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1079 139 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541115.[MT7]-GQELIYAGMPITEVFK[MT7].3b4_1.heavy 695.383 / 572.316 1480.0 43.90230178833008 46 16 10 10 10 2.632654091728998 31.471599548914266 0.0 3 0.9684508102219839 6.929785612678165 1480.0 10.44536052118223 0.0 - - - - - - - 170.53333333333333 2 15 ACLY ATP citrate lyase 1081 139 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541115.[MT7]-GQELIYAGMPITEVFK[MT7].3b5_1.heavy 695.383 / 685.4 2018.0 43.90230178833008 46 16 10 10 10 2.632654091728998 31.471599548914266 0.0 3 0.9684508102219839 6.929785612678165 2018.0 6.826691449814127 0.0 - - - - - - - 201.76923076923077 4 13 ACLY ATP citrate lyase 1083 139 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541115.[MT7]-GQELIYAGMPITEVFK[MT7].3b8_1.heavy 695.383 / 976.522 1076.0 43.90230178833008 46 16 10 10 10 2.632654091728998 31.471599548914266 0.0 3 0.9684508102219839 6.929785612678165 1076.0 12.711557022368904 0.0 - - - - - - - 134.57142857142858 2 7 ACLY ATP citrate lyase 1085 139 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB541115.[MT7]-GQELIYAGMPITEVFK[MT7].3y5_1.heavy 695.383 / 767.442 1143.0 43.90230178833008 46 16 10 10 10 2.632654091728998 31.471599548914266 0.0 3 0.9684508102219839 6.929785612678165 1143.0 7.3559405940594065 1.0 - - - - - - - 176.75 2 16 ACLY ATP citrate lyase 1087 140 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539444.[MT7]-ELLQHPFLK[MT7].3y3_1.heavy 471.622 / 551.367 109350.0 32.17620086669922 48 18 10 10 10 7.105227164043415 14.07414537089795 0.0 3 0.9830667219056891 9.470591451450822 109350.0 192.04410150918608 0.0 - - - - - - - 293.14285714285717 218 7 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1089 140 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539444.[MT7]-ELLQHPFLK[MT7].3b4_1.heavy 471.622 / 628.379 155368.0 32.17620086669922 48 18 10 10 10 7.105227164043415 14.07414537089795 0.0 3 0.9830667219056891 9.470591451450822 155368.0 385.2871104396726 0.0 - - - - - - - 313.5 310 8 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1091 140 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539444.[MT7]-ELLQHPFLK[MT7].3b3_1.heavy 471.622 / 500.32 76431.0 32.17620086669922 48 18 10 10 10 7.105227164043415 14.07414537089795 0.0 3 0.9830667219056891 9.470591451450822 76431.0 128.34958165865896 0.0 - - - - - - - 410.4 152 5 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1093 140 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539444.[MT7]-ELLQHPFLK[MT7].3y4_1.heavy 471.622 / 648.42 132814.0 32.17620086669922 48 18 10 10 10 7.105227164043415 14.07414537089795 0.0 3 0.9830667219056891 9.470591451450822 132814.0 325.1399152534541 0.0 - - - - - - - 342.0 265 6 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1095 141 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539544.[MT7]-AQWTEDC[CAM]RK[MT7].3y7_1.heavy 494.585 / 1138.54 N/A 19.986533482869465 42 15 10 7 10 2.872687858544633 34.8106041881843 0.029798507690429688 3 0.9502546762210633 5.510223918155894 0.0 0.0 2.0 - - - - - - - 0.0 0 0 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1097 141 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539544.[MT7]-AQWTEDC[CAM]RK[MT7].3y6_1.heavy 494.585 / 952.464 890.0 19.986533482869465 42 15 10 7 10 2.872687858544633 34.8106041881843 0.029798507690429688 3 0.9502546762210633 5.510223918155894 890.0 12.305754590237349 0.0 - - - - - - - 0.0 1 0 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1099 141 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539544.[MT7]-AQWTEDC[CAM]RK[MT7].3y3_1.heavy 494.585 / 607.347 1006.0 19.986533482869465 42 15 10 7 10 2.872687858544633 34.8106041881843 0.029798507690429688 3 0.9502546762210633 5.510223918155894 1006.0 4.689394318384848 0.0 - - - - - - - 214.85185185185185 2 27 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1101 141 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539544.[MT7]-AQWTEDC[CAM]RK[MT7].3b6_1.heavy 494.585 / 875.402 3251.0 19.986533482869465 42 15 10 7 10 2.872687858544633 34.8106041881843 0.029798507690429688 3 0.9502546762210633 5.510223918155894 3251.0 53.52505236698785 0.0 - - - - - - - 114.1 6 20 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1103 142 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46902.[MT7]-ATHPNK[MT7].2b3_1.heavy 478.282 / 454.253 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1105 142 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46902.[MT7]-ATHPNK[MT7].2y4_1.heavy 478.282 / 639.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1107 142 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46902.[MT7]-ATHPNK[MT7].2y5_1.heavy 478.282 / 740.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1109 142 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46902.[MT7]-ATHPNK[MT7].2y3_1.heavy 478.282 / 502.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1111 143 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58829.[MT7]-NNIDFPGHNYTTR.3y7_1.heavy 564.945 / 848.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1113 143 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58829.[MT7]-NNIDFPGHNYTTR.3b4_1.heavy 564.945 / 601.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1115 143 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58829.[MT7]-NNIDFPGHNYTTR.3b5_1.heavy 564.945 / 748.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1117 143 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58829.[MT7]-NNIDFPGHNYTTR.3y5_1.heavy 564.945 / 654.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1119 144 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539549.[MT7]-TIFGNIEDIYR.2y8_1.heavy 742.897 / 979.484 15026.0 41.296701431274414 47 20 10 7 10 6.7907545883167435 14.725903977158373 0.027599334716796875 3 0.99080182343893 12.858136830119069 15026.0 178.89597985042818 0.0 - - - - - - - 144.4 30 15 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1121 144 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539549.[MT7]-TIFGNIEDIYR.2y9_1.heavy 742.897 / 1126.55 16404.0 41.296701431274414 47 20 10 7 10 6.7907545883167435 14.725903977158373 0.027599334716796875 3 0.99080182343893 12.858136830119069 16404.0 287.4968910478834 0.0 - - - - - - - 200.64705882352942 32 17 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1123 144 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539549.[MT7]-TIFGNIEDIYR.2y10_1.heavy 742.897 / 1239.64 9777.0 41.296701431274414 47 20 10 7 10 6.7907545883167435 14.725903977158373 0.027599334716796875 3 0.99080182343893 12.858136830119069 9777.0 187.91832755031226 0.0 - - - - - - - 109.5 19 12 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1125 144 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539549.[MT7]-TIFGNIEDIYR.2b5_1.heavy 742.897 / 677.374 4790.0 41.296701431274414 47 20 10 7 10 6.7907545883167435 14.725903977158373 0.027599334716796875 3 0.99080182343893 12.858136830119069 4790.0 15.332450638792103 0.0 - - - - - - - 248.2173913043478 9 23 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1127 145 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538071.[MT7]-SSELIYSGELTR.3y7_1.heavy 500.267 / 825.41 24972.0 31.52720069885254 48 18 10 10 10 8.616336477184456 11.605860595717685 0.0 3 0.984422694484465 9.875311928440729 24972.0 7.589724021878887 1.0 - - - - - - - 207.0 62 5 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1129 145 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538071.[MT7]-SSELIYSGELTR.3y6_1.heavy 500.267 / 662.347 54087.0 31.52720069885254 48 18 10 10 10 8.616336477184456 11.605860595717685 0.0 3 0.984422694484465 9.875311928440729 54087.0 73.52712592288466 0.0 - - - - - - - 230.0 108 3 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1131 145 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538071.[MT7]-SSELIYSGELTR.3b4_1.heavy 500.267 / 561.3 98047.0 31.52720069885254 48 18 10 10 10 8.616336477184456 11.605860595717685 0.0 3 0.984422694484465 9.875311928440729 98047.0 65.24101353351907 0.0 - - - - - - - 287.5 196 2 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1133 145 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538071.[MT7]-SSELIYSGELTR.3y5_1.heavy 500.267 / 575.315 32912.0 31.52720069885254 48 18 10 10 10 8.616336477184456 11.605860595717685 0.0 3 0.984422694484465 9.875311928440729 32912.0 13.902527004550024 0.0 - - - - - - - 713.4 65 5 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1135 146 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 CH10_ECO24.SAGGIVLTGSAAAK.2y7.peptide 601.84 / 605.33 295759.0 25.78700065612793 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 295759.0 430.0466012117102 0.0 - - - - - - - 2188.8 591 10 1137 146 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 CH10_ECO24.SAGGIVLTGSAAAK.2y8.peptide 601.84 / 718.41 373553.0 25.78700065612793 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 373553.0 681.2144704705115 0.0 - - - - - - - 1744.0 747 2 1139 146 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 CH10_ECO24.SAGGIVLTGSAAAK.2y9.peptide 601.84 / 817.48 444017.0 25.78700065612793 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 444017.0 708.8376489638733 0.0 - - - - - - - 2749.8 888 10 1141 147 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538397.[MT7]-LLGELLLDR.2y8_1.heavy 593.37 / 928.546 63976.0 44.93439865112305 50 20 10 10 10 4.232112938323101 23.62885902558716 0.0 3 0.9905902146289696 12.71251183993068 63976.0 372.53176437027525 0.0 - - - - - - - 155.27272727272728 127 11 CAB39 calcium binding protein 39 1143 147 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538397.[MT7]-LLGELLLDR.2y5_1.heavy 593.37 / 629.398 18045.0 44.93439865112305 50 20 10 10 10 4.232112938323101 23.62885902558716 0.0 3 0.9905902146289696 12.71251183993068 18045.0 55.08120458048888 0.0 - - - - - - - 233.68421052631578 36 19 CAB39 calcium binding protein 39 1145 147 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538397.[MT7]-LLGELLLDR.2b4_1.heavy 593.37 / 557.341 19412.0 44.93439865112305 50 20 10 10 10 4.232112938323101 23.62885902558716 0.0 3 0.9905902146289696 12.71251183993068 19412.0 39.718232063852014 0.0 - - - - - - - 683.7777777777778 38 9 CAB39 calcium binding protein 39 1147 147 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538397.[MT7]-LLGELLLDR.2y7_1.heavy 593.37 / 815.462 44428.0 44.93439865112305 50 20 10 10 10 4.232112938323101 23.62885902558716 0.0 3 0.9905902146289696 12.71251183993068 44428.0 413.195461258895 0.0 - - - - - - - 196.88235294117646 88 17 CAB39 calcium binding protein 39 1149 148 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47265.[MT7]-NPQAVLDVLK[MT7].2b4_1.heavy 692.924 / 555.301 1836.0 37.19219970703125 41 17 4 10 10 2.197331201907622 35.46700734372085 0.0 3 0.9731455964214626 7.514116084585547 1836.0 8.952 1.0 - - - - - - - 229.5 3 12 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1151 148 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47265.[MT7]-NPQAVLDVLK[MT7].2y9_1.heavy 692.924 / 1126.7 3162.0 37.19219970703125 41 17 4 10 10 2.197331201907622 35.46700734372085 0.0 3 0.9731455964214626 7.514116084585547 3162.0 10.84225 0.0 - - - - - - - 221.0 6 6 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1153 148 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47265.[MT7]-NPQAVLDVLK[MT7].2y3_1.heavy 692.924 / 503.367 N/A 37.19219970703125 41 17 4 10 10 2.197331201907622 35.46700734372085 0.0 3 0.9731455964214626 7.514116084585547 3366.0 2.3908823529411767 4.0 - - - - - - - 238.0 13 6 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1155 148 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47265.[MT7]-NPQAVLDVLK[MT7].2y7_1.heavy 692.924 / 901.584 918.0 37.19219970703125 41 17 4 10 10 2.197331201907622 35.46700734372085 0.0 3 0.9731455964214626 7.514116084585547 918.0 2.6999999999999997 0.0 - - - - - - - 0.0 1 0 PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1157 149 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59699.[MT7]-NMINTFVPSGK[MT7].3b4_1.heavy 499.278 / 617.32 N/A 37.700199127197266 42 12 10 10 10 2.397520601781301 27.806504193179787 0.0 3 0.8845280244674133 3.596280886314844 799.0 0.7429338103756707 19.0 - - - - - - - 669.0 4 8 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1159 149 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59699.[MT7]-NMINTFVPSGK[MT7].3b5_1.heavy 499.278 / 718.367 N/A 37.700199127197266 42 12 10 10 10 2.397520601781301 27.806504193179787 0.0 3 0.8845280244674133 3.596280886314844 479.0 1.2532631997239274 9.0 - - - - - - - 291.14285714285717 2 14 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1161 149 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59699.[MT7]-NMINTFVPSGK[MT7].3b3_1.heavy 499.278 / 503.277 11343.0 37.700199127197266 42 12 10 10 10 2.397520601781301 27.806504193179787 0.0 3 0.8845280244674133 3.596280886314844 11343.0 23.4430903420459 0.0 - - - - - - - 239.66666666666666 22 3 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1163 149 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59699.[MT7]-NMINTFVPSGK[MT7].3y4_1.heavy 499.278 / 532.321 6870.0 37.700199127197266 42 12 10 10 10 2.397520601781301 27.806504193179787 0.0 3 0.8845280244674133 3.596280886314844 6870.0 8.28663220065387 1.0 - - - - - - - 425.6666666666667 13 3 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1165 150 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47775.[MT7]-QVVIDGETC[CAM]LLDILDTAGQEEYSAMR.3y11_1.heavy 1024.17 / 1242.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1167 150 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47775.[MT7]-QVVIDGETC[CAM]LLDILDTAGQEEYSAMR.3b4_1.heavy 1024.17 / 584.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1169 150 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47775.[MT7]-QVVIDGETC[CAM]LLDILDTAGQEEYSAMR.3b5_1.heavy 1024.17 / 699.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1171 150 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47775.[MT7]-QVVIDGETC[CAM]LLDILDTAGQEEYSAMR.3y9_1.heavy 1024.17 / 1070.46 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1173 151 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538593.[MT7]-FFSEYEK[MT7].3y3_1.heavy 413.216 / 583.321 14714.0 31.85810089111328 48 18 10 10 10 4.696137859561354 21.29409378312854 0.0 3 0.9888764786061458 11.690627570877675 14714.0 28.971477297743533 0.0 - - - - - - - 253.0 29 10 CAB39 calcium binding protein 39 1175 151 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538593.[MT7]-FFSEYEK[MT7].3b4_1.heavy 413.216 / 655.321 18967.0 31.85810089111328 48 18 10 10 10 4.696137859561354 21.29409378312854 0.0 3 0.9888764786061458 11.690627570877675 18967.0 50.13439320939282 0.0 - - - - - - - 258.75 37 8 CAB39 calcium binding protein 39 1177 151 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538593.[MT7]-FFSEYEK[MT7].3b5_1.heavy 413.216 / 818.384 920.0 31.85810089111328 48 18 10 10 10 4.696137859561354 21.29409378312854 0.0 3 0.9888764786061458 11.690627570877675 920.0 6.8 0.0 - - - - - - - 0.0 1 0 CAB39 calcium binding protein 39 1179 151 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538593.[MT7]-FFSEYEK[MT7].3b3_1.heavy 413.216 / 526.278 14254.0 31.85810089111328 48 18 10 10 10 4.696137859561354 21.29409378312854 0.0 3 0.9888764786061458 11.690627570877675 14254.0 140.99065217391305 0.0 - - - - - - - 198.63636363636363 28 11 CAB39 calcium binding protein 39 1181 152 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57727.[MT7]-NVTLQNIIDR.2y8_1.heavy 665.384 / 972.547 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1183 152 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57727.[MT7]-NVTLQNIIDR.2y9_1.heavy 665.384 / 1071.62 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1185 152 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57727.[MT7]-NVTLQNIIDR.2y6_1.heavy 665.384 / 758.416 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1187 152 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57727.[MT7]-NVTLQNIIDR.2y7_1.heavy 665.384 / 871.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1189 153 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538899.[MT7]-LIEPFFNK[MT7].2y4_1.heavy 648.384 / 699.395 823.0 38.76839828491211 41 11 10 10 10 0.9693247510904388 75.59354404713622 0.0 3 0.8637497454470137 3.3047197150482206 823.0 1.4928227571115973 6.0 - - - - - - - 0.0 1 0 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1191 153 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538899.[MT7]-LIEPFFNK[MT7].2b3_1.heavy 648.384 / 500.32 12711.0 38.76839828491211 41 11 10 10 10 0.9693247510904388 75.59354404713622 0.0 3 0.8637497454470137 3.3047197150482206 12711.0 31.59498919911202 0.0 - - - - - - - 335.25 25 12 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1193 153 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538899.[MT7]-LIEPFFNK[MT7].2y5_1.heavy 648.384 / 796.447 11980.0 38.76839828491211 41 11 10 10 10 0.9693247510904388 75.59354404713622 0.0 3 0.8637497454470137 3.3047197150482206 11980.0 32.60540300546448 0.0 - - - - - - - 182.72727272727272 23 11 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1195 153 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538899.[MT7]-LIEPFFNK[MT7].2y3_1.heavy 648.384 / 552.326 1646.0 38.76839828491211 41 11 10 10 10 0.9693247510904388 75.59354404713622 0.0 3 0.8637497454470137 3.3047197150482206 1646.0 4.197449908925319 0.0 - - - - - - - 225.4 3 15 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1197 154 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57821.[MT7]-LIEPIPDSHIR.3y6_1.heavy 478.613 / 724.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1199 154 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57821.[MT7]-LIEPIPDSHIR.3y4_1.heavy 478.613 / 512.294 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1201 154 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57821.[MT7]-LIEPIPDSHIR.3b3_1.heavy 478.613 / 500.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1203 154 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57821.[MT7]-LIEPIPDSHIR.3y5_1.heavy 478.613 / 627.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1205 155 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57925.[MT7]-AFDANTMTSAEK[MT7].3b4_1.heavy 525.264 / 549.279 963.0 32.64059829711914 37 7 10 10 10 0.4934832614026257 103.4719029735788 0.0 3 0.7451322827888466 2.390655155194604 963.0 0.48 20.0 - - - - - - - 834.6 3 10 MID1 midline 1 (Opitz/BBB syndrome) 1207 155 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57925.[MT7]-AFDANTMTSAEK[MT7].3b5_1.heavy 525.264 / 663.322 2353.0 32.64059829711914 37 7 10 10 10 0.4934832614026257 103.4719029735788 0.0 3 0.7451322827888466 2.390655155194604 2353.0 0.8269989615784006 0.0 - - - - - - - 749.0 4 8 MID1 midline 1 (Opitz/BBB syndrome) 1209 155 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57925.[MT7]-AFDANTMTSAEK[MT7].3y4_1.heavy 525.264 / 578.327 N/A 32.64059829711914 37 7 10 10 10 0.4934832614026257 103.4719029735788 0.0 3 0.7451322827888466 2.390655155194604 963.0 0.7499999999999999 22.0 - - - - - - - 796.5555555555555 4 9 MID1 midline 1 (Opitz/BBB syndrome) 1211 155 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57925.[MT7]-AFDANTMTSAEK[MT7].3y5_1.heavy 525.264 / 679.374 4921.0 32.64059829711914 37 7 10 10 10 0.4934832614026257 103.4719029735788 0.0 3 0.7451322827888466 2.390655155194604 4921.0 16.72088785046729 0.0 - - - - - - - 762.375 9 8 MID1 midline 1 (Opitz/BBB syndrome) 1213 156 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57926.[MT7]-LEIIPASQFC[CAM]PR.2b3_1.heavy 787.928 / 500.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1215 156 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57926.[MT7]-LEIIPASQFC[CAM]PR.2y8_1.heavy 787.928 / 962.451 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1217 156 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57926.[MT7]-LEIIPASQFC[CAM]PR.2y9_1.heavy 787.928 / 1075.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1219 156 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57926.[MT7]-LEIIPASQFC[CAM]PR.2y10_1.heavy 787.928 / 1188.62 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1221 157 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57927.[MT7]-RNTELETLLAK[MT7].3y3_1.heavy 525.982 / 475.336 5545.0 37.321998596191406 44 16 8 10 10 6.869034051589738 14.558087680007416 0.0 3 0.9678933024196353 6.869034064416315 5545.0 7.307685950413223 1.0 - - - - - - - 1253.142857142857 15 7 MID1 midline 1 (Opitz/BBB syndrome) 1223 157 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57927.[MT7]-RNTELETLLAK[MT7].3b6_1.heavy 525.982 / 887.47 N/A 37.321998596191406 44 16 8 10 10 6.869034051589738 14.558087680007416 0.0 3 0.9678933024196353 6.869034064416315 605.0 2.5632844528539893 6.0 - - - - - - - 0.0 1 0 MID1 midline 1 (Opitz/BBB syndrome) 1225 157 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57927.[MT7]-RNTELETLLAK[MT7].3b5_1.heavy 525.982 / 758.428 N/A 37.321998596191406 44 16 8 10 10 6.869034051589738 14.558087680007416 0.0 3 0.9678933024196353 6.869034064416315 101.0 6.622516556291647E-4 28.0 - - - - - - - 0.0 1 0 MID1 midline 1 (Opitz/BBB syndrome) 1227 157 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57927.[MT7]-RNTELETLLAK[MT7].3y4_1.heavy 525.982 / 588.42 2319.0 37.321998596191406 44 16 8 10 10 6.869034051589738 14.558087680007416 0.0 3 0.9678933024196353 6.869034064416315 2319.0 2.1533209727047145 2.0 - - - - - - - 630.125 6 8 MID1 midline 1 (Opitz/BBB syndrome) 1229 158 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538068.[MT7]-TLLVHK[MT7].2y4_1.heavy 499.834 / 640.426 3972.0 23.31232500076294 41 15 10 6 10 1.990654475121634 39.898164384953844 0.03289985656738281 3 0.9508084068146229 5.5414107845624 3972.0 18.599999999999998 0.0 - - - - - - - 226.52631578947367 7 19 SMAD7 SMAD family member 7 1231 158 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538068.[MT7]-TLLVHK[MT7].2y5_1.heavy 499.834 / 753.51 3074.0 23.31232500076294 41 15 10 6 10 1.990654475121634 39.898164384953844 0.03289985656738281 3 0.9508084068146229 5.5414107845624 3074.0 13.278655876548099 2.0 - - - - - - - 255.3 6 20 SMAD7 SMAD family member 7 1233 158 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538068.[MT7]-TLLVHK[MT7].2b4_1.heavy 499.834 / 571.394 7140.0 23.31232500076294 41 15 10 6 10 1.990654475121634 39.898164384953844 0.03289985656738281 3 0.9508084068146229 5.5414107845624 7140.0 20.954025340949265 0.0 - - - - - - - 709.2857142857143 14 7 SMAD7 SMAD family member 7 1235 158 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538068.[MT7]-TLLVHK[MT7].2y3_1.heavy 499.834 / 527.342 7850.0 23.31232500076294 41 15 10 6 10 1.990654475121634 39.898164384953844 0.03289985656738281 3 0.9508084068146229 5.5414107845624 7850.0 21.888143836121138 0.0 - - - - - - - 737.8 15 10 SMAD7 SMAD family member 7 1237 159 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47632.[MT7]-EEMGIGGVLGLLWFQK[MT7].3y3_1.heavy 689.051 / 566.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1239 159 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47632.[MT7]-EEMGIGGVLGLLWFQK[MT7].3b4_1.heavy 689.051 / 591.256 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1241 159 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47632.[MT7]-EEMGIGGVLGLLWFQK[MT7].3b5_1.heavy 689.051 / 704.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1243 159 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47632.[MT7]-EEMGIGGVLGLLWFQK[MT7].3b7_1.heavy 689.051 / 818.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1245 160 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57626.[MT7]-FGGALDAAAK[MT7].2y4_1.heavy 604.848 / 504.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1247 160 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57626.[MT7]-FGGALDAAAK[MT7].2y9_1.heavy 604.848 / 917.517 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1249 160 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57626.[MT7]-FGGALDAAAK[MT7].2b6_1.heavy 604.848 / 705.369 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1251 160 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57626.[MT7]-FGGALDAAAK[MT7].2b5_1.heavy 604.848 / 590.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1253 161 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59434.[MT7]-GWMDPQSK[MT7].2b3_1.heavy 618.818 / 519.251 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1255 161 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59434.[MT7]-GWMDPQSK[MT7].2y4_1.heavy 618.818 / 603.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1257 161 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59434.[MT7]-GWMDPQSK[MT7].2y5_1.heavy 618.818 / 718.385 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1259 161 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59434.[MT7]-GWMDPQSK[MT7].2b4_1.heavy 618.818 / 634.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1261 162 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57510.[MT7]-HVITLSQR.2y5_1.heavy 549.331 / 604.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1263 162 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57510.[MT7]-HVITLSQR.2y3_1.heavy 549.331 / 390.21 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1265 162 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57510.[MT7]-HVITLSQR.2y6_1.heavy 549.331 / 717.425 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1267 162 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57510.[MT7]-HVITLSQR.2y7_1.heavy 549.331 / 816.494 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1269 163 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59431.[MT7]-FFMPLYK[MT7].2b3_1.heavy 617.351 / 570.287 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1271 163 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59431.[MT7]-FFMPLYK[MT7].2y4_1.heavy 617.351 / 664.415 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1273 163 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59431.[MT7]-FFMPLYK[MT7].2y3_1.heavy 617.351 / 567.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1275 163 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59431.[MT7]-FFMPLYK[MT7].2y6_1.heavy 617.351 / 942.524 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1277 164 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58001.[MT7]-HPEVDVLINFASLR.3y7_1.heavy 585.329 / 820.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1279 164 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58001.[MT7]-HPEVDVLINFASLR.3b6_1.heavy 585.329 / 821.427 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1281 164 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58001.[MT7]-HPEVDVLINFASLR.3y6_1.heavy 585.329 / 707.383 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1283 164 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58001.[MT7]-HPEVDVLINFASLR.3b5_1.heavy 585.329 / 722.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1285 165 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TPX_ECO57.DLSDVTLGQFAGK.2y7.peptide 675.85 / 720.4 122743.0 35.81589889526367 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 122743.0 211.5732880796618 0.0 - - - - - - - 228.14285714285714 245 14 1287 165 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TPX_ECO57.DLSDVTLGQFAGK.2y8.peptide 675.85 / 821.45 256962.0 35.81589889526367 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 256962.0 159.42293830412598 0.0 - - - - - - - 219.6 513 15 1289 165 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TPX_ECO57.DLSDVTLGQFAGK.2y6.peptide 675.85 / 607.32 293286.0 35.81589889526367 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 293286.0 117.88188460121481 0.0 - - - - - - - 264.1764705882353 586 17 1291 166 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540690.[MT7]-YDLPASINFILNK[MT7].3b6_1.heavy 599.345 / 791.406 6035.0 44.649200439453125 43 13 10 10 10 2.176393601549685 34.949994434460415 0.0 3 0.9252059390505151 4.484190183359321 6035.0 29.032753488614272 0.0 - - - - - - - 212.05882352941177 12 17 LIPA lipase A, lysosomal acid, cholesterol esterase 1293 166 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540690.[MT7]-YDLPASINFILNK[MT7].3y3_1.heavy 599.345 / 518.342 29619.0 44.649200439453125 43 13 10 10 10 2.176393601549685 34.949994434460415 0.0 3 0.9252059390505151 4.484190183359321 29619.0 90.9680290711998 0.0 - - - - - - - 266.0 59 12 LIPA lipase A, lysosomal acid, cholesterol esterase 1295 166 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540690.[MT7]-YDLPASINFILNK[MT7].3b5_1.heavy 599.345 / 704.374 5341.0 44.649200439453125 43 13 10 10 10 2.176393601549685 34.949994434460415 0.0 3 0.9252059390505151 4.484190183359321 5341.0 18.18827027027027 0.0 - - - - - - - 300.53333333333336 10 15 LIPA lipase A, lysosomal acid, cholesterol esterase 1297 166 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540690.[MT7]-YDLPASINFILNK[MT7].3b3_1.heavy 599.345 / 536.284 15191.0 44.649200439453125 43 13 10 10 10 2.176393601549685 34.949994434460415 0.0 3 0.9252059390505151 4.484190183359321 15191.0 31.745883874433495 0.0 - - - - - - - 772.8571428571429 30 7 LIPA lipase A, lysosomal acid, cholesterol esterase 1299 167 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538388.[MT7]-VFPGFSIK[MT7].2y4_1.heavy 591.86 / 638.399 2340.0 37.76259994506836 43 18 10 5 10 3.578246144269052 27.946652065890106 0.04160308837890625 3 0.9841575300487978 9.792101196015969 2340.0 10.233906633906633 0.0 - - - - - - - 186.5 4 12 SMAD7 SMAD family member 7 1301 167 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538388.[MT7]-VFPGFSIK[MT7].2y5_1.heavy 591.86 / 695.421 5494.0 37.76259994506836 43 18 10 5 10 3.578246144269052 27.946652065890106 0.04160308837890625 3 0.9841575300487978 9.792101196015969 5494.0 19.16150614250614 0.0 - - - - - - - 248.44444444444446 10 9 SMAD7 SMAD family member 7 1303 167 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538388.[MT7]-VFPGFSIK[MT7].2y6_1.heavy 591.86 / 792.474 50058.0 37.76259994506836 43 18 10 5 10 3.578246144269052 27.946652065890106 0.04160308837890625 3 0.9841575300487978 9.792101196015969 50058.0 186.85697445972494 0.0 - - - - - - - 169.5 100 6 SMAD7 SMAD family member 7 1305 167 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538388.[MT7]-VFPGFSIK[MT7].2y7_1.heavy 591.86 / 939.542 14651.0 37.76259994506836 43 18 10 5 10 3.578246144269052 27.946652065890106 0.04160308837890625 3 0.9841575300487978 9.792101196015969 14651.0 63.31274736801456 0.0 - - - - - - - 165.375 29 8 SMAD7 SMAD family member 7 1307 168 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57315.[MT7]-GLDGLK[MT7].2y4_1.heavy 445.781 / 576.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1309 168 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57315.[MT7]-GLDGLK[MT7].2y5_1.heavy 445.781 / 689.431 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1311 168 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57315.[MT7]-GLDGLK[MT7].2b4_1.heavy 445.781 / 487.263 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1313 168 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57315.[MT7]-GLDGLK[MT7].2y3_1.heavy 445.781 / 461.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1315 169 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59051.[MT7]-IHVSAR.2y4_1.heavy 413.754 / 432.257 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1317 169 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59051.[MT7]-IHVSAR.2y5_1.heavy 413.754 / 569.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1319 169 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59051.[MT7]-IHVSAR.2y3_1.heavy 413.754 / 333.188 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1321 169 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59051.[MT7]-IHVSAR.2b4_2.heavy 413.754 / 291.18 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1323 170 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57819.[MT7]-ASVSGPNSPSETR.2y8_1.heavy 716.861 / 887.422 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1325 170 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57819.[MT7]-ASVSGPNSPSETR.2y12_1.heavy 716.861 / 1217.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1327 170 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57819.[MT7]-ASVSGPNSPSETR.2y9_1.heavy 716.861 / 944.443 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1329 170 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57819.[MT7]-ASVSGPNSPSETR.2y10_1.heavy 716.861 / 1031.48 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1331 171 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57612.[MT7]-ESMAVLEK[MT7].2b4_1.heavy 597.836 / 563.262 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1333 171 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57612.[MT7]-ESMAVLEK[MT7].2y3_1.heavy 597.836 / 533.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1335 171 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57612.[MT7]-ESMAVLEK[MT7].2b5_1.heavy 597.836 / 662.33 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1337 171 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57612.[MT7]-ESMAVLEK[MT7].2y7_1.heavy 597.836 / 921.52 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1339 172 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539853.[MT7]-FQAFDWGSSAK[MT7].3b4_1.heavy 511.264 / 638.342 14068.0 36.30820083618164 50 20 10 10 10 5.125300792544632 19.511049994463164 0.0 3 0.9904968435836259 12.649807000850911 14068.0 16.873669476271935 1.0 - - - - - - - 742.6666666666666 28 9 LIPA lipase A, lysosomal acid, cholesterol esterase 1341 172 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539853.[MT7]-FQAFDWGSSAK[MT7].3b5_1.heavy 511.264 / 753.369 55972.0 36.30820083618164 50 20 10 10 10 5.125300792544632 19.511049994463164 0.0 3 0.9904968435836259 12.649807000850911 55972.0 38.52284048746437 0.0 - - - - - - - 321.55555555555554 111 9 LIPA lipase A, lysosomal acid, cholesterol esterase 1343 172 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539853.[MT7]-FQAFDWGSSAK[MT7].3y4_1.heavy 511.264 / 536.316 31927.0 36.30820083618164 50 20 10 10 10 5.125300792544632 19.511049994463164 0.0 3 0.9904968435836259 12.649807000850911 31927.0 36.95764853809367 0.0 - - - - - - - 720.6666666666666 63 9 LIPA lipase A, lysosomal acid, cholesterol esterase 1345 172 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539853.[MT7]-FQAFDWGSSAK[MT7].3y5_1.heavy 511.264 / 593.338 39410.0 36.30820083618164 50 20 10 10 10 5.125300792544632 19.511049994463164 0.0 3 0.9904968435836259 12.649807000850911 39410.0 25.846084341555112 0.0 - - - - - - - 342.14285714285717 78 7 LIPA lipase A, lysosomal acid, cholesterol esterase 1347 173 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57714.[MT7]-LMASTQPFK[MT7].2y8_1.heavy 655.873 / 1053.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1349 173 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57714.[MT7]-LMASTQPFK[MT7].2y5_1.heavy 655.873 / 764.442 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1351 173 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57714.[MT7]-LMASTQPFK[MT7].2y3_1.heavy 655.873 / 535.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1353 173 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57714.[MT7]-LMASTQPFK[MT7].2y7_1.heavy 655.873 / 922.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1355 174 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57610.[MT7]-VEIIATMK[MT7].2y4_1.heavy 596.864 / 594.34 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1357 174 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57610.[MT7]-VEIIATMK[MT7].2y5_1.heavy 596.864 / 707.424 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1359 174 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57610.[MT7]-VEIIATMK[MT7].2y3_1.heavy 596.864 / 523.303 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1361 174 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57610.[MT7]-VEIIATMK[MT7].2y7_1.heavy 596.864 / 949.551 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 1363 175 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57718.[MT7]-RLHIGAVHK[MT7].3y3_1.heavy 440.282 / 527.342 4531.0 25.42020034790039 23 3 6 10 4 0.4087570498169238 116.41485488201931 0.0 10 0.5855783404842174 1.8465126137380297 4531.0 14.960688214930766 1.0 - - - - - - - 717.3125 9 16 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1365 175 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57718.[MT7]-RLHIGAVHK[MT7].3b5_2.heavy 440.282 / 361.233 1208.0 25.42020034790039 23 3 6 10 4 0.4087570498169238 116.41485488201931 0.0 10 0.5855783404842174 1.8465126137380297 1208.0 2.2565783156568964 12.0 - - - - - - - 696.25 4 12 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1367 175 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57718.[MT7]-RLHIGAVHK[MT7].3b3_1.heavy 440.282 / 551.353 2165.0 25.42020034790039 23 3 6 10 4 0.4087570498169238 116.41485488201931 0.0 10 0.5855783404842174 1.8465126137380297 2165.0 4.0632764721352235 4.0 - - - - - - - 716.5384615384615 14 13 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1369 175 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57718.[MT7]-RLHIGAVHK[MT7].3y5_1.heavy 440.282 / 655.401 906.0 25.42020034790039 23 3 6 10 4 0.4087570498169238 116.41485488201931 0.0 10 0.5855783404842174 1.8465126137380297 906.0 1.573697270471464 2.0 - - - - - - - 208.85185185185185 2 27 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1371 176 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59049.[MT7]-VSGMQR.2b3_1.heavy 411.225 / 388.231 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1373 176 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59049.[MT7]-VSGMQR.2y4_1.heavy 411.225 / 491.24 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1375 176 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59049.[MT7]-VSGMQR.2y5_1.heavy 411.225 / 578.271 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1377 176 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59049.[MT7]-VSGMQR.2b4_1.heavy 411.225 / 519.272 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1379 177 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539043.[MT7]-LAQQIANC[CAM]K[MT7].3y3_1.heavy 445.255 / 565.288 20760.0 25.45669937133789 39 17 4 10 8 4.102032878499273 24.378156626717477 0.0 4 0.9751568173567456 7.81367827862404 20760.0 77.01161538461538 0.0 - - - - - - - 313.3333333333333 41 15 MID1 midline 1 (Opitz/BBB syndrome) 1381 177 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539043.[MT7]-LAQQIANC[CAM]K[MT7].3b4_1.heavy 445.255 / 585.348 27213.0 25.45669937133789 39 17 4 10 8 4.102032878499273 24.378156626717477 0.0 4 0.9751568173567456 7.81367827862404 27213.0 101.85437142857143 1.0 - - - - - - - 640.0 102 10 MID1 midline 1 (Opitz/BBB syndrome) 1383 177 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539043.[MT7]-LAQQIANC[CAM]K[MT7].3y4_1.heavy 445.255 / 636.326 19860.0 25.45669937133789 39 17 4 10 8 4.102032878499273 24.378156626717477 0.0 4 0.9751568173567456 7.81367827862404 19860.0 102.38933333333333 0.0 - - - - - - - 225.0 39 18 MID1 midline 1 (Opitz/BBB syndrome) 1385 177 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539043.[MT7]-LAQQIANC[CAM]K[MT7].3b3_1.heavy 445.255 / 457.289 19059.0 25.45669937133789 39 17 4 10 8 4.102032878499273 24.378156626717477 0.0 4 0.9751568173567456 7.81367827862404 19059.0 41.89464228002213 0.0 - - - - - - - 625.0 38 10 MID1 midline 1 (Opitz/BBB syndrome) 1387 178 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538780.[MT7]-DHQVAALSER.3y6_1.heavy 423.894 / 646.352 15850.0 19.79509973526001 47 20 10 7 10 22.242648234341235 4.495867530989694 0.029600143432617188 3 0.999108658685522 41.33406206997954 15850.0 95.52456844893925 0.0 - - - - - - - 155.91666666666666 31 24 MID1 midline 1 (Opitz/BBB syndrome) 1389 178 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538780.[MT7]-DHQVAALSER.3y4_1.heavy 423.894 / 504.278 6969.0 19.79509973526001 47 20 10 7 10 22.242648234341235 4.495867530989694 0.029600143432617188 3 0.999108658685522 41.33406206997954 6969.0 15.723475771540288 0.0 - - - - - - - 577.75 13 8 MID1 midline 1 (Opitz/BBB syndrome) 1391 178 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538780.[MT7]-DHQVAALSER.3b3_1.heavy 423.894 / 525.254 8443.0 19.79509973526001 47 20 10 7 10 22.242648234341235 4.495867530989694 0.029600143432617188 3 0.999108658685522 41.33406206997954 8443.0 29.14424686192468 0.0 - - - - - - - 200.70833333333334 16 24 MID1 midline 1 (Opitz/BBB syndrome) 1393 178 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538780.[MT7]-DHQVAALSER.3y5_1.heavy 423.894 / 575.315 11947.0 19.79509973526001 47 20 10 7 10 22.242648234341235 4.495867530989694 0.029600143432617188 3 0.999108658685522 41.33406206997954 11947.0 29.177961789891153 0.0 - - - - - - - 209.08333333333334 23 24 MID1 midline 1 (Opitz/BBB syndrome) 1395 179 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59818.[MT7]-SASLISQAEHSLK[MT7].3b4_1.heavy 553.649 / 503.295 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1397 179 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59818.[MT7]-SASLISQAEHSLK[MT7].3b5_1.heavy 553.649 / 616.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1399 179 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59818.[MT7]-SASLISQAEHSLK[MT7].3y8_1.heavy 553.649 / 1043.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1401 179 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59818.[MT7]-SASLISQAEHSLK[MT7].3y5_1.heavy 553.649 / 757.432 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1403 180 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47641.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].2y8_1.heavy 1065.54 / 1074.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1405 180 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47641.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].2y5_1.heavy 1065.54 / 732.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1407 180 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47641.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].2y6_1.heavy 1065.54 / 833.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1409 180 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47641.[MT7]-LTDFGFC[CAM]AQITPEQSK[MT7].2b5_1.heavy 1065.54 / 678.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1411 181 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57711.[MT7]-SVSLLPLEFR.2y8_1.heavy 652.888 / 974.567 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1413 181 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57711.[MT7]-SVSLLPLEFR.2y5_1.heavy 652.888 / 661.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1415 181 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57711.[MT7]-SVSLLPLEFR.2b4_1.heavy 652.888 / 531.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1417 181 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57711.[MT7]-SVSLLPLEFR.2b5_1.heavy 652.888 / 644.41 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1419 182 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57613.[MT7]-YQDTPGVK[MT7].2b3_1.heavy 598.332 / 551.258 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1421 182 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57613.[MT7]-YQDTPGVK[MT7].2y4_1.heavy 598.332 / 544.357 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1423 182 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57613.[MT7]-YQDTPGVK[MT7].2y5_1.heavy 598.332 / 645.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1425 182 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57613.[MT7]-YQDTPGVK[MT7].2b4_1.heavy 598.332 / 652.306 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1427 183 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59953.[MT7]-LAQLLGEPAETQGTTEAR.2b3_1.heavy 1015.04 / 457.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1429 183 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59953.[MT7]-LAQLLGEPAETQGTTEAR.2y8_1.heavy 1015.04 / 863.422 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1431 183 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59953.[MT7]-LAQLLGEPAETQGTTEAR.2b4_1.heavy 1015.04 / 570.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1433 183 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59953.[MT7]-LAQLLGEPAETQGTTEAR.2y11_1.heavy 1015.04 / 1160.55 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1435 184 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58684.[MT7]-C[CAM]PVTIPEDQK[MT7].3y3_1.heavy 492.265 / 534.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1437 184 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58684.[MT7]-C[CAM]PVTIPEDQK[MT7].3y4_1.heavy 492.265 / 663.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1439 184 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58684.[MT7]-C[CAM]PVTIPEDQK[MT7].3b3_1.heavy 492.265 / 501.261 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1441 184 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58684.[MT7]-C[CAM]PVTIPEDQK[MT7].3y5_1.heavy 492.265 / 760.396 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1443 185 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46921.[MT7]-GEAPSQPR.2y5_1.heavy 493.263 / 584.315 8084.0 13.990749835968018 38 14 10 6 8 2.1163788769470178 37.21396911181075 0.03339958190917969 4 0.9390667659486471 4.973990492287159 8084.0 41.550304539360276 0.0 - - - - - - - 176.375 16 16 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1445 185 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46921.[MT7]-GEAPSQPR.2y6_1.heavy 493.263 / 655.352 4902.0 13.990749835968018 38 14 10 6 8 2.1163788769470178 37.21396911181075 0.03339958190917969 4 0.9390667659486471 4.973990492287159 4902.0 54.55406422659243 0.0 - - - - - - - 196.86666666666667 9 15 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1447 185 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46921.[MT7]-GEAPSQPR.2b5_1.heavy 493.263 / 586.295 1006.0 13.990749835968018 38 14 10 6 8 2.1163788769470178 37.21396911181075 0.03339958190917969 4 0.9390667659486471 4.973990492287159 1006.0 3.5157454890788227 0.0 - - - - - - - 142.0952380952381 2 21 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1449 185 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46921.[MT7]-GEAPSQPR.2y7_1.heavy 493.263 / 784.395 2889.0 13.990749835968018 38 14 10 6 8 2.1163788769470178 37.21396911181075 0.03339958190917969 4 0.9390667659486471 4.973990492287159 2889.0 31.112307692307695 1.0 - - - - - - - 104.44444444444444 10 18 LOC100291878;ARHGEF4 hypothetical protein LOC100291878;Rho guanine nucleotide exchange factor (GEF) 4 1451 186 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46928.[MT7]-TEGQEQR.2y5_1.heavy 496.25 / 617.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1453 186 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46928.[MT7]-TEGQEQR.2b6_1.heavy 496.25 / 817.381 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1455 186 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46928.[MT7]-TEGQEQR.2y6_1.heavy 496.25 / 746.343 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1457 186 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB46928.[MT7]-TEGQEQR.2b5_1.heavy 496.25 / 689.322 N/A N/A - - - - - - - - - 0.0 - - - - - - - P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1459 187 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47388.[MT7]-FQAFDWGSSAK[MT7].2y8_1.heavy 766.393 / 1041.51 N/A 36.30820083618164 47 17 10 10 10 3.5876283504496507 27.87356722372501 0.0 3 0.9724466856849067 7.417766922166078 702.0 3.101910788757933 1.0 - - - - - - - 180.2 2 5 LIPA lipase A, lysosomal acid, cholesterol esterase 1461 187 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47388.[MT7]-FQAFDWGSSAK[MT7].2y5_1.heavy 766.393 / 593.338 1604.0 36.30820083618164 47 17 10 10 10 3.5876283504496507 27.87356722372501 0.0 3 0.9724466856849067 7.417766922166078 1604.0 2.8279441117764472 1.0 - - - - - - - 576.125 3 8 LIPA lipase A, lysosomal acid, cholesterol esterase 1463 187 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47388.[MT7]-FQAFDWGSSAK[MT7].2y6_1.heavy 766.393 / 779.417 3108.0 36.30820083618164 47 17 10 10 10 3.5876283504496507 27.87356722372501 0.0 3 0.9724466856849067 7.417766922166078 3108.0 9.054151447727985 0.0 - - - - - - - 236.8181818181818 6 11 LIPA lipase A, lysosomal acid, cholesterol esterase 1465 187 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47388.[MT7]-FQAFDWGSSAK[MT7].2b5_1.heavy 766.393 / 753.369 3007.0 36.30820083618164 47 17 10 10 10 3.5876283504496507 27.87356722372501 0.0 3 0.9724466856849067 7.417766922166078 3007.0 9.300848676711416 0.0 - - - - - - - 293.57142857142856 6 14 LIPA lipase A, lysosomal acid, cholesterol esterase 1467 188 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539566.[MT7]-WYVVQTNYDR.2b3_1.heavy 744.374 / 593.32 12647.0 33.210201263427734 46 16 10 10 10 2.6841593392649745 37.25561241359979 0.0 3 0.9661258743132531 6.686435993740388 12647.0 45.446885878559605 0.0 - - - - - - - 206.1818181818182 25 11 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1469 188 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539566.[MT7]-WYVVQTNYDR.2y8_1.heavy 744.374 / 994.495 11674.0 33.210201263427734 46 16 10 10 10 2.6841593392649745 37.25561241359979 0.0 3 0.9661258743132531 6.686435993740388 11674.0 64.40652993208926 0.0 - - - - - - - 205.2 23 10 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1471 188 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539566.[MT7]-WYVVQTNYDR.2y9_1.heavy 744.374 / 1157.56 13944.0 33.210201263427734 46 16 10 10 10 2.6841593392649745 37.25561241359979 0.0 3 0.9661258743132531 6.686435993740388 13944.0 47.02629672447013 0.0 - - - - - - - 270.0 27 10 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1473 188 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539566.[MT7]-WYVVQTNYDR.2y7_1.heavy 744.374 / 895.427 11458.0 33.210201263427734 46 16 10 10 10 2.6841593392649745 37.25561241359979 0.0 3 0.9661258743132531 6.686435993740388 11458.0 41.174224590538145 0.0 - - - - - - - 245.45454545454547 22 11 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1475 189 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57808.[MT7]-NTELETLLAK[MT7].2b3_1.heavy 710.419 / 489.242 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1477 189 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57808.[MT7]-NTELETLLAK[MT7].2y4_1.heavy 710.419 / 588.42 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1479 189 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57808.[MT7]-NTELETLLAK[MT7].2y5_1.heavy 710.419 / 689.468 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1481 189 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57808.[MT7]-NTELETLLAK[MT7].2b4_1.heavy 710.419 / 602.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1483 190 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58038.[MT7]-GNNQWVPYISLQER.2y8_1.heavy 924.48 / 1005.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1485 190 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58038.[MT7]-GNNQWVPYISLQER.2y9_1.heavy 924.48 / 1104.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1487 190 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58038.[MT7]-GNNQWVPYISLQER.2b4_1.heavy 924.48 / 558.275 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1489 190 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58038.[MT7]-GNNQWVPYISLQER.2b5_1.heavy 924.48 / 744.354 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1491 191 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47248.[MT7]-AK[MT7]PAMPQGK[MT7].3y3_1.heavy 453.943 / 476.295 3281.0 18.355950355529785 40 14 10 6 10 5.9223488419242925 16.885192458117334 0.03429985046386719 3 0.9424115613267421 5.1178571765836764 3281.0 4.492762128325508 1.0 - - - - - - - 710.0833333333334 6 12 ACLY ATP citrate lyase 1493 191 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47248.[MT7]-AK[MT7]PAMPQGK[MT7].3b4_1.heavy 453.943 / 656.433 2983.0 18.355950355529785 40 14 10 6 10 5.9223488419242925 16.885192458117334 0.03429985046386719 3 0.9424115613267421 5.1178571765836764 2983.0 26.981344669117647 0.0 - - - - - - - 207.27272727272728 5 22 ACLY ATP citrate lyase 1495 191 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47248.[MT7]-AK[MT7]PAMPQGK[MT7].3y4_1.heavy 453.943 / 573.348 7585.0 18.355950355529785 40 14 10 6 10 5.9223488419242925 16.885192458117334 0.03429985046386719 3 0.9424115613267421 5.1178571765836764 7585.0 21.571460088247093 0.0 - - - - - - - 633.1428571428571 15 7 ACLY ATP citrate lyase 1497 191 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47248.[MT7]-AK[MT7]PAMPQGK[MT7].3b4_2.heavy 453.943 / 328.72 6008.0 18.355950355529785 40 14 10 6 10 5.9223488419242925 16.885192458117334 0.03429985046386719 3 0.9424115613267421 5.1178571765836764 6008.0 23.56856490541422 0.0 - - - - - - - 235.64705882352942 12 17 ACLY ATP citrate lyase 1499 192 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59566.[MT7]-EILYGTNEK[MT7].2b3_1.heavy 677.876 / 500.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1501 192 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59566.[MT7]-EILYGTNEK[MT7].2y5_1.heavy 677.876 / 692.37 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1503 192 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59566.[MT7]-EILYGTNEK[MT7].2y6_1.heavy 677.876 / 855.433 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1505 192 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59566.[MT7]-EILYGTNEK[MT7].2y7_1.heavy 677.876 / 968.517 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1507 193 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47249.[MT7]-ADEVAPAK[MT7]K[MT7].2b8_1.heavy 680.912 / 1070.61 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1509 193 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47249.[MT7]-ADEVAPAK[MT7]K[MT7].2b3_1.heavy 680.912 / 460.216 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1511 193 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47249.[MT7]-ADEVAPAK[MT7]K[MT7].2y6_1.heavy 680.912 / 901.607 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1513 194 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57346.[MT7]-SLPPPK[MT7].2y4_1.heavy 463.799 / 582.373 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1515 194 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57346.[MT7]-SLPPPK[MT7].2y3_1.heavy 463.799 / 485.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1517 195 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ENO_ECO24.IQLVGDDLFVTNTK.2y8.peptide 781.92 / 937.5 311931.0 38.68339920043945 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 311931.0 181.689316510876 0.0 - - - - - - - 270.375 623 8 1519 195 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ENO_ECO24.IQLVGDDLFVTNTK.2y6.peptide 781.92 / 709.39 547224.0 38.68339920043945 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 547224.0 244.2057006322775 0.0 - - - - - - - 346.25 1094 4 1521 195 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 ENO_ECO24.IQLVGDDLFVTNTK.2y5.peptide 781.92 / 562.32 686244.0 38.68339920043945 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 686244.0 208.0792576817767 0.0 - - - - - - - 245.33333333333334 1372 6 1523 196 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57942.[MT7]-DVAQIFNNILRR.3y6_1.heavy 534.978 / 785.474 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1525 196 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57942.[MT7]-DVAQIFNNILRR.3y11_2.heavy 534.978 / 672.399 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1527 196 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57942.[MT7]-DVAQIFNNILRR.3b4_1.heavy 534.978 / 558.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1529 196 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57942.[MT7]-DVAQIFNNILRR.3b3_1.heavy 534.978 / 430.242 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 1531 197 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47253.[MT7]-YLSFTPPEK[MT7].2b3_1.heavy 685.384 / 508.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1533 197 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47253.[MT7]-YLSFTPPEK[MT7].2y4_1.heavy 685.384 / 614.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1535 197 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47253.[MT7]-YLSFTPPEK[MT7].2y3_1.heavy 685.384 / 517.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1537 197 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47253.[MT7]-YLSFTPPEK[MT7].2y7_1.heavy 685.384 / 949.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1539 198 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539886.[MT7]-K[MT7]FIDQVVEK[MT7].3y3_1.heavy 513.315 / 519.326 49119.0 28.117900848388672 45 15 10 10 10 2.754592148109429 27.926023834155643 0.0 3 0.9502693182432329 5.511041885570201 49119.0 154.88764004193953 0.0 - - - - - - - 818.0769230769231 98 13 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1541 198 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539886.[MT7]-K[MT7]FIDQVVEK[MT7].3b4_1.heavy 513.315 / 792.486 7864.0 28.117900848388672 45 15 10 10 10 2.754592148109429 27.926023834155643 0.0 3 0.9502693182432329 5.511041885570201 7864.0 32.41857785393018 0.0 - - - - - - - 254.3684210526316 15 19 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1543 198 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539886.[MT7]-K[MT7]FIDQVVEK[MT7].3b5_1.heavy 513.315 / 920.544 7993.0 28.117900848388672 45 15 10 10 10 2.754592148109429 27.926023834155643 0.0 3 0.9502693182432329 5.511041885570201 7993.0 80.6459252118729 0.0 - - - - - - - 105.57142857142857 15 14 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1545 198 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539886.[MT7]-K[MT7]FIDQVVEK[MT7].3y4_1.heavy 513.315 / 618.394 11216.0 28.117900848388672 45 15 10 10 10 2.754592148109429 27.926023834155643 0.0 3 0.9502693182432329 5.511041885570201 11216.0 20.492210638866613 0.0 - - - - - - - 617.9166666666666 22 12 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1547 199 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538573.[MT7]-TIVSIGDPK[MT7].3b4_1.heavy 406.583 / 545.341 31001.0 28.86405086517334 42 20 10 6 6 13.395343125088042 7.465280961165579 0.03149986267089844 5 0.9974465081805812 24.417583250008263 31001.0 79.03215460526314 0.0 - - - - - - - 256.5 62 16 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1549 199 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538573.[MT7]-TIVSIGDPK[MT7].3y7_2.heavy 406.583 / 430.254 6915.0 28.86405086517334 42 20 10 6 6 13.395343125088042 7.465280961165579 0.03149986267089844 5 0.9974465081805812 24.417583250008263 6915.0 2.372702037351443 2.0 - - - - - - - 781.7142857142857 27 7 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1551 199 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538573.[MT7]-TIVSIGDPK[MT7].3y4_1.heavy 406.583 / 560.316 6839.0 28.86405086517334 42 20 10 6 6 13.395343125088042 7.465280961165579 0.03149986267089844 5 0.9974465081805812 24.417583250008263 6839.0 5.1421052631578945 0.0 - - - - - - - 228.0 13 15 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1553 199 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538573.[MT7]-TIVSIGDPK[MT7].3b3_1.heavy 406.583 / 458.31 23555.0 28.86405086517334 42 20 10 6 6 13.395343125088042 7.465280961165579 0.03149986267089844 5 0.9974465081805812 24.417583250008263 23555.0 41.066282894736844 0.0 - - - - - - - 283.73333333333335 47 15 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1555 200 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537901.[MT7]-AINQAGSR.2y5_1.heavy 480.771 / 518.268 2316.0 14.846524715423584 46 20 10 6 10 11.480349693730068 8.71053606098902 0.03709983825683594 3 0.9959079526720154 19.286074425060338 2316.0 12.654219415943173 0.0 - - - - - - - 165.52380952380952 4 21 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1557 200 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537901.[MT7]-AINQAGSR.2b4_1.heavy 480.771 / 571.332 2172.0 14.846524715423584 46 20 10 6 10 11.480349693730068 8.71053606098902 0.03709983825683594 3 0.9959079526720154 19.286074425060338 2172.0 14.3501497069647 0.0 - - - - - - - 127.63157894736842 4 19 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1559 200 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537901.[MT7]-AINQAGSR.2y6_1.heavy 480.771 / 632.311 6044.0 14.846524715423584 46 20 10 6 10 11.480349693730068 8.71053606098902 0.03709983825683594 3 0.9959079526720154 19.286074425060338 6044.0 11.562335456475584 1.0 - - - - - - - 212.625 12 16 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1561 200 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537901.[MT7]-AINQAGSR.2y7_1.heavy 480.771 / 745.395 10279.0 14.846524715423584 46 20 10 6 10 11.480349693730068 8.71053606098902 0.03709983825683594 3 0.9959079526720154 19.286074425060338 10279.0 129.9606548735364 0.0 - - - - - - - 122.125 20 16 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1563 201 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47759.[MT7]-GLNELMNVC[CAM]QHVLDK[MT7]FEASIK[MT7].4b7_1.heavy 720.139 / 916.468 1298.0 47.82892608642578 33 10 10 3 10 0.7882489172628068 77.64819610160795 0.060199737548828125 3 0.8293244034965961 2.94372195296482 1298.0 6.144378698224852 0.0 - - - - - - - 136.0 2 17 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1565 201 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47759.[MT7]-GLNELMNVC[CAM]QHVLDK[MT7]FEASIK[MT7].4b4_1.heavy 720.139 / 558.3 1410.0 47.82892608642578 33 10 10 3 10 0.7882489172628068 77.64819610160795 0.060199737548828125 3 0.8293244034965961 2.94372195296482 1410.0 5.3911392405063285 0.0 - - - - - - - 140.9090909090909 2 22 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1567 201 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47759.[MT7]-GLNELMNVC[CAM]QHVLDK[MT7]FEASIK[MT7].4b5_1.heavy 720.139 / 671.385 2426.0 47.82892608642578 33 10 10 3 10 0.7882489172628068 77.64819610160795 0.060199737548828125 3 0.8293244034965961 2.94372195296482 2426.0 12.88141592920354 0.0 - - - - - - - 156.30769230769232 4 13 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1569 201 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47759.[MT7]-GLNELMNVC[CAM]QHVLDK[MT7]FEASIK[MT7].4b6_1.heavy 720.139 / 802.425 677.0 47.82892608642578 33 10 10 3 10 0.7882489172628068 77.64819610160795 0.060199737548828125 3 0.8293244034965961 2.94372195296482 677.0 0.0 2.0 - - - - - - - 0.0 1 0 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1571 202 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y7.peptide 503.96 / 728.39 675688.0 33.87860107421875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 675688.0 522.5278309628316 0.0 - - - - - - - 715.6 1351 10 1573 202 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y6.peptide 503.96 / 631.34 121123.0 33.87860107421875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 121123.0 166.42751542939067 0.0 - - - - - - - 777.8571428571429 242 14 1575 202 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 RBSB_ECOLI.LAATIAQLPDQIGAK.3y5.peptide 503.96 / 516.31 85139.0 33.87860107421875 27 -3 10 10 10 null 0.0 0.0 3 0.0 0.0 85139.0 103.23703576657618 0.0 - - - - - - - 1127.75 170 8 1577 203 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57604.[MT7]-HPFFLDDR.2y5_1.heavy 595.807 / 665.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1579 203 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57604.[MT7]-HPFFLDDR.2y3_1.heavy 595.807 / 405.173 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1581 203 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57604.[MT7]-HPFFLDDR.2y7_1.heavy 595.807 / 909.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1583 204 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538046.[MT7]-SQLVQK[MT7].2y4_1.heavy 495.813 / 631.426 7641.0 19.318199157714844 48 18 10 10 10 7.936558243208997 12.599920133587641 0.0 3 0.9834834337330381 9.589653493040615 7641.0 38.778573045296966 0.0 - - - - - - - 194.53846153846155 15 26 SMAD7 SMAD family member 7 1585 204 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538046.[MT7]-SQLVQK[MT7].2y5_1.heavy 495.813 / 759.484 6347.0 19.318199157714844 48 18 10 10 10 7.936558243208997 12.599920133587641 0.0 3 0.9834834337330381 9.589653493040615 6347.0 31.36658628643321 0.0 - - - - - - - 238.71428571428572 12 28 SMAD7 SMAD family member 7 1587 204 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538046.[MT7]-SQLVQK[MT7].2b4_1.heavy 495.813 / 572.352 6890.0 19.318199157714844 48 18 10 10 10 7.936558243208997 12.599920133587641 0.0 3 0.9834834337330381 9.589653493040615 6890.0 27.366135910629026 0.0 - - - - - - - 320.77272727272725 13 22 SMAD7 SMAD family member 7 1589 204 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538046.[MT7]-SQLVQK[MT7].2y3_1.heavy 495.813 / 518.342 10523.0 19.318199157714844 48 18 10 10 10 7.936558243208997 12.599920133587641 0.0 3 0.9834834337330381 9.589653493040615 10523.0 15.953604762294855 0.0 - - - - - - - 599.8181818181819 21 11 SMAD7 SMAD family member 7 1591 205 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538577.[MT7]-SATLDNPDSR.2y5_1.heavy 610.305 / 588.274 9675.0 18.433224201202393 43 17 10 6 10 4.488914677718754 22.27709974002436 0.03429985046386719 3 0.9721283276341576 7.375083673539269 9675.0 28.87182437407953 0.0 - - - - - - - 721.6666666666666 19 9 SMAD7 SMAD family member 7 1593 205 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538577.[MT7]-SATLDNPDSR.2y9_1.heavy 610.305 / 988.469 2374.0 18.433224201202393 43 17 10 6 10 4.488914677718754 22.27709974002436 0.03429985046386719 3 0.9721283276341576 7.375083673539269 2374.0 60.291053010552446 0.0 - - - - - - - 124.0 4 13 SMAD7 SMAD family member 7 1595 205 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538577.[MT7]-SATLDNPDSR.2b6_1.heavy 610.305 / 746.38 2777.0 18.433224201202393 43 17 10 6 10 4.488914677718754 22.27709974002436 0.03429985046386719 3 0.9721283276341576 7.375083673539269 2777.0 41.43855058043117 0.0 - - - - - - - 93.81818181818181 5 11 SMAD7 SMAD family member 7 1597 205 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538577.[MT7]-SATLDNPDSR.2b5_1.heavy 610.305 / 632.337 8107.0 18.433224201202393 43 17 10 6 10 4.488914677718754 22.27709974002436 0.03429985046386719 3 0.9721283276341576 7.375083673539269 8107.0 69.9965562501298 0.0 - - - - - - - 146.6818181818182 16 22 SMAD7 SMAD family member 7 1599 206 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47652.[MT7]-LPGLLGNFPGPFEEEMK[MT7].3y3_1.heavy 721.718 / 551.298 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1601 206 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47652.[MT7]-LPGLLGNFPGPFEEEMK[MT7].3b4_1.heavy 721.718 / 525.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1603 206 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47652.[MT7]-LPGLLGNFPGPFEEEMK[MT7].3b3_1.heavy 721.718 / 412.268 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1605 206 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47652.[MT7]-LPGLLGNFPGPFEEEMK[MT7].3y4_1.heavy 721.718 / 680.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1607 207 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57944.[MT7]-IEDLLQSEENK[MT7].2b3_1.heavy 803.432 / 502.263 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1609 207 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57944.[MT7]-IEDLLQSEENK[MT7].2y5_1.heavy 803.432 / 750.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1611 207 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57944.[MT7]-IEDLLQSEENK[MT7].2b4_1.heavy 803.432 / 615.347 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1613 207 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57944.[MT7]-IEDLLQSEENK[MT7].2y6_1.heavy 803.432 / 878.434 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1615 208 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47651.[MT7]-GAVPWYTINLDLPPYK[MT7].2b3_1.heavy 1068.09 / 372.236 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1617 208 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47651.[MT7]-GAVPWYTINLDLPPYK[MT7].2y4_1.heavy 1068.09 / 648.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1619 208 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47651.[MT7]-GAVPWYTINLDLPPYK[MT7].2y8_2.heavy 1068.09 / 552.315 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1621 208 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47651.[MT7]-GAVPWYTINLDLPPYK[MT7].2y3_1.heavy 1068.09 / 551.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1623 209 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59178.[MT7]-FEASIK[MT7].2y4_1.heavy 491.794 / 562.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1625 209 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59178.[MT7]-FEASIK[MT7].2y5_1.heavy 491.794 / 691.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1627 209 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59178.[MT7]-FEASIK[MT7].2b4_1.heavy 491.794 / 579.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1629 209 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59178.[MT7]-FEASIK[MT7].2b5_1.heavy 491.794 / 692.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1631 210 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57532.[MT7]-FYWGHK[MT7].2y4_1.heavy 563.308 / 671.375 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1633 210 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57532.[MT7]-FYWGHK[MT7].2y5_1.heavy 563.308 / 834.438 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1635 210 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57532.[MT7]-FYWGHK[MT7].2b4_1.heavy 563.308 / 698.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1637 210 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57532.[MT7]-FYWGHK[MT7].2b5_1.heavy 563.308 / 835.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1639 211 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59193.[MT7]-QDISDK[MT7].2b3_1.heavy 497.276 / 501.279 2308.0 15.763099670410156 38 14 6 10 8 2.3870646402762072 32.145772330674646 0.0 4 0.9392422106418714 4.98124127732044 2308.0 26.51092826209753 0.0 - - - - - - - 210.15384615384616 4 13 CAB39 calcium binding protein 39 1641 211 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59193.[MT7]-QDISDK[MT7].2y4_1.heavy 497.276 / 606.358 5936.0 15.763099670410156 38 14 6 10 8 2.3870646402762072 32.145772330674646 0.0 4 0.9392422106418714 4.98124127732044 5936.0 19.92650176678445 0.0 - - - - - - - 137.25 11 12 CAB39 calcium binding protein 39 1643 211 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59193.[MT7]-QDISDK[MT7].2y5_1.heavy 497.276 / 721.385 7773.0 15.763099670410156 38 14 6 10 8 2.3870646402762072 32.145772330674646 0.0 4 0.9392422106418714 4.98124127732044 7773.0 78.30398836560683 1.0 - - - - - - - 170.30769230769232 23 13 CAB39 calcium binding protein 39 1645 211 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59193.[MT7]-QDISDK[MT7].2b4_1.heavy 497.276 / 588.311 942.0 15.763099670410156 38 14 6 10 8 2.3870646402762072 32.145772330674646 0.0 4 0.9392422106418714 4.98124127732044 942.0 3.594791987673344 7.0 - - - - - - - 196.22222222222223 8 18 CAB39 calcium binding protein 39 1647 212 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539555.[MT7]-RNVTLQNIIDR.3b4_1.heavy 495.959 / 615.37 35758.0 31.204700469970703 48 18 10 10 10 6.61885788836138 15.10834673997765 0.0 3 0.980937475718045 8.92441680358112 35758.0 76.4225971511832 0.0 - - - - - - - 740.0 71 8 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1649 212 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539555.[MT7]-RNVTLQNIIDR.3b5_1.heavy 495.959 / 728.453 46348.0 31.204700469970703 48 18 10 10 10 6.61885788836138 15.10834673997765 0.0 3 0.980937475718045 8.92441680358112 46348.0 291.3690058479532 0.0 - - - - - - - 207.27272727272728 92 11 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1651 212 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539555.[MT7]-RNVTLQNIIDR.3y4_1.heavy 495.959 / 516.314 50903.0 31.204700469970703 48 18 10 10 10 6.61885788836138 15.10834673997765 0.0 3 0.980937475718045 8.92441680358112 50903.0 46.730273943956504 0.0 - - - - - - - 1227.4444444444443 101 9 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1653 212 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539555.[MT7]-RNVTLQNIIDR.3y5_1.heavy 495.959 / 630.357 110803.0 31.204700469970703 48 18 10 10 10 6.61885788836138 15.10834673997765 0.0 3 0.980937475718045 8.92441680358112 110803.0 112.69629423561909 0.0 - - - - - - - 342.0 221 4 MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1655 213 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59195.[MT7]-FLQTAK[MT7].2b3_1.heavy 498.31 / 533.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1657 213 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59195.[MT7]-FLQTAK[MT7].2y4_1.heavy 498.31 / 591.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1659 213 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59195.[MT7]-FLQTAK[MT7].2y5_1.heavy 498.31 / 704.442 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1661 213 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59195.[MT7]-FLQTAK[MT7].2y3_1.heavy 498.31 / 463.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1663 214 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58027.[MT7]-YDLPASINFILNK[MT7].2b3_1.heavy 898.513 / 536.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 1665 214 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58027.[MT7]-YDLPASINFILNK[MT7].2y3_1.heavy 898.513 / 518.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 1667 214 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58027.[MT7]-YDLPASINFILNK[MT7].2b5_1.heavy 898.513 / 704.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 1669 214 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58027.[MT7]-YDLPASINFILNK[MT7].2b9_1.heavy 898.513 / 1165.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - LIPA lipase A, lysosomal acid, cholesterol esterase 1671 215 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59190.[MT7]-FLPDEAR.2y5_1.heavy 496.27 / 587.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1673 215 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59190.[MT7]-FLPDEAR.2b4_1.heavy 496.27 / 617.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1675 215 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59190.[MT7]-FLPDEAR.2y6_1.heavy 496.27 / 700.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1677 215 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59190.[MT7]-FLPDEAR.2b5_1.heavy 496.27 / 746.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - NDUFC2 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 1679 216 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539417.[MT7]-YVYFFEAC[CAM]R.2b3_1.heavy 699.835 / 570.304 4641.0 39.35459899902344 44 14 10 10 10 1.9694109548923922 42.013878079947226 0.0 3 0.9382328958137416 4.939950185807713 4641.0 4.665555555555556 0.0 - - - - - - - 218.30769230769232 9 13 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1681 216 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539417.[MT7]-YVYFFEAC[CAM]R.2y8_1.heavy 699.835 / 1091.5 3610.0 39.35459899902344 44 14 10 10 10 1.9694109548923922 42.013878079947226 0.0 3 0.9382328958137416 4.939950185807713 3610.0 58.13779069767442 0.0 - - - - - - - 147.42857142857142 7 7 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1683 216 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539417.[MT7]-YVYFFEAC[CAM]R.2y6_1.heavy 699.835 / 829.366 3782.0 39.35459899902344 44 14 10 10 10 1.9694109548923922 42.013878079947226 0.0 3 0.9382328958137416 4.939950185807713 3782.0 16.799116279069764 0.0 - - - - - - - 251.3846153846154 7 13 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1685 216 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539417.[MT7]-YVYFFEAC[CAM]R.2y7_1.heavy 699.835 / 992.43 4727.0 39.35459899902344 44 14 10 10 10 1.9694109548923922 42.013878079947226 0.0 3 0.9382328958137416 4.939950185807713 4727.0 102.23511627906976 0.0 - - - - - - - 211.0909090909091 9 11 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1687 217 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57335.[MT7]-LLEEK[MT7].2y4_1.heavy 460.289 / 662.384 N/A N/A - - - - - - - - - 0.0 - - - - - - - MRPL28;TTBK2;TRAK1;NINL;FLT4;HMMR;KIF3C;MYH7B;TPM2;HOOK3;SESTD1;RB1CC1 mitochondrial ribosomal protein L28;tau tubulin kinase 2;trafficking protein, kinesin binding 1;ninein-like;fms-related tyrosine kinase 4;hyaluronan-mediated motility receptor (RHAMM);kinesin family member 3C;myosin, heavy chain 7B, cardiac muscle, beta;tropomyosin 2 (beta);hook homolog 3 (Drosophila);SEC14 and spectrin domains 1;RB1-inducible coiled-coil 1 1689 217 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57335.[MT7]-LLEEK[MT7].2y3_1.heavy 460.289 / 549.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - MRPL28;TTBK2;TRAK1;NINL;FLT4;HMMR;KIF3C;MYH7B;TPM2;HOOK3;SESTD1;RB1CC1 mitochondrial ribosomal protein L28;tau tubulin kinase 2;trafficking protein, kinesin binding 1;ninein-like;fms-related tyrosine kinase 4;hyaluronan-mediated motility receptor (RHAMM);kinesin family member 3C;myosin, heavy chain 7B, cardiac muscle, beta;tropomyosin 2 (beta);hook homolog 3 (Drosophila);SEC14 and spectrin domains 1;RB1-inducible coiled-coil 1 1691 218 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47101.[MT7]-VDEEERK[MT7].2y4_1.heavy 596.824 / 705.401 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1693 218 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47101.[MT7]-VDEEERK[MT7].2y5_1.heavy 596.824 / 834.444 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1695 218 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47101.[MT7]-VDEEERK[MT7].2b4_1.heavy 596.824 / 617.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1697 218 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47101.[MT7]-VDEEERK[MT7].2y6_1.heavy 596.824 / 949.471 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1699 219 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47110.[MT7]-NVAQLINER.2y4_1.heavy 600.844 / 531.289 6929.0 30.21109962463379 47 17 10 10 10 3.409127786213759 29.333016029610867 0.0 3 0.9711373665957734 7.246766163587548 6929.0 23.55623281821336 0.0 - - - - - - - 654.8888888888889 13 9 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1701 219 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47110.[MT7]-NVAQLINER.2y8_1.heavy 600.844 / 942.537 8997.0 30.21109962463379 47 17 10 10 10 3.409127786213759 29.333016029610867 0.0 3 0.9711373665957734 7.246766163587548 8997.0 126.89310398198958 0.0 - - - - - - - 183.66666666666666 17 9 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1703 219 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47110.[MT7]-NVAQLINER.2b4_1.heavy 600.844 / 557.316 10858.0 30.21109962463379 47 17 10 10 10 3.409127786213759 29.333016029610867 0.0 3 0.9711373665957734 7.246766163587548 10858.0 11.52979907271099 0.0 - - - - - - - 753.4285714285714 21 7 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1705 219 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47110.[MT7]-NVAQLINER.2y7_1.heavy 600.844 / 843.468 12410.0 30.21109962463379 47 17 10 10 10 3.409127786213759 29.333016029610867 0.0 3 0.9711373665957734 7.246766163587548 12410.0 35.82729706368587 1.0 - - - - - - - 165.3 34 10 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1707 220 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57931.[MT7]-TIITSPESLNLPR.2y8_1.heavy 792.958 / 925.51 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1709 220 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57931.[MT7]-TIITSPESLNLPR.2y9_1.heavy 792.958 / 1012.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1711 220 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57931.[MT7]-TIITSPESLNLPR.2y10_1.heavy 792.958 / 1113.59 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1713 220 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57931.[MT7]-TIITSPESLNLPR.2y11_1.heavy 792.958 / 1226.67 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1715 221 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539878.[MT7]-TNVINEILSTER.3b6_1.heavy 511.618 / 815.438 106236.0 40.30329895019531 48 18 10 10 10 6.3440843868108585 15.76271592602026 0.0 3 0.9829649993454129 9.44219229270161 106236.0 377.21478260869566 0.0 - - - - - - - 197.14285714285714 212 14 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1717 221 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539878.[MT7]-TNVINEILSTER.3b4_1.heavy 511.618 / 572.352 83057.0 40.30329895019531 48 18 10 10 10 6.3440843868108585 15.76271592602026 0.0 3 0.9829649993454129 9.44219229270161 83057.0 103.63495928226362 0.0 - - - - - - - 759.0 166 12 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1719 221 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539878.[MT7]-TNVINEILSTER.3b5_1.heavy 511.618 / 686.395 62638.0 40.30329895019531 48 18 10 10 10 6.3440843868108585 15.76271592602026 0.0 3 0.9829649993454129 9.44219229270161 62638.0 108.66630578117537 0.0 - - - - - - - 715.875 125 8 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1721 221 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539878.[MT7]-TNVINEILSTER.3y5_1.heavy 511.618 / 605.325 284975.0 40.30329895019531 48 18 10 10 10 6.3440843868108585 15.76271592602026 0.0 3 0.9829649993454129 9.44219229270161 284975.0 338.8246734237404 0.0 - - - - - - - 310.5 569 4 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1723 222 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538766.[MT7]-FIDQVVEK[MT7].3y3_1.heavy 422.583 / 519.326 72706.0 31.295900344848633 44 14 10 10 10 1.356127579584673 49.159583265081864 0.0 3 0.9389207838080887 4.96798107950909 72706.0 112.71017467248907 0.0 - - - - - - - 735.8571428571429 145 7 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1725 222 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538766.[MT7]-FIDQVVEK[MT7].3b4_1.heavy 422.583 / 648.347 60570.0 31.295900344848633 44 14 10 10 10 1.356127579584673 49.159583265081864 0.0 3 0.9389207838080887 4.96798107950909 60570.0 218.91711426873107 0.0 - - - - - - - 254.22222222222223 121 9 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1727 222 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538766.[MT7]-FIDQVVEK[MT7].3b5_1.heavy 422.583 / 747.416 7442.0 31.295900344848633 44 14 10 10 10 1.356127579584673 49.159583265081864 0.0 3 0.9389207838080887 4.96798107950909 7442.0 9.612505776180097 1.0 - - - - - - - 228.66666666666666 21 6 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1729 222 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538766.[MT7]-FIDQVVEK[MT7].3b3_1.heavy 422.583 / 520.289 54959.0 31.295900344848633 44 14 10 10 10 1.356127579584673 49.159583265081864 0.0 3 0.9389207838080887 4.96798107950909 54959.0 72.74420568224149 0.0 - - - - - - - 257.25 109 8 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1731 223 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538763.[MT7]-DC[CAM]PDPC[CAM]IGW.2b3_1.heavy 632.266 / 517.22 2808.0 36.11662483215332 40 16 10 6 8 1.6099780540317457 46.540733098222134 0.03730010986328125 4 0.9678687970256435 6.866399984149094 2808.0 1.7176595744680851 4.0 - - - - - - - 673.1428571428571 6 7 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1733 223 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538763.[MT7]-DC[CAM]PDPC[CAM]IGW.2b6_1.heavy 632.266 / 889.33 15342.0 36.11662483215332 40 16 10 6 8 1.6099780540317457 46.540733098222134 0.03730010986328125 4 0.9678687970256435 6.866399984149094 15342.0 58.05960159430484 0.0 - - - - - - - 209.63636363636363 30 11 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1735 223 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538763.[MT7]-DC[CAM]PDPC[CAM]IGW.2b7_1.heavy 632.266 / 1002.41 5415.0 36.11662483215332 40 16 10 6 8 1.6099780540317457 46.540733098222134 0.03730010986328125 4 0.9678687970256435 6.866399984149094 5415.0 63.324441396508725 0.0 - - - - - - - 246.92307692307693 10 13 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1737 223 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538763.[MT7]-DC[CAM]PDPC[CAM]IGW.2b5_1.heavy 632.266 / 729.299 2306.0 36.11662483215332 40 16 10 6 8 1.6099780540317457 46.540733098222134 0.03730010986328125 4 0.9678687970256435 6.866399984149094 2306.0 1.839282153539382 1.0 - - - - - - - 230.8 4 10 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1739 224 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59832.[MT7]-SMGFIGHYLDQK[MT7].3y3_1.heavy 561.964 / 534.3 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1741 224 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59832.[MT7]-SMGFIGHYLDQK[MT7].3b6_1.heavy 561.964 / 737.377 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1743 224 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59832.[MT7]-SMGFIGHYLDQK[MT7].3b4_1.heavy 561.964 / 567.272 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1745 224 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59832.[MT7]-SMGFIGHYLDQK[MT7].3y5_1.heavy 561.964 / 810.448 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1747 225 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58167.[MT7]-TSQENISFETMYDVLSTK[MT7]PVLNK[MT7].4y5_1.heavy 769.911 / 714.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1749 225 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58167.[MT7]-TSQENISFETMYDVLSTK[MT7]PVLNK[MT7].4b4_1.heavy 769.911 / 590.29 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1751 225 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58167.[MT7]-TSQENISFETMYDVLSTK[MT7]PVLNK[MT7].4b5_1.heavy 769.911 / 704.333 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1753 225 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58167.[MT7]-TSQENISFETMYDVLSTK[MT7]PVLNK[MT7].4b6_1.heavy 769.911 / 817.417 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1755 226 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47665.[MT7]-SVIDPVPAPVGDSHVDGAAK[MT7].3y7_1.heavy 740.402 / 841.465 837.0 28.794925212860107 42 18 10 6 8 2.3003395068062162 43.47184391874383 0.030500411987304688 4 0.981859304543838 9.149064205690241 837.0 0.0 1.0 - - - - - - - 0.0 1 0 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1757 226 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47665.[MT7]-SVIDPVPAPVGDSHVDGAAK[MT7].3b6_1.heavy 740.402 / 755.442 1842.0 28.794925212860107 42 18 10 6 8 2.3003395068062162 43.47184391874383 0.030500411987304688 4 0.981859304543838 9.149064205690241 1842.0 2.1761235955056177 2.0 - - - - - - - 225.46153846153845 3 13 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1759 226 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47665.[MT7]-SVIDPVPAPVGDSHVDGAAK[MT7].3b4_1.heavy 740.402 / 559.321 7956.0 28.794925212860107 42 18 10 6 8 2.3003395068062162 43.47184391874383 0.030500411987304688 4 0.981859304543838 9.149064205690241 7956.0 0.2374925373134328 2.0 - - - - - - - 209.1 15 10 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1761 226 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB47665.[MT7]-SVIDPVPAPVGDSHVDGAAK[MT7].3y5_1.heavy 740.402 / 605.338 2429.0 28.794925212860107 42 18 10 6 8 2.3003395068062162 43.47184391874383 0.030500411987304688 4 0.981859304543838 9.149064205690241 2429.0 1.6918407960199005 0.0 - - - - - - - 1196.4285714285713 4 7 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1763 227 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58169.[MT7]-ERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWAR.4y4_1.heavy 1029.24 / 560.294 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1765 227 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58169.[MT7]-ERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWAR.4y8_1.heavy 1029.24 / 974.451 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1767 227 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58169.[MT7]-ERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWAR.4y9_1.heavy 1029.24 / 1075.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1769 227 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58169.[MT7]-ERPEISPPSDFEHTIHVGFDAVTGEFTGMPEQWAR.4y6_1.heavy 1029.24 / 786.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1771 228 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58168.[MT7]-SALTIQLIQNHFVDEYDPTIEDSYRK[MT7].4y4_1.heavy 846.69 / 697.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1773 228 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58168.[MT7]-SALTIQLIQNHFVDEYDPTIEDSYRK[MT7].4b7_1.heavy 846.69 / 871.537 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1775 228 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58168.[MT7]-SALTIQLIQNHFVDEYDPTIEDSYRK[MT7].4b4_1.heavy 846.69 / 517.31 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1777 228 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58168.[MT7]-SALTIQLIQNHFVDEYDPTIEDSYRK[MT7].4b6_1.heavy 846.69 / 758.453 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1779 229 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540385.[MT7]-NIQFEAFHVFK[MT7].3b6_1.heavy 556.643 / 847.443 64444.0 37.658599853515625 43 13 10 10 10 1.2221094390111389 50.86152069395251 0.0 3 0.9165433664164533 4.241937214224846 64444.0 840.928714955706 0.0 - - - - - - - 146.11111111111111 128 9 CAB39 calcium binding protein 39 1781 229 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540385.[MT7]-NIQFEAFHVFK[MT7].3y3_1.heavy 556.643 / 537.352 138514.0 37.658599853515625 43 13 10 10 10 1.2221094390111389 50.86152069395251 0.0 3 0.9165433664164533 4.241937214224846 138514.0 152.77226504687022 0.0 - - - - - - - 709.4285714285714 277 7 CAB39 calcium binding protein 39 1783 229 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540385.[MT7]-NIQFEAFHVFK[MT7].3b5_1.heavy 556.643 / 776.406 43672.0 37.658599853515625 43 13 10 10 10 1.2221094390111389 50.86152069395251 0.0 3 0.9165433664164533 4.241937214224846 43672.0 202.72434567901232 0.0 - - - - - - - 220.8181818181818 87 11 CAB39 calcium binding protein 39 1785 229 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540385.[MT7]-NIQFEAFHVFK[MT7].3b3_1.heavy 556.643 / 500.295 52184.0 37.658599853515625 43 13 10 10 10 1.2221094390111389 50.86152069395251 0.0 3 0.9165433664164533 4.241937214224846 52184.0 45.4110239518316 0.0 - - - - - - - 1241.375 104 8 CAB39 calcium binding protein 39 1787 230 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59505.[MT7]-VIHAIANSGK[MT7].3b4_1.heavy 433.266 / 565.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1789 230 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59505.[MT7]-VIHAIANSGK[MT7].3y4_1.heavy 433.266 / 549.311 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1791 230 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59505.[MT7]-VIHAIANSGK[MT7].3b3_1.heavy 433.266 / 494.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1793 230 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59505.[MT7]-VIHAIANSGK[MT7].3y5_1.heavy 433.266 / 620.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1795 231 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539588.[MT7]-LLHSENYVTK[MT7].3y3_1.heavy 497.952 / 491.331 61721.0 25.45669937133789 46 16 10 10 10 3.640575107751529 22.993813600978026 0.0 3 0.9601329217451224 6.160297196629263 61721.0 20.20565562401064 0.0 - - - - - - - 649.0 123 2 CAB39 calcium binding protein 39 1797 231 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539588.[MT7]-LLHSENYVTK[MT7].3b6_1.heavy 497.952 / 838.454 8739.0 25.45669937133789 46 16 10 10 10 3.640575107751529 22.993813600978026 0.0 3 0.9601329217451224 6.160297196629263 8739.0 70.46891422845691 0.0 - - - - - - - 324.5 17 12 CAB39 calcium binding protein 39 1799 231 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539588.[MT7]-LLHSENYVTK[MT7].3y4_1.heavy 497.952 / 654.394 15230.0 25.45669937133789 46 16 10 10 10 3.640575107751529 22.993813600978026 0.0 3 0.9601329217451224 6.160297196629263 15230.0 35.87930864634116 0.0 - - - - - - - 349.57142857142856 30 7 CAB39 calcium binding protein 39 1801 231 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539588.[MT7]-LLHSENYVTK[MT7].3b3_1.heavy 497.952 / 508.336 14082.0 25.45669937133789 46 16 10 10 10 3.640575107751529 22.993813600978026 0.0 3 0.9601329217451224 6.160297196629263 14082.0 20.60387800432822 0.0 - - - - - - - 704.0 28 10 CAB39 calcium binding protein 39 1803 232 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539483.[MT7]-LIYQTLSWK[MT7].2y8_1.heavy 720.429 / 1182.66 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1805 232 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539483.[MT7]-LIYQTLSWK[MT7].2y5_1.heavy 720.429 / 778.458 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1807 232 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539483.[MT7]-LIYQTLSWK[MT7].2y3_1.heavy 720.429 / 564.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1809 232 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539483.[MT7]-LIYQTLSWK[MT7].2y7_1.heavy 720.429 / 1069.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1811 233 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540785.[MT7]-AFDSGIIPMEFVNK[MT7].3y7_1.heavy 619.334 / 1008.53 3915.0 41.49304962158203 41 14 10 7 10 2.2199966559002027 34.7430325672962 0.0290985107421875 3 0.9419400266102799 5.096827809276662 3915.0 57.9603515625 0.0 - - - - - - - 132.78571428571428 7 14 ACLY ATP citrate lyase 1813 233 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540785.[MT7]-AFDSGIIPMEFVNK[MT7].3b6_1.heavy 619.334 / 735.379 11361.0 41.49304962158203 41 14 10 7 10 2.2199966559002027 34.7430325672962 0.0290985107421875 3 0.9419400266102799 5.096827809276662 11361.0 39.36493032662554 0.0 - - - - - - - 207.0909090909091 22 22 ACLY ATP citrate lyase 1815 233 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540785.[MT7]-AFDSGIIPMEFVNK[MT7].3b5_1.heavy 619.334 / 622.295 9628.0 41.49304962158203 41 14 10 7 10 2.2199966559002027 34.7430325672962 0.0290985107421875 3 0.9419400266102799 5.096827809276662 9628.0 34.34306126888907 0.0 - - - - - - - 178.94736842105263 19 19 ACLY ATP citrate lyase 1817 233 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540785.[MT7]-AFDSGIIPMEFVNK[MT7].3y5_1.heavy 619.334 / 780.437 2952.0 41.49304962158203 41 14 10 7 10 2.2199966559002027 34.7430325672962 0.0290985107421875 3 0.9419400266102799 5.096827809276662 2952.0 25.734155844155843 0.0 - - - - - - - 167.3913043478261 5 23 ACLY ATP citrate lyase 1819 234 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540092.[MT7]-IEDLLQSEENK[MT7].3y3_1.heavy 535.957 / 534.3 65882.0 34.06630039215088 39 13 10 6 10 1.7313159322156773 45.70311016743549 0.038402557373046875 3 0.9048290770466683 3.968296870397039 65882.0 42.67020915736964 0.0 - - - - - - - 208.0 131 2 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1821 234 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540092.[MT7]-IEDLLQSEENK[MT7].3b4_1.heavy 535.957 / 615.347 168804.0 34.06630039215088 39 13 10 6 10 1.7313159322156773 45.70311016743549 0.038402557373046875 3 0.9048290770466683 3.968296870397039 168804.0 96.26399256825975 0.0 - - - - - - - 899.3333333333334 337 3 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1823 234 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540092.[MT7]-IEDLLQSEENK[MT7].3b3_1.heavy 535.957 / 502.263 106864.0 34.06630039215088 39 13 10 6 10 1.7313159322156773 45.70311016743549 0.038402557373046875 3 0.9048290770466683 3.968296870397039 106864.0 78.29348209872185 0.0 - - - - - - - 726.3333333333334 213 3 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1825 234 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB540092.[MT7]-IEDLLQSEENK[MT7].3y5_1.heavy 535.957 / 750.375 70240.0 34.06630039215088 39 13 10 6 10 1.7313159322156773 45.70311016743549 0.038402557373046875 3 0.9048290770466683 3.968296870397039 70240.0 92.83689634671616 0.0 - - - - - - - 222.42857142857142 140 7 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1827 235 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59300.[MT7]-RQIIGTK[MT7].2y4_1.heavy 552.361 / 562.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1829 235 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59300.[MT7]-RQIIGTK[MT7].2y5_1.heavy 552.361 / 675.452 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1831 235 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59300.[MT7]-RQIIGTK[MT7].2y3_1.heavy 552.361 / 449.284 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1833 235 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59300.[MT7]-RQIIGTK[MT7].2y6_1.heavy 552.361 / 803.511 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1835 236 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538754.[MT7]-FYDSNTVK[MT7].3b4_1.heavy 421.227 / 657.3 8715.0 25.022500038146973 40 18 10 6 6 9.941103994762475 10.059244934233215 0.03840065002441406 5 0.9881463657572648 11.324177703246146 8715.0 62.63792529985169 0.0 - - - - - - - 224.07142857142858 17 14 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1837 236 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538754.[MT7]-FYDSNTVK[MT7].3b5_1.heavy 421.227 / 771.343 4283.0 25.022500038146973 40 18 10 6 6 9.941103994762475 10.059244934233215 0.03840065002441406 5 0.9881463657572648 11.324177703246146 4283.0 14.567038660455562 0.0 - - - - - - - 211.5625 8 16 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1839 236 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538754.[MT7]-FYDSNTVK[MT7].3b3_1.heavy 421.227 / 570.268 29532.0 25.022500038146973 40 18 10 6 6 9.941103994762475 10.059244934233215 0.03840065002441406 5 0.9881463657572648 11.324177703246146 29532.0 20.284414576338136 0.0 - - - - - - - 761.2857142857143 59 7 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1841 236 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538754.[MT7]-FYDSNTVK[MT7].3y3_2.heavy 421.227 / 246.169 6175.0 25.022500038146973 40 18 10 6 6 9.941103994762475 10.059244934233215 0.03840065002441406 5 0.9881463657572648 11.324177703246146 6175.0 3.4098895582329316 2.0 - - - - - - - 1743.090909090909 13 11 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 1843 237 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539300.[MT7]-IQTYAEYMGR.2y8_1.heavy 688.343 / 990.435 3450.0 31.622600555419922 44 14 10 10 10 1.9554901939481621 40.70372551849102 0.0 3 0.9305687023506555 4.656282423404098 3450.0 39.99 0.0 - - - - - - - 368.0 6 5 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1845 237 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539300.[MT7]-IQTYAEYMGR.2y9_1.heavy 688.343 / 1118.49 2760.0 31.622600555419922 44 14 10 10 10 1.9554901939481621 40.70372551849102 0.0 3 0.9305687023506555 4.656282423404098 2760.0 16.4 0.0 - - - - - - - 230.0 5 5 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1847 237 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539300.[MT7]-IQTYAEYMGR.2y6_1.heavy 688.343 / 726.324 2300.0 31.622600555419922 44 14 10 10 10 1.9554901939481621 40.70372551849102 0.0 3 0.9305687023506555 4.656282423404098 2300.0 18.0 0.0 - - - - - - - 195.5 4 10 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1849 237 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539300.[MT7]-IQTYAEYMGR.2y7_1.heavy 688.343 / 889.387 805.0 31.622600555419922 44 14 10 10 10 1.9554901939481621 40.70372551849102 0.0 3 0.9305687023506555 4.656282423404098 805.0 3.2327272727272724 5.0 - - - - - - - 249.16666666666666 2 12 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 1851 238 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59716.[MT7]-LYRPGSVAYVSR.3y4_1.heavy 504.62 / 524.283 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1853 238 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59716.[MT7]-LYRPGSVAYVSR.3b8_1.heavy 504.62 / 988.57 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1855 238 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59716.[MT7]-LYRPGSVAYVSR.3y5_1.heavy 504.62 / 595.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1857 238 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59716.[MT7]-LYRPGSVAYVSR.3y9_1.heavy 504.62 / 935.495 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1859 239 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58047.[MT7]-NVTLQNIIDRFQK[MT7].3y3_1.heavy 626.366 / 566.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1861 239 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58047.[MT7]-NVTLQNIIDRFQK[MT7].3y6_1.heavy 626.366 / 950.554 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1863 239 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58047.[MT7]-NVTLQNIIDRFQK[MT7].3y11_2.heavy 626.366 / 760.439 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1865 239 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58047.[MT7]-NVTLQNIIDRFQK[MT7].3b5_1.heavy 626.366 / 700.411 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID2;MID1 midline 2;midline 1 (Opitz/BBB syndrome) 1867 240 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y7.peptide 661.38 / 836.43 216685.0 42.16019821166992 24 -3 10 7 10 null 0.0 0.029399871826171875 3 0.0 0.0 216685.0 310.1069659098388 0.0 - - - - - - - 705.2857142857143 433 7 1869 240 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y9.peptide 661.38 / 502.76 440141.0 42.16019821166992 24 -3 10 7 10 null 0.0 0.029399871826171875 3 0.0 0.0 440141.0 557.8997570885765 0.0 - - - - - - - 380.0 880 2 1871 240 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 BLAT_ECOLX.VAGPLLRSALPAGWFIADK.3y17.peptide 661.38 / 906.51 308637.0 42.16019821166992 24 -3 10 7 10 null 0.0 0.029399871826171875 3 0.0 0.0 308637.0 586.8913959455386 0.0 - - - - - - - 190.0 617 4 1873 241 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57354.[MT7]-GHLIHGR.2y4_1.heavy 467.279 / 482.283 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1875 241 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57354.[MT7]-GHLIHGR.2y5_1.heavy 467.279 / 595.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1877 241 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57354.[MT7]-GHLIHGR.2b4_1.heavy 467.279 / 565.358 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1879 241 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57354.[MT7]-GHLIHGR.2y6_1.heavy 467.279 / 732.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1881 242 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537715.[MT7]-SSEPGK[MT7].2y4_1.heavy 446.753 / 574.332 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1883 242 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537715.[MT7]-SSEPGK[MT7].2b3_1.heavy 446.753 / 448.216 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1885 242 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537715.[MT7]-SSEPGK[MT7].2y5_1.heavy 446.753 / 661.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1887 242 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537715.[MT7]-SSEPGK[MT7].2y3_1.heavy 446.753 / 445.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1889 243 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539473.[MT7]-GATGDSHLLC[CAM]TR.3b6_1.heavy 477.909 / 633.296 8127.0 22.07659912109375 47 17 10 10 10 2.761051438154684 28.997112721459324 0.0 3 0.9795266251707194 8.610411312675241 8127.0 13.631106965174128 0.0 - - - - - - - 666.4166666666666 16 12 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1891 243 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539473.[MT7]-GATGDSHLLC[CAM]TR.3b5_1.heavy 477.909 / 546.264 12622.0 22.07659912109375 47 17 10 10 10 2.761051438154684 28.997112721459324 0.0 3 0.9795266251707194 8.610411312675241 12622.0 16.27958365046387 0.0 - - - - - - - 718.3076923076923 25 13 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1893 243 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539473.[MT7]-GATGDSHLLC[CAM]TR.3y4_1.heavy 477.909 / 549.281 17204.0 22.07659912109375 47 17 10 10 10 2.761051438154684 28.997112721459324 0.0 3 0.9795266251707194 8.610411312675241 17204.0 19.482459163862654 0.0 - - - - - - - 742.7272727272727 34 11 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1895 243 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539473.[MT7]-GATGDSHLLC[CAM]TR.3y5_1.heavy 477.909 / 662.365 15691.0 22.07659912109375 47 17 10 10 10 2.761051438154684 28.997112721459324 0.0 3 0.9795266251707194 8.610411312675241 15691.0 31.387941105603744 0.0 - - - - - - - 306.75 31 20 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1897 244 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537886.[MT7]-RLDDK[MT7].2y4_1.heavy 467.782 / 634.353 1726.0 15.1993248462677 39 15 10 6 8 3.5169131188870026 28.434026266661654 0.03390026092529297 4 0.9545066881435422 5.764056483029313 1726.0 11.272155797101451 0.0 - - - - - - - 166.69230769230768 3 26 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1899 244 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537886.[MT7]-RLDDK[MT7].2b3_1.heavy 467.782 / 529.321 3299.0 15.1993248462677 39 15 10 6 8 3.5169131188870026 28.434026266661654 0.03390026092529297 4 0.9545066881435422 5.764056483029313 3299.0 26.68308823529412 1.0 - - - - - - - 182.95454545454547 7 22 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1901 244 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537886.[MT7]-RLDDK[MT7].2b4_1.heavy 467.782 / 644.348 8286.0 15.1993248462677 39 15 10 6 8 3.5169131188870026 28.434026266661654 0.03390026092529297 4 0.9545066881435422 5.764056483029313 8286.0 36.19276449549851 0.0 - - - - - - - 214.8 16 20 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1903 244 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537886.[MT7]-RLDDK[MT7].2y3_1.heavy 467.782 / 521.269 806.0 15.1993248462677 39 15 10 6 8 3.5169131188870026 28.434026266661654 0.03390026092529297 4 0.9545066881435422 5.764056483029313 806.0 10.059454825990057 0.0 - - - - - - - 0.0 1 0 P2RX7 purinergic receptor P2X, ligand-gated ion channel, 7 1905 245 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57755.[MT7]-GTLPAVEPFQR.2y4_1.heavy 679.881 / 547.299 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1907 245 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57755.[MT7]-GTLPAVEPFQR.2y8_1.heavy 679.881 / 943.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1909 245 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57755.[MT7]-GTLPAVEPFQR.2b5_1.heavy 679.881 / 584.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1911 245 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57755.[MT7]-GTLPAVEPFQR.2y7_1.heavy 679.881 / 846.447 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1913 246 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537883.[MT7]-LISVDSR.2b3_1.heavy 467.278 / 458.31 N/A 27.010000228881836 43 13 10 10 10 1.8613723738740244 42.03278088773882 0.0 3 0.9190467173250914 4.307952059535516 11248.0 3.4847750684324863 3.0 - - - - - - - 3227.0 26 12 IL21R interleukin 21 receptor 1915 246 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537883.[MT7]-LISVDSR.2y5_1.heavy 467.278 / 563.278 17103.0 27.010000228881836 43 13 10 10 10 1.8613723738740244 42.03278088773882 0.0 3 0.9190467173250914 4.307952059535516 17103.0 19.487802536009408 0.0 - - - - - - - 738.375 34 8 IL21R interleukin 21 receptor 1917 246 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537883.[MT7]-LISVDSR.2y6_1.heavy 467.278 / 676.362 27939.0 27.010000228881836 43 13 10 10 10 1.8613723738740244 42.03278088773882 0.0 3 0.9190467173250914 4.307952059535516 27939.0 42.16361855727797 0.0 - - - - - - - 695.7272727272727 55 11 IL21R interleukin 21 receptor 1919 246 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537883.[MT7]-LISVDSR.2b5_1.heavy 467.278 / 672.405 57265.0 27.010000228881836 43 13 10 10 10 1.8613723738740244 42.03278088773882 0.0 3 0.9190467173250914 4.307952059535516 57265.0 68.50166735259387 0.0 - - - - - - - 667.7142857142857 114 7 IL21R interleukin 21 receptor 1921 247 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57753.[MT7]-LTVGVYESAK[MT7].2y5_1.heavy 677.895 / 741.39 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1923 247 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57753.[MT7]-LTVGVYESAK[MT7].2y9_1.heavy 677.895 / 1097.6 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1925 247 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57753.[MT7]-LTVGVYESAK[MT7].2b4_1.heavy 677.895 / 515.331 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1927 247 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57753.[MT7]-LTVGVYESAK[MT7].2y7_1.heavy 677.895 / 897.48 N/A N/A - - - - - - - - - 0.0 - - - - - - - GADD45B growth arrest and DNA-damage-inducible, beta 1929 248 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57658.[MT7]-EILIPVFK[MT7].2b3_1.heavy 623.904 / 500.32 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1931 248 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57658.[MT7]-EILIPVFK[MT7].2y4_1.heavy 623.904 / 634.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1933 248 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57658.[MT7]-EILIPVFK[MT7].2b4_1.heavy 623.904 / 613.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1935 248 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57658.[MT7]-EILIPVFK[MT7].2y3_1.heavy 623.904 / 537.352 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 1937 249 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538744.[MT7]-LQYELQYR.2y4_1.heavy 628.841 / 579.325 2928.0 31.072099685668945 48 18 10 10 10 4.597989558022935 21.748635732656705 0.0 3 0.9875409007939565 11.045035204256472 2928.0 12.736663058215182 0.0 - - - - - - - 347.0833333333333 5 12 IL21R interleukin 21 receptor 1939 249 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538744.[MT7]-LQYELQYR.2b4_1.heavy 628.841 / 678.358 3378.0 31.072099685668945 48 18 10 10 10 4.597989558022935 21.748635732656705 0.0 3 0.9875409007939565 11.045035204256472 3378.0 20.117866666666668 0.0 - - - - - - - 247.8 6 10 IL21R interleukin 21 receptor 1941 249 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538744.[MT7]-LQYELQYR.2y6_1.heavy 628.841 / 871.431 6419.0 31.072099685668945 48 18 10 10 10 4.597989558022935 21.748635732656705 0.0 3 0.9875409007939565 11.045035204256472 6419.0 39.7978 0.0 - - - - - - - 194.63636363636363 12 11 IL21R interleukin 21 receptor 1943 249 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538744.[MT7]-LQYELQYR.2y7_1.heavy 628.841 / 999.489 8333.0 31.072099685668945 48 18 10 10 10 4.597989558022935 21.748635732656705 0.0 3 0.9875409007939565 11.045035204256472 8333.0 61.65272881022615 0.0 - - - - - - - 180.4 16 10 IL21R interleukin 21 receptor 1945 250 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57652.[MT7]-LVVVGAGGVGK[MT7].2y8_1.heavy 622.402 / 788.475 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1947 250 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57652.[MT7]-LVVVGAGGVGK[MT7].2y5_1.heavy 622.402 / 561.348 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1949 250 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57652.[MT7]-LVVVGAGGVGK[MT7].2y9_1.heavy 622.402 / 887.543 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1951 250 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57652.[MT7]-LVVVGAGGVGK[MT7].2y7_1.heavy 622.402 / 689.406 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;KRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 1953 251 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57650.[MT7]-SSYPIFIK[MT7].3y3_1.heavy 414.916 / 551.367 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 1955 251 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57650.[MT7]-SSYPIFIK[MT7].3b4_1.heavy 414.916 / 579.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 1957 251 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57650.[MT7]-SSYPIFIK[MT7].3b5_1.heavy 414.916 / 692.374 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 1959 251 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57650.[MT7]-SSYPIFIK[MT7].3b3_1.heavy 414.916 / 482.237 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 1961 252 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537476.[MT7]-AYGPK[MT7].2b3_1.heavy 412.249 / 436.231 2408.0 16.742799758911133 44 14 10 10 10 2.5160008252153254 29.912671001164348 0.0 3 0.9411960449395644 5.0641620293947245 2408.0 8.034706918586577 0.0 - - - - - - - 202.82608695652175 4 23 PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1963 252 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537476.[MT7]-AYGPK[MT7].2y4_1.heavy 412.249 / 608.352 10566.0 16.742799758911133 44 14 10 10 10 2.5160008252153254 29.912671001164348 0.0 3 0.9411960449395644 5.0641620293947245 10566.0 62.92060810321834 0.0 - - - - - - - 229.16666666666666 21 18 PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1965 252 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537476.[MT7]-AYGPK[MT7].2b4_1.heavy 412.249 / 533.284 344.0 16.742799758911133 44 14 10 10 10 2.5160008252153254 29.912671001164348 0.0 3 0.9411960449395644 5.0641620293947245 344.0 0.7593495934959351 24.0 - - - - - - - 215.1904761904762 5 21 PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1967 252 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537476.[MT7]-AYGPK[MT7].2y3_1.heavy 412.249 / 445.289 7322.0 16.742799758911133 44 14 10 10 10 2.5160008252153254 29.912671001164348 0.0 3 0.9411960449395644 5.0641620293947245 7322.0 24.093136743615307 0.0 - - - - - - - 346.7647058823529 14 17 PAK1;PAK2;PAK3 p21 protein (Cdc42/Rac)-activated kinase 1;p21 protein (Cdc42/Rac)-activated kinase 2;p21 protein (Cdc42/Rac)-activated kinase 3 1969 253 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57387.[MT7]-YMIMK[MT7].2y4_1.heavy 487.276 / 666.38 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1971 253 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57387.[MT7]-YMIMK[MT7].2y3_1.heavy 487.276 / 535.339 N/A N/A - - - - - - - - - 0.0 - - - - - - - POLR1D polymerase (RNA) I polypeptide D, 16kDa 1973 254 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539647.[MT7]-TALEMVQAAGTDR.3y6_1.heavy 502.928 / 590.289 85181.0 32.550201416015625 47 17 10 10 10 3.600519140432447 27.77377264212775 0.0 3 0.9718581488495505 7.339428695306336 85181.0 101.95550033169286 0.0 - - - - - - - 735.7142857142857 170 7 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1975 254 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539647.[MT7]-TALEMVQAAGTDR.3b4_1.heavy 502.928 / 559.321 120104.0 32.550201416015625 47 17 10 10 10 3.600519140432447 27.77377264212775 0.0 3 0.9718581488495505 7.339428695306336 120104.0 129.17241431726546 0.0 - - - - - - - 336.0 240 2 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1977 254 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539647.[MT7]-TALEMVQAAGTDR.3b5_1.heavy 502.928 / 690.361 90666.0 32.550201416015625 47 17 10 10 10 3.600519140432447 27.77377264212775 0.0 3 0.9718581488495505 7.339428695306336 90666.0 154.93097288920688 0.0 - - - - - - - 687.7142857142857 181 7 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1979 254 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539647.[MT7]-TALEMVQAAGTDR.3y5_1.heavy 502.928 / 519.252 66712.0 32.550201416015625 47 17 10 10 10 3.600519140432447 27.77377264212775 0.0 3 0.9718581488495505 7.339428695306336 66712.0 152.0582095397623 0.0 - - - - - - - 655.8571428571429 133 7 POLR1D polymerase (RNA) I polypeptide D, 16kDa 1981 255 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57503.[MT7]-YIFMVK[MT7].2b3_1.heavy 544.824 / 568.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1983 255 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57503.[MT7]-YIFMVK[MT7].2y4_1.heavy 544.824 / 668.392 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1985 255 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57503.[MT7]-YIFMVK[MT7].2y5_1.heavy 544.824 / 781.476 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1987 255 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57503.[MT7]-YIFMVK[MT7].2y3_1.heavy 544.824 / 521.324 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 1989 256 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538336.[MT7]-DIC[CAM]EGYVR.2y5_1.heavy 578.283 / 623.315 3182.0 24.469999313354492 50 20 10 10 10 5.669891808261661 17.637020843023656 0.0 3 0.992529295110301 14.26956829301934 3182.0 18.572977732555863 0.0 - - - - - - - 163.05555555555554 6 18 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1991 256 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538336.[MT7]-DIC[CAM]EGYVR.2y6_1.heavy 578.283 / 783.345 7575.0 24.469999313354492 50 20 10 10 10 5.669891808261661 17.637020843023656 0.0 3 0.992529295110301 14.26956829301934 7575.0 51.375 0.0 - - - - - - - 151.7058823529412 15 17 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1993 256 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538336.[MT7]-DIC[CAM]EGYVR.2b5_1.heavy 578.283 / 719.315 3889.0 24.469999313354492 50 20 10 10 10 5.669891808261661 17.637020843023656 0.0 3 0.992529295110301 14.26956829301934 3889.0 34.29876326190971 0.0 - - - - - - - 167.86363636363637 7 22 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1995 256 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538336.[MT7]-DIC[CAM]EGYVR.2y7_1.heavy 578.283 / 896.43 8686.0 24.469999313354492 50 20 10 10 10 5.669891808261661 17.637020843023656 0.0 3 0.992529295110301 14.26956829301934 8686.0 79.73561151079136 0.0 - - - - - - - 118.16666666666667 17 12 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 1997 257 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57791.[MT7]-NRGDPWAVSPR.3y7_1.heavy 466.917 / 812.441 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 1999 257 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57791.[MT7]-NRGDPWAVSPR.3y6_1.heavy 466.917 / 715.389 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2001 257 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57791.[MT7]-NRGDPWAVSPR.3b4_1.heavy 466.917 / 587.302 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2003 257 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57791.[MT7]-NRGDPWAVSPR.3y5_1.heavy 466.917 / 529.309 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2005 258 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58745.[MT7]-QGVEDAFYTLVR.2y9_1.heavy 771.408 / 1113.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 2007 258 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58745.[MT7]-QGVEDAFYTLVR.2b7_1.heavy 771.408 / 891.433 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 2009 258 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58745.[MT7]-QGVEDAFYTLVR.2b5_1.heavy 771.408 / 673.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 2011 258 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58745.[MT7]-QGVEDAFYTLVR.2y7_1.heavy 771.408 / 869.488 N/A N/A - - - - - - - - - 0.0 - - - - - - - HRAS;NRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog;neuroblastoma RAS viral (v-ras) oncogene homolog 2013 259 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538339.[MT7]-GQFETYLR.2y4_1.heavy 579.307 / 552.314 10183.0 31.028200149536133 48 18 10 10 10 3.834836353272315 20.876478122832793 0.0 3 0.9886096280310854 11.552615561691193 10183.0 14.181803652968036 0.0 - - - - - - - 383.25 20 8 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 2015 259 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538339.[MT7]-GQFETYLR.2b4_1.heavy 579.307 / 606.3 9416.0 31.028200149536133 48 18 10 10 10 3.834836353272315 20.876478122832793 0.0 3 0.9886096280310854 11.552615561691193 9416.0 32.189981718464345 0.0 - - - - - - - 248.54545454545453 18 11 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 2017 259 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538339.[MT7]-GQFETYLR.2y6_1.heavy 579.307 / 828.425 13029.0 31.028200149536133 48 18 10 10 10 3.834836353272315 20.876478122832793 0.0 3 0.9886096280310854 11.552615561691193 13029.0 29.29086533370556 0.0 - - - - - - - 168.8181818181818 26 11 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 2019 259 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538339.[MT7]-GQFETYLR.2b5_1.heavy 579.307 / 707.348 8540.0 31.028200149536133 48 18 10 10 10 3.834836353272315 20.876478122832793 0.0 3 0.9886096280310854 11.552615561691193 8540.0 19.17597911227154 0.0 - - - - - - - 643.0 17 8 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 2021 260 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538874.[MT7]-RC[CAM]LNPESK[MT7].3y3_1.heavy 431.239 / 507.289 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 2023 260 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538874.[MT7]-RC[CAM]LNPESK[MT7].3b4_1.heavy 431.239 / 688.368 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 2025 260 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538874.[MT7]-RC[CAM]LNPESK[MT7].3b3_1.heavy 431.239 / 574.325 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 2027 260 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB538874.[MT7]-RC[CAM]LNPESK[MT7].3y4_1.heavy 431.239 / 604.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - CXCL10 chemokine (C-X-C motif) ligand 10 2029 261 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57646.[MT7]-FFSEYEK[MT7].2y4_1.heavy 619.321 / 712.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2031 261 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57646.[MT7]-FFSEYEK[MT7].2y5_1.heavy 619.321 / 799.395 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2033 261 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57646.[MT7]-FFSEYEK[MT7].2y3_1.heavy 619.321 / 583.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2035 261 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57646.[MT7]-FFSEYEK[MT7].2y6_1.heavy 619.321 / 946.464 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2037 262 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58080.[MT7]-TIAIIAEGIPEALTRK[MT7].3y7_1.heavy 662.073 / 958.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 2039 262 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58080.[MT7]-TIAIIAEGIPEALTRK[MT7].3b4_1.heavy 662.073 / 543.362 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 2041 262 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58080.[MT7]-TIAIIAEGIPEALTRK[MT7].3b5_1.heavy 662.073 / 656.446 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 2043 262 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58080.[MT7]-TIAIIAEGIPEALTRK[MT7].3y5_1.heavy 662.073 / 732.485 N/A N/A - - - - - - - - - 0.0 - - - - - - - ACLY ATP citrate lyase 2045 263 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58134.[MT7]-LK[MT7]PPLADGEDWAGGLPWGGR.3y8_1.heavy 794.093 / 799.421 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2047 263 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58134.[MT7]-LK[MT7]PPLADGEDWAGGLPWGGR.3y5_1.heavy 794.093 / 572.294 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2049 263 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58134.[MT7]-LK[MT7]PPLADGEDWAGGLPWGGR.3b7_2.heavy 794.093 / 512.326 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2051 263 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58134.[MT7]-LK[MT7]PPLADGEDWAGGLPWGGR.3y9_1.heavy 794.093 / 870.458 N/A N/A - - - - - - - - - 0.0 - - - - - - - IL21R interleukin 21 receptor 2053 264 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB60013.[MT7]-HPALPSNRPQQQVLVLAEPR.4y5_1.heavy 599.343 / 585.336 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2055 264 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB60013.[MT7]-HPALPSNRPQQQVLVLAEPR.4b11_2.heavy 599.343 / 685.874 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2057 264 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB60013.[MT7]-HPALPSNRPQQQVLVLAEPR.4b4_1.heavy 599.343 / 563.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2059 264 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB60013.[MT7]-HPALPSNRPQQQVLVLAEPR.4y6_1.heavy 599.343 / 684.404 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2061 265 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59807.[MT7]-SDNVLLGMEGSVK[MT7].3b4_1.heavy 546.299 / 560.28 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2063 265 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59807.[MT7]-SDNVLLGMEGSVK[MT7].3b5_1.heavy 546.299 / 673.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2065 265 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59807.[MT7]-SDNVLLGMEGSVK[MT7].3y4_1.heavy 546.299 / 534.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2067 265 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59807.[MT7]-SDNVLLGMEGSVK[MT7].3y5_1.heavy 546.299 / 663.379 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2069 266 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537898.[MT7]-ASVSGPNSPSETR.3y6_1.heavy 478.243 / 676.326 5888.0 17.047300338745117 50 20 10 10 10 7.649735104034208 13.072348080035272 0.0 3 0.9908286434043027 12.876952624655459 5888.0 11.874809161064357 0.0 - - - - - - - 189.75 11 16 MID1 midline 1 (Opitz/BBB syndrome) 2071 266 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537898.[MT7]-ASVSGPNSPSETR.3b5_1.heavy 478.243 / 546.3 22318.0 17.047300338745117 50 20 10 10 10 7.649735104034208 13.072348080035272 0.0 3 0.9908286434043027 12.876952624655459 22318.0 23.34966774787697 0.0 - - - - - - - 880.7272727272727 44 11 MID1 midline 1 (Opitz/BBB syndrome) 2073 266 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537898.[MT7]-ASVSGPNSPSETR.3y4_1.heavy 478.243 / 492.241 12821.0 17.047300338745117 50 20 10 10 10 7.649735104034208 13.072348080035272 0.0 3 0.9908286434043027 12.876952624655459 12821.0 37.73498564076317 0.0 - - - - - - - 700.375 25 8 MID1 midline 1 (Opitz/BBB syndrome) 2075 266 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537898.[MT7]-ASVSGPNSPSETR.3y5_1.heavy 478.243 / 589.294 31198.0 17.047300338745117 50 20 10 10 10 7.649735104034208 13.072348080035272 0.0 3 0.9908286434043027 12.876952624655459 31198.0 41.38725324347094 0.0 - - - - - - - 752.8571428571429 62 7 MID1 midline 1 (Opitz/BBB syndrome) 2077 267 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537899.[MT7]-STTLFSR.2y4_1.heavy 478.27 / 522.304 4233.0 27.223424911499023 41 20 10 3 8 16.539963883399345 6.045962415937735 0.05419921875 4 0.9919112179632497 13.712846841971997 4233.0 1.3625313283208023 2.0 - - - - - - - 1183.2 13 10 ACLY ATP citrate lyase 2079 267 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537899.[MT7]-STTLFSR.2y5_1.heavy 478.27 / 623.351 4029.0 27.223424911499023 41 20 10 3 8 16.539963883399345 6.045962415937735 0.05419921875 4 0.9919112179632497 13.712846841971997 4029.0 5.120370370370371 2.0 - - - - - - - 1236.75 8 8 ACLY ATP citrate lyase 2081 267 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537899.[MT7]-STTLFSR.2b4_1.heavy 478.27 / 547.321 5661.0 27.223424911499023 41 20 10 3 8 16.539963883399345 6.045962415937735 0.05419921875 4 0.9919112179632497 13.712846841971997 5661.0 11.244155844155845 1.0 - - - - - - - 1262.25 11 8 ACLY ATP citrate lyase 2083 267 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537899.[MT7]-STTLFSR.2y6_1.heavy 478.27 / 724.399 15351.0 27.223424911499023 41 20 10 3 8 16.539963883399345 6.045962415937735 0.05419921875 4 0.9919112179632497 13.712846841971997 15351.0 49.2135 0.0 - - - - - - - 745.875 30 8 ACLY ATP citrate lyase 2085 268 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57902.[MT7]-TNVINEILSTER.2y8_1.heavy 766.924 / 961.495 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2087 268 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57902.[MT7]-TNVINEILSTER.2y9_1.heavy 766.924 / 1074.58 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2089 268 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57902.[MT7]-TNVINEILSTER.2b6_1.heavy 766.924 / 815.438 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2091 268 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57902.[MT7]-TNVINEILSTER.2y6_1.heavy 766.924 / 718.409 N/A N/A - - - - - - - - - 0.0 - - - - - - - ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2093 269 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59808.[MT7]-EQEELNDAVGFSR.2b3_1.heavy 819.398 / 531.253 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2095 269 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59808.[MT7]-EQEELNDAVGFSR.2y9_1.heavy 819.398 / 978.5 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2097 269 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59808.[MT7]-EQEELNDAVGFSR.2y6_1.heavy 819.398 / 636.346 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2099 269 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59808.[MT7]-EQEELNDAVGFSR.2y10_1.heavy 819.398 / 1107.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2101 270 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539323.[MT7]-IISIFSGTEK[MT7].3y3_1.heavy 461.609 / 521.305 41425.0 38.47100067138672 50 20 10 10 10 10.96821953593166 9.117250039753678 0.0 3 0.9946098907711041 16.802283922731466 41425.0 135.87880423860594 0.0 - - - - - - - 317.8 82 10 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2103 270 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539323.[MT7]-IISIFSGTEK[MT7].3b4_1.heavy 461.609 / 571.394 64274.0 38.47100067138672 50 20 10 10 10 10.96821953593166 9.117250039753678 0.0 3 0.9946098907711041 16.802283922731466 64274.0 63.470061247235996 0.0 - - - - - - - 298.0 128 4 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2105 270 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539323.[MT7]-IISIFSGTEK[MT7].3y4_1.heavy 461.609 / 578.327 72519.0 38.47100067138672 50 20 10 10 10 10.96821953593166 9.117250039753678 0.0 3 0.9946098907711041 16.802283922731466 72519.0 183.84071191171722 0.0 - - - - - - - 253.88888888888889 145 9 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2107 270 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539323.[MT7]-IISIFSGTEK[MT7].3y5_1.heavy 461.609 / 665.359 77089.0 38.47100067138672 50 20 10 10 10 10.96821953593166 9.117250039753678 0.0 3 0.9946098907711041 16.802283922731466 77089.0 145.11740909420115 0.0 - - - - - - - 340.57142857142856 154 7 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2109 271 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58944.[MT7]-IC[CAM]K[MT7]YPLQLAELLK[MT7].3b4_1.heavy 674.411 / 853.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 2111 271 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58944.[MT7]-IC[CAM]K[MT7]YPLQLAELLK[MT7].3y4_1.heavy 674.411 / 646.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 2113 271 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58944.[MT7]-IC[CAM]K[MT7]YPLQLAELLK[MT7].3y5_1.heavy 674.411 / 717.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 2115 271 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58944.[MT7]-IC[CAM]K[MT7]YPLQLAELLK[MT7].3b7_2.heavy 674.411 / 596.344 N/A N/A - - - - - - - - - 0.0 - - - - - - - SPATA13;ARHGEF9;ARHGEF4 spermatogenesis associated 13;Cdc42 guanine nucleotide exchange factor (GEF) 9;Rho guanine nucleotide exchange factor (GEF) 4 2117 272 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537893.[MT7]-QIIGTK[MT7].2b3_1.heavy 474.31 / 499.336 5263.0 21.670650482177734 42 15 10 7 10 2.5572859810167357 30.89834586827053 0.026699066162109375 3 0.9553108285808712 5.816081007347661 5263.0 7.543219779617345 1.0 - - - - - - - 758.4444444444445 10 9 MID1 midline 1 (Opitz/BBB syndrome) 2119 272 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537893.[MT7]-QIIGTK[MT7].2y4_1.heavy 474.31 / 562.368 14021.0 21.670650482177734 42 15 10 7 10 2.5572859810167357 30.89834586827053 0.026699066162109375 3 0.9553108285808712 5.816081007347661 14021.0 64.26291666666667 0.0 - - - - - - - 611.1428571428571 28 7 MID1 midline 1 (Opitz/BBB syndrome) 2121 272 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537893.[MT7]-QIIGTK[MT7].2y5_1.heavy 474.31 / 675.452 14844.0 21.670650482177734 42 15 10 7 10 2.5572859810167357 30.89834586827053 0.026699066162109375 3 0.9553108285808712 5.816081007347661 14844.0 66.98646995708154 0.0 - - - - - - - 669.7142857142857 29 7 MID1 midline 1 (Opitz/BBB syndrome) 2123 272 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537893.[MT7]-QIIGTK[MT7].2b5_1.heavy 474.31 / 657.405 1398.0 21.670650482177734 42 15 10 7 10 2.5572859810167357 30.89834586827053 0.026699066162109375 3 0.9553108285808712 5.816081007347661 1398.0 -0.19999999999999996 6.0 - - - - - - - 328.96 7 25 MID1 midline 1 (Opitz/BBB syndrome) 2125 273 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537482.[MT7]-LFLMR.2b3_1.heavy 412.253 / 518.346 6429.0 37.36410140991211 42 16 10 10 6 2.979563668638086 33.561961119531475 0.0 5 0.9643352353733423 6.515434966054615 6429.0 82.97040996677741 2.0 - - - - - - - 259.5 16 12 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2127 273 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537482.[MT7]-LFLMR.2y4_1.heavy 412.253 / 566.312 10246.0 37.36410140991211 42 16 10 10 6 2.979563668638086 33.561961119531475 0.0 5 0.9643352353733423 6.515434966054615 10246.0 63.99495016611295 0.0 - - - - - - - 182.45454545454547 20 11 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2129 273 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537482.[MT7]-LFLMR.2y3_2.heavy 412.253 / 210.125 N/A 37.36410140991211 42 16 10 10 6 2.979563668638086 33.561961119531475 0.0 5 0.9643352353733423 6.515434966054615 201.0 0.2019999999999999 21.0 - - - - - - - 210.6 7 10 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2131 273 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB537482.[MT7]-LFLMR.2y3_1.heavy 412.253 / 419.243 2913.0 37.36410140991211 42 16 10 10 6 2.979563668638086 33.561961119531475 0.0 5 0.9643352353733423 6.515434966054615 2913.0 15.941791044776119 3.0 - - - - - - - 615.25 18 8 PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2133 274 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539937.[MT7]-TIITSPESLNLPR.3y7_1.heavy 528.974 / 828.457 52985.0 35.015499114990234 48 18 10 10 10 7.995906739514201 12.506398993602518 0.0 3 0.9830202074289118 9.457573788031992 52985.0 36.88829113924051 0.0 - - - - - - - 268.3333333333333 105 3 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2135 274 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539937.[MT7]-TIITSPESLNLPR.3y6_1.heavy 528.974 / 699.415 168306.0 35.015499114990234 48 18 10 10 10 7.995906739514201 12.506398993602518 0.0 3 0.9830202074289118 9.457573788031992 168306.0 37.64382823148334 0.0 - - - - - - - 251.5 336 2 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2137 274 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539937.[MT7]-TIITSPESLNLPR.3y4_1.heavy 528.974 / 499.299 163279.0 35.015499114990234 48 18 10 10 10 7.995906739514201 12.506398993602518 0.0 3 0.9830202074289118 9.457573788031992 163279.0 56.41108816045228 0.0 - - - - - - - 754.25 326 4 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2139 274 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539937.[MT7]-TIITSPESLNLPR.3y5_1.heavy 528.974 / 612.383 58716.0 35.015499114990234 48 18 10 10 10 7.995906739514201 12.506398993602518 0.0 3 0.9830202074289118 9.457573788031992 58716.0 57.030615559175914 0.0 - - - - - - - 251.5 117 2 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2141 275 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59518.[MT7]-VSHDNLTVER.2y4_1.heavy 657.35 / 504.278 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 2143 275 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59518.[MT7]-VSHDNLTVER.2y9_1.heavy 657.35 / 1070.52 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 2145 275 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59518.[MT7]-VSHDNLTVER.2y6_1.heavy 657.35 / 731.405 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 2147 275 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB59518.[MT7]-VSHDNLTVER.2y7_1.heavy 657.35 / 846.432 N/A N/A - - - - - - - - - 0.0 - - - - - - - MID1 midline 1 (Opitz/BBB syndrome) 2149 276 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57635.[MT7]-TIVSIGDPK[MT7].2b3_1.heavy 609.371 / 458.31 1261.0 33.7958984375 29 -1 10 10 10 0.22499819442239288 170.85061721604092 0.0 3 0.28910616451701715 1.3662032913457445 1261.0 2.78009331541126 2.0 - - - - - - - 315.0 2 12 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2151 276 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57635.[MT7]-TIVSIGDPK[MT7].2b4_1.heavy 609.371 / 545.341 1997.0 33.7958984375 29 -1 10 10 10 0.22499819442239288 170.85061721604092 0.0 3 0.28910616451701715 1.3662032913457445 1997.0 2.7975352504933477 1.0 - - - - - - - 328.125 3 8 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2153 276 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57635.[MT7]-TIVSIGDPK[MT7].2y6_1.heavy 609.371 / 760.432 11245.0 33.7958984375 29 -1 10 10 10 0.22499819442239288 170.85061721604092 0.0 3 0.28910616451701715 1.3662032913457445 11245.0 23.78164524133169 0.0 - - - - - - - 256.6666666666667 22 9 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2155 276 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57635.[MT7]-TIVSIGDPK[MT7].2b7_1.heavy 609.371 / 830.474 420.0 33.7958984375 29 -1 10 10 10 0.22499819442239288 170.85061721604092 0.0 3 0.28910616451701715 1.3662032913457445 420.0 1.4666666666666666 17.0 - - - - - - - 0.0 1 0 PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2157 277 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58126.[MT7]-LLGELLLDRHNFTIMTK[MT7].4y4_1.heavy 576.335 / 636.387 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2159 277 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58126.[MT7]-LLGELLLDRHNFTIMTK[MT7].4b4_1.heavy 576.335 / 557.341 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2161 277 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58126.[MT7]-LLGELLLDRHNFTIMTK[MT7].4b5_1.heavy 576.335 / 670.426 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2163 277 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB58126.[MT7]-LLGELLLDRHNFTIMTK[MT7].4y3_1.heavy 576.335 / 523.303 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2165 278 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57773.[MT7]-IISIFSGTEK[MT7].2y4_1.heavy 691.91 / 578.327 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2167 278 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57773.[MT7]-IISIFSGTEK[MT7].2y8_1.heavy 691.91 / 1012.54 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2169 278 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57773.[MT7]-IISIFSGTEK[MT7].2y5_1.heavy 691.91 / 665.359 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2171 278 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57773.[MT7]-IISIFSGTEK[MT7].2y6_1.heavy 691.91 / 812.427 N/A N/A - - - - - - - - - 0.0 - - - - - - - PAK2 p21 protein (Cdc42/Rac)-activated kinase 2 2173 279 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57770.[MT7]-EVDGVWVYNR.2y9_1.heavy 690.855 / 1107.56 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 2175 279 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57770.[MT7]-EVDGVWVYNR.2b4_1.heavy 690.855 / 545.269 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 2177 279 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57770.[MT7]-EVDGVWVYNR.2b5_1.heavy 690.855 / 644.337 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 2179 279 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57770.[MT7]-EVDGVWVYNR.2y7_1.heavy 690.855 / 893.463 N/A N/A - - - - - - - - - 0.0 - - - - - - - SMAD7 SMAD family member 7 2181 280 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539836.[MT7]-RADMFSEEQLR.3y7_1.heavy 509.257 / 908.447 3776.0 27.704099655151367 45 18 10 7 10 4.796562835351035 20.84826227293268 0.028501510620117188 3 0.9802575145027502 8.768884530331999 3776.0 40.821621621621624 0.0 - - - - - - - 135.34782608695653 7 23 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2183 280 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539836.[MT7]-RADMFSEEQLR.3y8_1.heavy 509.257 / 1039.49 N/A 27.704099655151367 45 18 10 7 10 4.796562835351035 20.84826227293268 0.028501510620117188 3 0.9802575145027502 8.768884530331999 167.0 3.5541232303732304 0.0 - - - - - - - 0.0 0 0 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2185 280 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539836.[MT7]-RADMFSEEQLR.3b4_1.heavy 509.257 / 618.315 16269.0 27.704099655151367 45 18 10 7 10 4.796562835351035 20.84826227293268 0.028501510620117188 3 0.9802575145027502 8.768884530331999 16269.0 29.034589276724283 0.0 - - - - - - - 777.3157894736842 32 19 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2187 280 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB539836.[MT7]-RADMFSEEQLR.3y4_1.heavy 509.257 / 545.304 26986.0 27.704099655151367 45 18 10 7 10 4.796562835351035 20.84826227293268 0.028501510620117188 3 0.9802575145027502 8.768884530331999 26986.0 29.647170133013525 0.0 - - - - - - - 765.2857142857143 53 14 ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 2189 281 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57381.[MT7]-NLVAMK[MT7].2y4_1.heavy 482.299 / 592.361 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2191 281 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57381.[MT7]-NLVAMK[MT7].2y5_1.heavy 482.299 / 705.445 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2193 281 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57381.[MT7]-NLVAMK[MT7].2b4_1.heavy 482.299 / 542.342 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2195 281 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57381.[MT7]-NLVAMK[MT7].2y3_1.heavy 482.299 / 493.293 N/A N/A - - - - - - - - - 0.0 - - - - - - - CAB39 calcium binding protein 39 2197 282 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57634.[MT7]-ETPFNPPK[MT7].2y4_1.heavy 609.342 / 599.363 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2199 282 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57634.[MT7]-ETPFNPPK[MT7].2b4_1.heavy 609.342 / 619.321 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2201 282 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57634.[MT7]-ETPFNPPK[MT7].2y6_1.heavy 609.342 / 843.484 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease) 2203 282 B20140228_KEGG1700_set09_03 B20140228_KEGG1700_set09_03 TB57634.[MT7]-ETPFNPPK[MT7].2b5_1.heavy 609.342 / 733.364 N/A N/A - - - - - - - - - 0.0 - - - - - - - PARN poly(A)-specific ribonuclease (deadenylation nuclease)